#news for #investors and #media: The Committee for Medicinal Products for Human Use (CHMP) has recommended a new variation for one of our vaccines.
Read more: gsk.to/48WRV81
GSK plc
GSK plc (an abbreviation of its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. More on Wikipedia
-
GSK
@GSK
-
GSK
@GSK
#news for #investors and #media: We’re proud to rank 2nd overall in the Access to Medicines Index, reflecting our ongoing commitment to ensuring vital medicines and vaccines reach people who need them: gsk.to/4zF8ph2
#atmindex10 -
GSK
@GSK
#news for #investors and #media: At #tlm26 we’re unveiling our latest advancements across our hepatology pipeline for chronic hepatitis B (CHB), metabolic dysfunction-associated steatohepatitis (MASH), and alcohol-related liver disease (ALD).
🔗 Find out more: -
GSK
@GSK
#investors: Join GSK’s CEO, Luke Miels, and other members of our leadership team for our Q3 2026 results webcast at 12:00 GMT, 08:00 EDT. $GSK
-
GSK
@GSK
News for #investors and #media
Watch our CEO, Luke Miels, as he delivers news of our strong Q3 performance and continued momentum ⤵️
Find out more: gsk.to/4zggYib
#gskresults #earnings
GSK
@GSK
#investors and #media: Please read our cautionary statement regarding forward-looking statements and the definitions and reconciliations for non-IFRS measures in our Q3 2026 results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates. gsk.to/3U65izg $GSK
-
GSK
@GSK
We’re announcing our Q3 2026 results tomorrow at 07:00 GMT, 03:00 EDT. $GSK
-
GSK
@GSK
#news for #investors and #media:
Today, our licensor Hansoh Pharma presented new Phase 3 data in osteosarcoma, building on ongoing research efforts for patients with difficult-to-treat solid tumours. #esmo2026
Learn more: gsk.to/3TZ5Yq9 -
GSK
@GSK
#news for #investors and #media: Today, we presented data from one of our immunotherapies used to treat people living with colorectal cancer.
Read more: gsk.to/3VTGgUy
#esmo2026 -
GSK
@GSK
#news for #investors and #media: Today, we presented longer-term late-breaking data, marking encouraging progress for people living with ovarian cancer. #esmo2026
Learn more: gsk.to/3Uh1bAd -
GSK
@GSK
#news for #investors & #media: Today marks an important milestone in chronic hepatitis B (CHB), with the U.S. FDA approving a new therapy for people living with the disease.
This approval reflects years of research and a continued commitment to advancing innovation in liver disease, where significant unmet need remains.
Learn more: gsk.to/4Bisj2s -
GSK
@GSK
#news for #investors and #media: The US Food and Drug Administration (FDA) has approved a new indication for one of our immunotherapies. Read more: gsk.to/4iwAy2D
-
GSK
@GSK
#news for #investors and #media: Today, we shared the first data for our investigational treatment for extensive-stage small-cell lung cancer in a global population.
Learn more: gsk.to/4z38aw4
#esmo2026 -
GSK
@GSK
#news for #investors and #media: At ESMO 2026, we're showcasing over 20 abstracts from our oncology portfolio and pipeline, underscoring our expansion into solid tumours like lung, gynaecological, gastrointestinal, and GIST.
Read more:gsk.to/4dCmnr6
#esmo2026 -
GSK
@GSK
Dementia is one of the greatest health challenges facing society today. We're proud to support The BARBARA Alliance in a major new partnership, announced today by UK Government, bringing together academia, charities and industry to help accelerate research.
Read more here: -
GSK
@GSK
#news for #investors and #media:
Today our specialist HIV company, @ViiVHC, announced phase III study results in #hiv evaluating a long-acting option versus daily oral therapy.
Our mission: to leave no person living with HIV behind.
👉 Find out more: gsk.to/3VpWIM1 -
GSK
@GSK
#news for #investors and #media: We have entered a licence agreement with Chimagen Biosciences for an investigational T-cell engager for multiple myeloma, advancing our leadership ambitions in blood cancer.
Find out more: www.gsk.com/en-gb/media/press-releases/gsk-to-acquire-pot… -
GSK
@GSK
#news for #investors and #media: Today, we announced new positive data at #wclc26 representing encouraging news for people living with ROS1-positive non-small cell lung cancer.
Learn more: gsk.to/4xolucI -
GSK
@GSK
#news for #investors and #media: Today, our licensor Hansoh Pharma presented positive data at #wclc26 from a pivotal trial of an investigational antibody-drug conjugate in our pipeline.
Learn more: gsk.to/4xRUa7t -
GSK
@GSK
#news for #investors and #media: Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a new prefilled syringe presentation of one of our vaccines.
Learn more: gsk.to/4xSAW1Q -
GSK
@GSK
The data we’ve shared at #erscongress underscores how much more we can achieve for respiratory patients when science and partnership come together.
Building on our proven track record of innovation, we’re accelerating our R&D programmes in COPD to target multiple inflammatory pathways, aiming for ambitious trial outcomes that look beyond the disease impact on the lungs so that we can transform outcomes for a broad range of patients, with varying severities of disease.
#erscongress -
GSK
@GSK
#media #investors Climate change is one of the greatest threats to human health, and its impact on patients with respiratory health conditions should not be underestimated. Through advances in sustainable respiratory care, we’re making progress towards our environmental goals.
Read the media statement gsk.to/4iFXSfO -
GSK
@GSK
#news for #investors and #media: Today we announced Phase II data for a seasonal flu vaccine candidate at #optionsxiii.
Learn more: gsk.to/3Sqbt0e -
GSK
@GSK
#news for #investors & #media: Japan has become the first country to approve a new therapy for people living with chronic hepatitis B (CHB), marking an important milestone in liver disease innovation.
CHB remains a leading cause of liver cancer worldwide. This approval reflects continued commitment to progress in liver disease research.
Learn more: gsk.to/4wNSLxB -
GSK
@GSK
#news for #investors and #media: Today, we announced the US FDA accepted the application for one of our immuno-oncology therapies for priority review.
Learn more: gsk.to/4zAczXU -
GSK
@GSK
#news for #investors and #media: At #aids2026 we’re presenting new clinical and real-world insights from across our long-acting portfolio and pipeline for #hiv treatment and prevention, through our specialist HIV company, @ViiVHC.
Find out more: gsk.to/44YUip5 -
GSK
@GSK
Yesterday we announced we will be establishing a new flagship R&D centre on the Cambridge Biomedical Campus.
This will feature state-of-the-art, tech-enabled labs and infrastructure, providing GSK scientists with access to a world-class ecosystem of biomedical research, patient care and academia as part of a £400 million investment in UK life sciences.
Learn more gsk.to/4hE7vuR -
GSK
@GSK
#investors: Join our webcast (14:00 BST, 09:00 EST) to hear our CEO Luke Miels and other members of our senior leadership team including R&D experts talk about our Q2 2026 results and plans to accelerate growth. $GSK
-
GSK
@GSK
Today, we’re announcing a £400 million investment in UK life sciences, including plans to establish a new flagship R&D centre in Cambridge. The new site on the city’s Biomedical Campus, one of the world’s leading life sciences ecosystems, will be a catalyst to fuel collaboration and accelerate GSK R&D.
-
GSK
@GSK
News for #investors and #media
Watch our CEO Luke Miels as he shares our strong Q2 core performance, continued momentum and plans to accelerate our R&D, including a new flagship R&D centre in Cambridge.
Find out more: gsk.to/4pG56BQ
#q2results $GSK
GSK
@GSK
Please read the ‘Guidance and outlooks, assumptions and cautionary statements’ on pages 52-53 of the Q2 press release. Certain non-IFRS measures are defined on pages 50-51 of the Q2 press release.
-
GSK
@GSK
#news for #investors and #media: Today our licensor Hansoh Pharma announced another positive pivotal dataset on an investigational antibody-drug conjugate in our oncology pipeline.
Learn more: gsk.to/3RV5Si5 -
GSK
@GSK
#news for #investors and #media: We are announcing new data from the first randomised head-to-head study comparing daily oral 2-drug regimen vs 3-drug regimen in treatment-naïve adults at #aids2026.
🔗 Find out more in the press release: gsk.to/44QBFUg
Through our specialist HIV company, @ViiVHC, our goal is to empower individuals and communities, driving towards a future where HIV is no longer a global health threat. -
GSK
@GSK
#news for #investors and #media: Today we announced that the US Food and Drug Administration (FDA) granted approval for one of our therapies to treat ROS1-positive non-small cell lung cancer.
Learn more: gsk.to/4ft4CdU -
GSK
@GSK
#news for #investors and #media: We’ll be at #aids2026 with @ViiVHC, our specialist HIV company, presenting research and insights from our innovative portfolio and integrase strand transfer inhibitor (INSTI)-powered pipeline.
Find out more in the press release: gsk.to/4fdROcs
Our mission: to leave no person living with HIV behind. -
GSK
@GSK
News for #media and #investors: EMA has accepted our submission to update the label of one of our vaccines.
Learn more: gsk.to/4wS2jbl -
GSK
@GSK
#news for #investors and #media: Today marks another step forward for a GSK-developed vaccine candidate. This significant step reinforces our commitment to partnerships that help improve global public health.
Learn more: gsk.to/4vymcTG -
GSK
@GSK
#news for #investors and #media:
Today we announced the completion of our acquisition of clinical-stage precision oncology company Nuvalent, Inc., bringing in multiple lung cancer assets to our existing oncology portfolio.
Find out more: gsk.to/4wIsLE2 -
GSK
@GSK
#news for #media and #investors: Today we announced interim positive headline results from our phase II trial evaluating one of our immuno-oncology therapies.
Learn more: gsk.to/4vZVG6L -
GSK
@GSK
#news for #investors and #media: Today, our licensor Hansoh Pharma announced data on an investigational antibody-drug conjugate in our oncology pipeline for cancers with high unmet needs.
Learn more: gsk.to/44X0o9i -
GSK
@GSK
#news for #media and #investors: The FDA has approved our oral anti-infective for complicated urinary tract infections (cUTIs).
With three million cUTIs treated annually in the US, this approval reflects our commitment to innovation in anti-infectives.
Learn more: -
GSK
@GSK
#news for #investors and #media: Today, we announced that the US FDA and the EMA have granted regulatory designations for one of our therapies for the treatment of VEXAS syndrome.
Learn more: gsk.to/4vJGgCT -
GSK
@GSK
#news for #investors and #media:
Following today’s agreement to acquire Nuvalent, Inc., our CEO Luke Miels shares why this acquisition is strategically important to our oncology business as we continue to strengthen our pipeline and commitment to patients.
Read more from Luke in our press release: gsk.to/4gaudKr -
GSK
@GSK
#news for #investors and #media:
We have entered an agreement to acquire clinical-stage precision oncology company Nuvalent, Inc., bringing in multiple lung cancer assets to our existing oncology portfolio.
Find out more: gsk.to/4ooHOjy -
GSK
@GSK
#news for #investors & #media: Today at #easlcongress, we’re presenting results from a phase III trial in chronic hepatitis B, a disease affecting approximately 240 million people globally.
Thank you to everyone involved who made this research possible.
🔗 Learn more: gsk.to/3Q8X47g -
GSK
@GSK
#news for #investors and #media: We're excited to be at #asco26 and #eha2026, where we will share data on how we're delivering a meaningful impact for cancer patients today while innovating for tomorrow.
Learn more: gsk.to/4wPL9f1 -
GSK
@GSK
#news for #investors and #media: Today, we are announcing that one of our vaccines has been approved for an expanded population by the Japanese Ministry of Health, Labour and Welfare (MHLW).
Learn more: gsk.to/3PKzP3i -
GSK
@GSK
At #ats2026, we're sharing findings from 33 research projects across our portfolio of inhaled therapies and biologics – reflecting our ambitious treatment goals, moving beyond symptom control to transform outcomes for people living with chronic respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD).
Our innovation is driving new treatment approaches including long-acting therapies, which aim to redefine care and alleviate the significant burden on patients and health systems worldwide.
We believe advancing research is one of the most meaningful investments we can make for a healthier future. -
GSK
@GSK
#news for #investors and #media: At #ats2026, we’ll be presenting data across 33 abstracts to highlight our research as we work to redefine respiratory care.
gsk.to/42ejQxd -
GSK
@GSK
News for #investors and #media
Explore the key highlights from our Q1 2026 results announcement ⤵️
Find out more: gsk.to/4uelV7Y $GSK -
GSK
@GSK
#investors: Join GSK’s CEO Luke Miels and other members of our leadership team for our Q1 2026 results webcast at 12:00 BST, 07:00 EST. $GSK
-
GSK
@GSK
News for #investors and #media
Watch our CEO Luke Miels as he shares our strong Q1 performance and start to 2026.
Find out more: gsk.to/3OA31JU
$GSK #q1results
GSK
@GSK
#investors and #media: Cautionary statement regarding forward-looking statements & the definitions & reconciliations for non-IFRS measures in our results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates. gsk.to/4tGAJg4
-
GSK
@GSK
We’re announcing our Q1 2026 results tomorrow at 07:00 BST, 02:00 EST. $GSK
-
GSK
@GSK
#news for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B has been accepted for regulatory review by the US FDA.
It has also received Breakthrough Therapy designation.
🔗 Learn more: gsk.to/4tG7JoC -
GSK
@GSK
#news for #investors and #media: Today we announced that our investigational liver therapy received US FDA Breakthrough Therapy and EMA Priority Medicine (PRIME) regulatory designations for metabolic dysfunction-associated steatohepatitis (MASH).
Find out more: -
GSK
@GSK
#news for #investors and #media
China’s National Medical Products Administration (NMPA) has approved our therapy to treat an incurable and challenging blood cancer.
For more information, visit: gsk.to/3QbmAsq -
GSK
@GSK
#news for #investors and #media: Today we announced the completion of our acquisition of 35Pharma Inc., adding to our Respiratory, Immunology & Inflammation pipeline.
Find out more: gsk.to/4cslO1G -
GSK
@GSK
#news for #investors and #media: Today at #sgo2026, we’re presenting new data on an investigational antibody-drug conjugate from our oncology pipeline.
Learn more: gsk.to/4c4OqPv -
GSK
@GSK
#news for #media and #investors:
China's National Medical Products Administration (NMPA) has approved our new therapy for people living with chronic rhinosinusitis with nasal polyps (CRSwNP).
For more information, visit: www.gsk.com/en-gb/ -
GSK
@GSK
The UK-US deal on pharmaceuticals is now finalised, an important step for UK life sciences.
Read our short statement ⤵️ -
GSK
@GSK
#news for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B has been accepted for regulatory review in China.
Learn more: gsk.to/4rXFC2t -
GSK
@GSK
#news for #media and #investors: China’s National Medical Products Administration (NMPA) has approved our new therapy for the treatment of severe asthma.
For more information, visit: gsk.to/485LKP5 -
GSK
@GSK
#news for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B has been accepted for regulatory review by the EMA.
Learn more: gsk.to/3O6PSaN -
GSK
@GSK
#news for #investors and #media: Today, we announced that the Ministry of Health, Labour and Welfare in Japan has granted Orphan Drug Designation (ODD) to an investigational antibody-drug conjugate in our oncology pipeline.
Learn more: gsk.to/4186fqJ -
GSK
@GSK
#news for #investors and #media: Today, we are announcing that one of our liver medicines has been approved by the US Food and Drug Administration (FDA).
Find out more: gsk.to/4sTSzv0 -
GSK
@GSK
#news for #investors and #media: Today, we are announcing that one of our vaccines has been approved for an expanded population by the US Food and Drug Administration (FDA).
Learn more: gsk.to/47Kyn6H -
GSK
@GSK
We‘ve topped the Access to Medicine Index's 2026 Antimicrobial Resistance Benchmark, reflecting our continuous focus on delivering innovative antibiotic medicines and vaccines for patients with significant unmet medical need.
Check out our #amr podcast: gsk.to/4rYwjQD -
GSK
@GSK
Our latest Annual Report and Responsible Business Report show our progress in creating value for patients and shareholders.
Take a look at the highlights ⤵️
🔗 Investors and media can read more: gsk.to/4ubX9pQ
GSK
@GSK
#investors and #media
Please read our cautionary statement regarding forward-looking statements and the definitions and reconciliations for non-IFRS measures in our 2025 Annual Report. CER% represents constant exchange rates. AER% represents actual exchange rates. $GSK
For investors: www.gsk.com/en-gb/investors/cautionary-statement/ -
GSK
@GSK
#news for #investors and #media: Today we announced the completion of our acquisition of RAPT Therapeutics, adding to our growing Respiratory, Immunology & Inflammation (RI&I) pipeline.
Find out more: gsk.to/4b3MN2O -
GSK
@GSK
#news for #investors and #media: Today we are announcing that our potential first-in-class treatment for chronic hepatitis B has been accepted for regulatory review in Japan.
Learn more: gsk.to/3MGEOk5 -
GSK
@GSK
News for #investors and #media:
Today at #croi2026, our specialist HIV company @ViiVHC, presented new insights on our investigational long-acting therapies.
🔗 Find out more on our website: gsk.to/4rDvSew -
GSK
@GSK
#news for #investors and #media: We’ve announced an agreement to acquire 35Pharma.
Find out more: gsk.to/4kS3iUd -
GSK
@GSK
News for #investors and #media:
New data published in the New England Journal of Medicine compare efficacy of different forms of HIV treatment for people with adherence challenges.
🔗 Find out more on our website: gsk.to/3Oyvcs2 -
GSK
@GSK
#news for #investors and #media: Today we are presenting new data about one of our vaccines.
Learn more: gsk.to/4c0bUWj -
GSK
@GSK
#news for #investors and #media: The European Commission has approved our new therapy to treat two respiratory diseases.
Learn more here: gsk.to/4qEAcsE -
GSK
@GSK
#news for #investors and #media: Today, we are announcing that one of our vaccines has been accepted for review by the China National Medical Products Administration.
Learn more: gsk.to/4qw7IkO -
GSK
@GSK
#news for #investors and #media: We have announced that the European Commission has approved a new therapy for use in adults with chronic obstructive pulmonary disease (COPD).
Learn more here: gsk.to/46mm140 -
GSK
@GSK
Explore the key highlights from our Q4 and full year 2025 results announcement ⤵️
More information for media and investors: gsk.to/4a2WXQw $GSK -
GSK
@GSK
#investors: Join GSK’s CEO Luke Miels and other members of our leadership team for our full year and fourth quarter 2025 results webcast at 11:00 GMT, 06:00 EST. $GSK
-
GSK
@GSK
Watch our CEO Luke Miels as he shares our strong 2025 performance and reaffirms our long-term outlooks.
More insights and information for media and investors: gsk.to/4ti5YOs $GSK #fyresults
GSK
@GSK
#investors and #media: Cautionary statement regarding forward-looking statements & the definitions & reconciliations for non-IFRS measures for our results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates. gsk.to/4tmvbaS
-
GSK
@GSK
We’re announcing our full-year and fourth quarter 2025 results tomorrow at 07:00 GMT, 02:00 EST. $GSK
-
GSK
@GSK
We’re strengthening our efforts to eliminate neglected tropical diseases (NTDs) through our new three-year project with @TheENDFund, who are ideally placed to deliver this project to help towards our shared goals of controlling and eliminating NTDs.
#worldntdday #uniteacteliminate -
GSK
@GSK
#news for #investors and #media: Today, we are announcing that one of our vaccines has been approved for an expanded indication by the European Commission (EC).
Learn more: gsk.to/45yZ1yy -
GSK
@GSK
#news for #investors and #media: We have announced that China’s health authority has approved one of our therapies for use in adults with asthma.
Learn more here: gsk.to/4bN33XO -
GSK
@GSK
#news for #investors and #media: We’ve announced an agreement to acquire RAPT Therapeutics.
Find out more: gsk.to/3NuAT9Z -
GSK
@GSK
We're leaving #jpm2026 inspired and confident in our R&D momentum & future pipeline impact.
Our approach, built on cutting-edge innovation and industry-leading partnerships, is driving us to get ahead of disease together.
#aheadtogether -
GSK
@GSK
Yesterday at #jpm2026: our CSO Tony Wood joined Endpoint News to share how our focused R&D approach – driven by science, advanced tech, and strategic partnerships – is accelerating pipeline momentum and our ambition to transform health.
🔗 Learn more: gsk.to/4sIV3gM -
GSK
@GSK
We're at the @jpmorgan Healthcare Conference this week, sharing how our R&D momentum, pipeline progress and strategic investments are driving innovation for patients.
🔗 gsk.to/3YAgR0e
#jpm2026 #jpm26 -
GSK
@GSK
Great to see @TheEconomist highlight the #ai revolution in drugmaking, featuring GSK!
We're using AI, including agentic AI, to deepen our understanding of biology, amplifying R&D for faster, more precise medicines.
The Economist
@TheEconomist
Designing a new drug generally starts by screening small organic molecules for promising biological activity and selecting the likeliest
AI can sift through libraries of tens of billions of these www.economist.com/science-and-technology/2026/01/05/an-ai… -
GSK
@GSK
#news for #investors and #media: The European Commission (EC) has approved a new prefilled syringe presentation of one of our vaccines.
👉 Learn more: gsk.to/4aK1SYR -
GSK
@GSK
#news for #investors and #media: We’ve just announced data from our pivotal phase III clinical programmes for chronic hepatitis B (CHB).
We remain committed to addressing the global burden of CHB.
Learn more: gsk.to/4aNQtqY -
GSK
@GSK
#news for #investors and #media:
A new therapy for two respiratory diseases has received approval from Japan’s health authority.
Learn more here: gsk.to/3N8aEGf -
GSK
@GSK
#news for #investors and #media:
We have announced that China’s health authority has approved one of our therapies for use in adults with a respiratory disease.
Learn more here: gsk.to/4sndkQi -
GSK
@GSK
#news for #media and #investors
A new therapy for a respiratory disease has received approval today from the US Food and Drug Administration (FDA).
For more information, visit: gsk.to/3XVuN4z -
GSK
@GSK
#news for #media and #investors:
Today, we are announcing that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new therapy to treat two respiratory diseases.
For more information, visit: www.gsk.com/en-gb/ -
GSK
@GSK
Human diseases have puzzled researchers for centuries.
Through a new collaboration with Cambridge Stem Cell Institute’s Teichmann Laboratory, we’re aiming to demystify them and get ahead of disease together.
Read more on how this partnership impacts drug discovery and testing: gsk.to/4awbx5h -
GSK
@GSK
#news for #investors and #media:
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of two potential biologic treatments across three respiratory conditions today.
Read more: gsk.to/4qpw1Bp -
GSK
@GSK
#news for #investors and #media: The European Medicines Agency’s CHMP have issued a positive opinion on the expansion to a younger population for one of our vaccines.
Access our website here: gsk.to/3Ym4ODk -
GSK
@GSK
#news for #media and #investors: Today, we are announcing that one of our oral anti-infectives has been approved by the FDA.
Learn more: www.gsk.com -
GSK
@GSK
#news for #investors and #media: Today we announced that the Food and Drug Administration (FDA) has granted Orphan Drug Designation to an investigational antibody-drug conjugate in our oncology pipeline.
Learn more here: gsk.to/4oEGszr -
GSK
@GSK
Outsmarting cancer demands focus.
That’s why we’re channelling our science and technology where it can make the biggest difference for people living with cancer.
Find us at #ash25 this weekend.
🔗 gsk.to/4rujL3A -
GSK
@GSK
Cancer remains one of the world’s leading causes of death – yet people living with difficult-to-treat blood cancers still face limited treatment options.
By combining targeted science and innovative tech, we’re working to change that.
Learn more: gsk.to/43Z592f #ash25 -
GSK
@GSK
Big news for U.S. innovation!
We've officially opened our new Vaccine & Infectious Disease R&D HQ in Boston's Cambridge Park Drive. This expanded space is central to our 5-year investment in the U.S., driving faster, better innovation for patients globally. -
GSK
@GSK
What does "early" intervention truly mean for lupus patients? Dr. Roger A. Levy explores how providers and patients often have different interpretations and how we can bridge this gap to optimise treatment.
Follow the discussion: gsk.to/4oxIoK6 -
GSK
@GSK
Our response to today's UK-US pharmaceuticals deal:
-
GSK
@GSK
#news for #investors and #media: We are pleased to present new data from our #bloodcancer pipeline and portfolio at #ash25.
Learn more: gsk.to/3Kpb6im -
GSK
@GSK
Since 2000, we have partnered with the @WHO on the Global Programme to Eliminate Lymphatic Filariasis. 25 years on, we remain committed to helping prevent lymphatic filariasis in endemic countries: gsk.to/4orse54
-
GSK
@GSK
#news for #investors and #media: We’ve announced a collaboration with LTZ Therapeutics to advance up to four oncology therapies targeting haematologic cancers and solid tumours. gsk.to/3LKN3L7
-
GSK
@GSK
#news for #investors and #media: At #tlm25 we’ll share new data from our advancing hepatology pipeline - with 21 abstracts covering CHB, MASH, ALD and PBC.
We remain committed to addressing the global burden of liver disease.
Learn more: gsk.to/3JLzg6l -
GSK
@GSK
Take a look at the highlights from our Q3 2025 performance 👇
More information for media and investors: gsk.to/3JzxOnq
$GSK #q3results #earnings -
GSK
@GSK
#investors: Join our CEO Emma Walmsley and other members of our leadership team for our Q3 2025 results webcast at 12:00 GMT, 08:00 EDT.
$GSK #q3results -
GSK
@GSK
Today we announce our Q3 2025 results, with another quarter of strong performance and upgraded guidance for 2025.
Hear more from our CEO Emma Walmsley ⤵️
More information for media and investors: gsk.to/4ns8cXo
$GSK #q3resultsThis media couldn't be displayed. See it on the original post.
GSK
@GSK
#investors and #media: Cautionary statement regarding forward-looking statements & the definitions & reconciliations for non-IFRS measures in our Q3 2025 results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates. gsk.to/4nqVdW4
-
GSK
@GSK
We’re announcing our Q3 2025 results tomorrow at 0700 GMT, 0300 EDT. $GSK
-
GSK
@GSK
#news for #investors and #media: Today we announced an agreement with Empirico to add to our pipeline in COPD and potentially other inflammatory respiratory diseases.
Find out more: gsk.to/49kXgrd -
GSK
@GSK
#news for #investors and #media: Today we announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to an investigational antibody-drug conjugate in our oncology pipeline.
Learn more here: gsk.to/4njZlXL -
GSK
@GSK
#news for #investors and #media: Today we announced an agreement with Syndivia to add to our growing oncology pipeline in prostate cancer.
Find out more: gsk.to/49sNsvg -
GSK
@GSK
7 years strong! GSK has again been named a @ScienceMagazine Top Employer, driven by our purpose to unite science, tech & talent to get ahead of disease, together.
Find out more here: gsk.to/47jG6HR
#aheadtogether #gskproud #sctopemployersThis media couldn't be displayed. See it on the original post. -
GSK
@GSK
Our Chief Digital & Technology Officer, Shobie Ramakrishnan, spoke at #bloombergtech this week about how an integrated use of tech across everything we do is helping us get ahead of disease. Here, Shobie shares why it's so critical to drive innovation - bringing science, tech and talent together to innovate in R&D 👇
Bloomberg Live
@BloombergLive
"It takes over 10-12 years to bring a really big medicine to market - being able to change - by engineering biology - [will have] a massive impact on patients."
@GSK's Shobie Ramakrishnan explores the intersection between tech and medicine at #bloombergtech.This media couldn't be displayed. See it on the original post. -
GSK
@GSK
#news for #investors and #media
The US Food and Drug Administration (FDA) has approved our therapy to treat an incurable and challenging blood cancer.
For more information, visit: www.gsk.com -
GSK
@GSK
At GSK, we're driven by the hope of a future where people don't just survive cancer but thrive long after.
🔗 Read more about this potential future and how we're working to get there: gsk.to/4nZ2EVz -
GSK
@GSK
#news for #investors and #media: We’ve just announced data from our pivotal phase III clinical programme for a metered dose inhaler (MDI).
Learn more: gsk.to/4hit4Pq -
GSK
@GSK
#news for #investors and #media: @GlobalFund welcomes renewed commitment from GSK and @ViiVHC to expand community-led health solutions with £6 million joint pledge ahead of 8th replenishment: gsk.to/42OTyCh
-
GSK
@GSK
#news for #investors and #media: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion for a new prefilled syringe presentation of one of our vaccines.
Learn more: gsk.to/47hYtgy -
GSK
@GSK
#news for #media and #investors: Today, with @Spero_Tx, we are sharing an update on the Phase III trial results of one of our investigational oral anti-infectives, presented during #idweek2025 in Atlanta.
Learn more: gsk.to/47o7pB1 -
GSK
@GSK
“It’s hard to explain the pain of a UTI to people who’ve never had one.”
🔗 Read LeAnn’s story and why she thinks personalised care is so important: gsk.to/3KWFctl
#idweek2025 -
GSK
@GSK
Modern medicine has revolutionised the way we live, but the challenges to our health are evolving. We need to shift our health systems from reactive to proactive care.
Find out why preventing disease is the best investment not just for people, but for the world’s health systems, societies and economies 👇
#idweek2025 gsk.to/49aqskH -
GSK
@GSK
#news for #investors and #media: Data presented at #eacs2025 by our specialist HIV company - @ViiVHC - offer a deeper understanding of therapy options and could help individuals and their healthcare providers make more fully informed choices about their HIV care.
Find out more: gsk.to/3W6Eexa -
GSK
@GSK
Inspiring to see our CEO Emma Walmsley alongside so many trailblazing women at today’s #fortunempw summit. From discoveries in cancer treatments to leveraging AI, Emma shared her vision for the future of healthcare and reflected on the significant transformation she has led as a change agent for GSK over the past nine years.
-
GSK
@GSK
#news for #investors and #media: The China National Medical Products Administration has approved a new indication for one of our vaccines.
Learn more: gsk.to/4n5b9NB -
GSK
@GSK
Invasive meningococcal disease (IMD) is uncommon but can strike fast with serious consequences. Together with the wider community, this #worldmeningitisday we’re raising awareness of IMD and highlighting the need for continued action to #defeatmeningitis.
🔗 Learn more here: -
GSK reposted
Meningitis Research Foundation
@M_R_F
🌍 Today is World Meningitis Day.
Get involved:
🗣️ Share your story
💡 Help light the road ahead
📢 Spread life-saving awareness with our free ready-to-use resources.
Together, we can defeat meningitis.
👉 worldmeningitisday.org
#defeatmeningitis #worldmeningitisday -
GSK reposted
Meningitis Research Foundation
@M_R_F
Meningitis is more than just a rash.
Would you be able to spot the symptoms? It could save a life.
👉 www.worldmeningitisday.org
#defeatmeningitis #worldmeningitisday -
GSK
@GSK
#erscongress 2025 has closed, but every day we apply our expertise and take on the complex challenges in respiratory health to help more people breathe with ease. Our aim, to improve the lives of half a billion people around the world living with chronic respiratory disease.
-
GSK
@GSK
As #erscongress 2025 comes to a close, Katharina Wolff, VP, Global Medical Affairs, Specialty Care, reflects on why our data line-up is testament to our focus on targeting the underlying drivers of respiratory disease to improve patients’ future health and long-term outcomes.
-
GSK
@GSK
Kaivan Khavandi, SVP and Global Head Respiratory, Immunology and Inflammation R&D at GSK, explains why getting ahead of COPD exacerbations is so important and why different patients need personalised treatment approaches. gsk.to/4mD2qSF
-
GSK
@GSK
Luke Miels has been appointed CEO Designate. He assumes full responsibility as CEO on 1 Jan. Luke joined GSK in 2017 and is currently CCO. He succeeds Dame Emma Walmsley, who delivered a step-change in GSK’s performance, portfolio & pipeline.
-
GSK
@GSK
Rav Seeruthun and Barbara Cygler share their excitement about #erscongress 2025 and what they feel are the key data from more than 60 abstracts including research from our portfolio of inhaled therapies, biologics, vaccines and pipeline assets.
-
GSK
@GSK
We are preparing to share our latest research at #erscongress2025 starting this weekend and we want to hear from you - what aspect of respiratory disease are you interested in knowing more about? 👇
-
GSK
@GSK
As we prepare for #erscongress 2025, watch this thought-provoking conversation between GSK’s CEO, Emma Walmsley, Tonya Winders, CEO of the Global Allergy and Airways Patient Platform, and Jean Wright, CEO of the COPD foundation gsk.to/3VBGWdO
-
GSK
@GSK
On #worldlungday, as we aim to get ahead of respiratory disease, we are supporting FIRS Lungs First and the global respiratory community to raise awareness of the importance of vaccinations in protecting the future health of our lungs.
Read more here gsk.to/4mC9jnb -
GSK
@GSK
On #worldlungday and as we prepare to share our latest research at #erscongress, GSK’s Chief Scientific Officer, Tony Wood explains why getting ahead of respiratory disease demands a preventative approach and breathtaking innovation.
-
GSK
@GSK
We are investing $30 billion in R&D and manufacturing in the US over the next 5 years. The new facilities will bridge R&D & manufacturing across the US and UK, strengthening the two countries’ leadership in life sciences.
-
GSK
@GSK
#news for #investors and #media: At #erscongress 2025 we’ll be sharing our latest research across more than 60 abstracts including 3 late breakers.
We’re redefining respiratory care for millions of people living with respiratory diseases.
Learn more: gsk.to/465oCQh -
GSK
@GSK
Our Chairman, Sir Jonathan Symonds, was part of a UK business delegation joining the new Business and Trade Secretary, Peter Kyle, in China for the first trade talks in 7 years. At GSK, we're committed to global collaboration to drive innovation and growth.
Dept. for Business, Innovation, Science and Trade
@biztradegovuk
NEWS: UK-China holding first trade talks in 7 years
We’re securing economic growth for British businesses and working people by engaging with the world’s biggest economies.
Find out more www.gov.uk/government/news/uk-to-hold-first-trade-talks-w… -
GSK
@GSK
Healthy ageing is not just about living longer, it’s about living well for longer. We are currently at #escmidvaccines 2025 congress sharing the latest data on how our vaccines can help individuals and societies do just this. Hear from experts about why this is important
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
Huge congratulations to last night’s #wellchildaward winners. Your courageous stories inspired us all!
WellChild
@WellChild
What an incredible evening we’ve had. Our winners met WellChild Patron Prince Harry, Duke of Sussex, chatted with each other and mingled with the stars. They’ve collected their awards and had an unforgettable night. As always a huge thank you to headline sponsor @gsk, our incredible host @GabyRoslin and everyone who helped make this evening so special.
-
GSK
@GSK
GSK's Katie Ewer takes us on a journey inside the lab to explore the innovative research behind the second generation of malaria vaccine: gsk.to/47WuPiI
-
GSK
@GSK
🔍 AI is changing the way we understand disease.
Not just by helping us analyse data at speed — but identify how diseases progress and which patients respond best to treatments.
Read our article to find out more: gsk.to/3JeEvLa -
GSK
@GSK
Imagine a future where cancer is managed like any other long-term condition, allowing people to live fuller lives.
At GSK, we’re working to turn that vision into a reality.
🔗 Read more about this potential future and how we're working to get there: gsk.to/45ezx9R -
GSK
@GSK
🦠 “I was resistant to nine antibiotics,” says AMR survivor, Vanessa Carter.
“I had to learn how to walk again. It took me years to recover.”
The human impact of antimicrobial resistance is real – but it is preventable.
🔗 Read our article to find out how we’re fighting back: gsk.to/4mFccUE
#amr -
GSK
@GSK
The global population is ageing, and with it, the burden of infectious disease is set to grow.
Innovative health policies are needed to help strengthen economies, bolster health services, and ensure people are able to live healthy lives.
🔗Read more: gsk.to/45hube5 -
GSK
@GSK
It’s a time of life when many may feel invincible, but adolescents are at risk of invasive meningococcal disease (IMD), a bacterial infection that can be life-threatening.
Read our article to hear from IMD survivor Kate – and mother Michelle, who lost her son Ryan within 24 hours: gsk.to/4mfBuJi -
GSK
@GSK
#news for #investors and #media: Today we announced that one of our investigational oral anti-infectives has been accepted for priority review by US FDA.
Learn more: gsk.to/3Hotczx -
Post not available here, view on X
GSK
@GSK
Hello Divyaanshu. Calcium Citrate Malate Tablets is now made by Haleon, not GSK. You can get in touch with them via their channel @Haleon_health or their website, www.haleon.com/contact-us/. Sorry we couldn't be of help this time.
GSK
@GSK
Hi again, we’re following up to apologise for the inaccurate response you previously received. To clarify, this product is made by GSK in India. Please can you contact our GSK India team so we can assist you further – you can find their details here: india-pharma.gsk.com/en-in/contact-us/. We’re sorry for any confusion this may have caused. Thank you for your understanding.
-
GSK
@GSK
Take a look at the highlights from our strong Q2 2025 performance 👇
More information for media and investors: gsk.to/3UDdbZo. $GSK -
GSK
@GSK
#investors: Join our CEO Emma Walmsley and other members of our leadership team for our Q2 2025 results webcast at 12:00 BST, 07:00 EDT. $GSK
-
GSK
@GSK
Our CEO Emma Walmsley announces another quarter of excellent performance. Strong results in Q2 2025 were driven by double-digit growth in Specialty Medicines.
More information for media and investors: gsk.to/40IlmqT $GSK #q2results
GSK
@GSK
#investors and #media: Cautionary statement regarding forward-looking statements & the definitions & reconciliations for non-IFRS measures for our results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates. gsk.to/40FRBqJ
-
GSK
@GSK
We’re announcing our Q2 2025 results tomorrow at 0700 BST, 0200 EDT. $GSK
-
GSK
@GSK
#news for #investors and #media:
Today we are sharing new findings on Dementia and Alzheimer’s Disease at #aaic2025, building on our leadership in immunology and inflammation.
🔗 Find out more: gsk.to/41bPfzV -
GSK
@GSK
It’s #worldhepatitisday and we are proud to sponsor @Hep_Alliance in raising awareness of chronic hepatitis B (CHB)
World Hepatitis Alliance
@Hep_Alliance
What's it like living with hepatitis? 🤔
Like many others, you may have hepatitis but not know it.
This #worldhepatitisday, let’s break the stigma and debunk the myths around hepatitis.
Get the facts. Get tested for hepatitis. It could save your life.
Download and share our campaign film: www.worldhepatitisday.org/wp-content/uploads/2025/07/WHA-… -
GSK
@GSK
#news for #investors and #media: We’ve announced a collaboration with Hengrui Pharma to develop up to 12 innovative medicines across respiratory, immunology and oncology. Find out more: gsk.to/46AlM6B
-
GSK
@GSK
#news for #investors and #media
The European Commission has granted marketing authorisation for one of our blood cancer therapies. For more information, visit: gsk.to/44ZsQqH -
GSK
@GSK
#news for #investors and #media: The US FDA has approved a new presentation of one of our vaccines.
Learn more: gsk.to/3GQEkVp -
GSK
@GSK
🚀 At GSK, R&D is central to our purpose: to get ahead of disease together. Much of our cutting-edge innovation happens in the UK, where we invested £1.5bn in 2024 alone. That’s why we welcome the UK Government’s new Life Sciences Sector Plan.
🔗 Read the plan here: gsk.to/4nSdSLT -
GSK
@GSK
Many blood cancer patients face lifelong treatment challenges, but thankfully scientists are working hard to give them the quality of life they deserve.
🔗 Find out why patients living with incurable blood cancers need more treatment options in our latest Behind the Science article: gsk.to/3It5NNq -
GSK
@GSK
#news for #investors and #media: @ViiVHC (our specialist HIV company) has expanded its voluntary license with the Medicines Patent Pool to include further innovative treatments alongside prevention to enable increased access and reach those most impacted by #hiv.
🔗 Find out more: gsk.to/46I9Nnf -
GSK
@GSK
#news for #investors and #media: The United States Food and Drug Administration has accepted a regulatory application to expand the population indication for one of our vaccines.
Access our website here. gsk.to/3Ipu9rw -
GSK
@GSK
#news for #investors and #media: at #ias2025, @ViiVHC (our specialist HIV company) is presenting new data that highlight how its industry leading portfolio is continuing to transform HIV innovation for both treatment and prevention.
🔗 Find out more: gsk.to/4eO8nK3 -
GSK
@GSK
#news for #investors and #media: We’ve announced the completion of our agreement to acquire a promising hepatology asset from Boston Pharmaceuticals.
Learn more here: gsk.to/462pu8N -
GSK
@GSK
This week at 'The Global Summit’, world leaders gathered to pledge support for @gavi, the Vaccine Alliance.
Learn about GSK’s commitments, including our partnership that’s led to Bharat Biotech halving the price of the world's first malaria vaccine for children in endemic countries by 2028: www.gavi.org/news/media-room/world-leaders-recommit-immun… -
GSK
@GSK
#news for #investors and #media: Bharat Biotech and GSK announce partnership impact and ambition ahead of Gavi, the Vaccine Alliance’s ‘Global Summit: Health & Prosperity through Immunisation.’ Learn more: gsk.to/40iEpI0
-
GSK
@GSK
#news for #investors and #media: We're pleased to share the EMA has accepted for review the use of one of our investigational assets to treat cholestatic pruritus in patients with primary biliary cholangitis (PBC).
Learn more here gsk.to/3Tzes35 -
GSK
@GSK
#news for #investors and #media: Japan’s Ministry of Health, Labour and Welfare has accepted a regulatory application to expand the population indication for one of our vaccines.
Access our website here www.gsk.com/en-gb/ -
GSK
@GSK
At GSK, we empower our team with data tech, including AI, to enhance skills and integrate innovation into every aspect of our work.
Our focus on the complete patient journey ensures that we use technology to develop and deliver medicines and vaccines more efficiently than ever before, supporting health systems and enhancing patient care.
Discover how we're shaping the future of healthcare through technology: gsk.to/4e7iDgi -
GSK
@GSK
Thanks for having us #londontechweek! We’ve had a blast connecting with the tech community here in London and beyond.
Find out more: gsk.to/45S2UiO
#ltw25 -
GSK
@GSK
#news for #investors and #media: Today we have announced that the European Medicines Agency (EMA) have accepted a regulatory submission to expand the population for one of our vaccines.
Access our website here: gsk.to/3ZtgYLV -
GSK
@GSK
#news for #investors and #media: GSK out-licenses to Bharat Biotech for further vaccine development in diarrhoeal disease. Learn more: gsk.to/45l5AW1
-
GSK
@GSK
We are at #eha2025 in Milan presenting our research in challenging blood cancers, such as multiple myeloma and myelofibrosis.
🔗 Hear from people impacted by blood cancer and find out what scientists are doing to improve patient care: gsk.to/45YHzEmThis media couldn't be displayed. See it on the original post. -
GSK
@GSK
At #londontechweek, we captured some quick takes from our leaders on the buzzing show floor. These leaders share how tech is transforming our work today, and what excites them when they look ahead.
To kick things off, our Chief Digital & Technology Officer, Shobie Ramakrishnan, shares what it takes to build a tech-enabled culture. #ltw25 -
GSK
@GSK
Scientists at GSK are using digital biological twins and organoids – miniature living replicas of tumours grown in a lab – to create personalised solutions for patients with cancer: gsk.to/3SLOQQo
#ltw25 -
GSK
@GSK
Using the power of technology, we're revolutionising the development and delivery of medicines and vaccines to make a real difference to people's health on a global scale.
Through cutting-edge data tech and platform technologies, we delve deeper into patient care, human biology, and disease mechanisms. This allows us to work with unprecedented speed, scale, and precision, empowering our teams to drive innovation like never before.
Discover how we are transforming healthcare for the better, one breakthrough at a time: gsk.to/3FI7QMC -
GSK
@GSK
Heading to #londontechweek? Join our leaders discussing everything from driving growth and transforming the future of healthcare, to exploring the impact of generative AI on drug discovery and the world of digital twins in drug development.
🔗 Can't make it? Learn how we are using tech to reach patients better and faster than ever before: gsk.to/43WXuSl
#ltw25 -
GSK
@GSK
#asco25 may be over for another year but our drive to push the boundaries of innovation by combining science, technology and partnership to get head of cancer never stops.
Hear from our oncology leaders as they reflect on this year’s conference.
🔗 gsk.to/43EoAfy -
GSK
@GSK
At this year’s @ERAkidney congress, we’re focused on preventative measures in managing lupus nephritis to preserve kidney function. Early conversations between patients and doctors can facilitate a treatment plan to help reduce the risks of irreversible organ damage.
-
GSK
@GSK
We're at #asco25, where we caught up with our oncology leaders Hesham and Nina. Curious to know what sets GSK Oncology apart? Let's hear what they had to say 👇
🔗 gsk.to/3HmmolH -
GSK
@GSK
Cancer is unrelenting, but so are we.
We believe that getting ahead of disease is the best investment – for patients, communities, health systems, and economies.
Learn more: gsk.to/4mGaMKk -
GSK
@GSK
News for #investors and #media:
Today, we announced that the FDA has accepted a new drug application for a medicine to treat cholestatic pruritus in patients with primary biliary cholangitis (PBC).
Learn more here: gsk.to/3SsudZn -
GSK
@GSK
We’re at #asco25 - showcasing groundbreaking cancer research at the world's largest oncology gathering.
Hear from our CEO Emma Walmsley & SVP, Global Head Oncology R&D, Hesham Abdullah, as they share how we're tackling complex oncology challenges for patients.
🔗 gsk.to/45GEybE -
GSK
@GSK
Many blood cancer patients face lifelong treatment challenges, but thankfully scientists are working hard to give them the quality of life they deserve.
We're sharing our progress in reshaping the landscape of cancer care at #asco25
🔗 gsk.to/3ZBe2wv -
GSK
@GSK
#news for #investors and #media: We’re pleased to present new data from our oncology portfolio at ASCO25 and EHA25. Read more: gsk.to/4dIm24S
-
GSK
@GSK
At the @WSJ's "The Future of Everything", our CEO Emma Walmsley joined leaders across business, tech, sports, and style to tackle tomorrow's challenges, including the future of drug discovery using cutting-edge tech and the impact of prevention on disease.
#thefutureofeverything -
GSK
@GSK
#news for #media and #investors: Today we are announcing with @Spero_Tx an update on the Phase III trial of one of our investigational oral anti-infectives, following a recommendation by an Independent Data Monitoring Committee.
Learn more: gsk.to/3HfBPMj -
GSK
@GSK
#news for #investors and #media
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending approval of our blood cancer therapy.
For more information: www.gsk.com/en-gb/ -
GSK
@GSK
#news for #investors and #media: Today we announced that one of our biologic treatments has been approved by the US Food and Drug Administration (FDA) as an add-on treatment for people living with COPD. Learn more: www.gsk.com/en-gb/
-
GSK
@GSK
We are leaving #ats2025 inspired to continue our work to redefine respiratory care.
Hear more from GSK’s own Kaivan Khavandi as he shares his key insights and takeaways from ATS.This media couldn't be displayed. See it on the original post. -
GSK
@GSK
We’re in Toronto at the biannual @LupusCongress reinforcing our commitment to the global lupus community and sharing research about the importance of early intervention and disease management.
#lupus2025 -
GSK
@GSK
At #ats2025 we’re sharing our latest research as we continue in our work reduce the impact that exacerbations can have on the future lung health of patients with conditions like #asthma and #copd.
Read more on why it’s important to prevent exacerbations. 👉gsk.to/4k4WNMu -
GSK
@GSK
#news for #investors and #media
The Japan Ministry of Health, Labour and Welfare (MHLW) has approved one of our blood cancer therapies.
Find more information here: gsk.to/3S7wwAV -
GSK
@GSK
We’re at #ats2025 to share our latest research from across 40 abstracts from our respiratory portfolio.
Court Horncastle, SVP, US Specialty Business Unit head, shares his thoughts on why ATS is so important to getting ahead of respiratory disease.
gsk.to/4ksZebr -
GSK
@GSK
In advance of #ats2025 Kaivan Khavandi shares his thoughts on how we are applying our expertise to deliver the next generation standard of care and help millions of patients with respiratory conditions. 👉 gsk.to/3ZjYAEY
-
GSK
@GSK
#news for #investors and #media: Today we announced an agreement with Boston Pharmaceuticals to further strengthen our hepatology pipeline in steatotic liver disease.
www.gsk.com/en-gb/ -
GSK
@GSK
Congratulations to our CEO Emma Walmsley on being named in the 2025 #time100health list, which recognises the most influential leaders in health each year.
See the full list here: gsk.to/4iRvtzG
#time100 -
GSK
@GSK
#news for #investors and #media: New data has been presented at #easl2025 on our research into cholestatic pruritus (relentless itch) associated with primary biliary cholangitis (PBC), a rare autoimmune liver disease.
More information: gsk.to/4572tke -
GSK
@GSK
Years of innovation have expanded the menu of preventative medicines available but science alone isn’t enough to make sure people have access to them.
Here, @ProfHeidiLarson, anthropologist and co-founder of the Global Listening Project, explains why 👇 gsk.to/4m5ohD4 -
GSK
@GSK
The race against malaria is on – find out why, and how, we’re accelerating research to help #changethetrajectory of the disease, here 👇
www.gsk.com/en-gb/behind-the-science-magazine/second-gene… -
GSK
@GSK
“It took 35 years to even get to the point where malaria vaccines are available. And now we’re excited to be researching a second-generation vaccine”.
Katie Ewer, GSK Malaria Vaccine Project Leader explains to The Telegraph that our research aims to work at a different stage of the life cycle of the malaria parasite
www.telegraph.co.uk/global-health/science-and-disease/gsk… -
GSK
@GSK
#news for #investors and #media: At #ats2025, we’ll be presenting data from 40+ abstracts on our work to redefine the future of respiratory care.
Learn more: gsk.to/4cYZHQf -
GSK
@GSK
#news for #investors and #media:
Today we have announced the full results of a phase III trial of one of our biologics in patients with chronic obstructive pulmonary disease (COPD) have been published in the New England Journal of Medicine. Learn more at: gsk.to/3Gz5YpG -
GSK
@GSK
Explore the key highlights from our Q1 2025 performance.
More information for media and investors: gsk.to/42TtzIS. $GSK -
GSK
@GSK
#investors: Join our CEO Emma Walmsley and other members of our leadership team for our Q1 2025 results webcast at 12:00 BST, 07:00 EST. $GSK
-
GSK
@GSK
Our CEO Emma Walmsley announces our strong Q1 2025 performance, demonstrating the quality, strength and resilience of our portfolio.
More information for media and investors: gsk.to/4iE8HLC
$GSK #fyresults
GSK
@GSK
#investors and #media: Read our cautionary statement regarding forward-looking statements: gsk.to/4jWX8R0. Definitions and reconciliations for non-IFRS measures are included in our Q1 2025 results press release: gsk.to/4iE8HLC. CER% represents constant exchange rates. £% or AER% represents actual exchange rates
-
GSK
@GSK
We’re announcing our Q1 2025 results tomorrow at 0700 BST, 0200 EST. $GSK
-
GSK
@GSK
#news for #investors and #media:
Two of our vaccines have received new recommendations from the US Advisory Committee on Immunization Practices (ACIP). These recommendations will be reviewed for official adoption.
Learn more: www.gsk.com/en-gb/ -
GSK
@GSK
#news for #investors and #media
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has licensed one of our blood cancer therapies.
More information for media and investors: www.gsk.com/en-gb/ -
GSK
@GSK
In a recent interview with Bloomberg in London, our CEO, Emma Walmsley, discussed GSK’s progress, including our further improved long-term outlook for more than £40bn sales by 2031 and increased investment in R&D,
-
GSK
@GSK
COPD exacerbations can cause changes to lung tissue which can accumulate over time leading to irreversible lung damage.
We are ambitious for people living with COPD and have developed the COPD Exacerbation Recognition Tool to support them.
Read more: gsk.to/4cn25Qh -
GSK
@GSK
GSK welcomes the ambition and urgency of yesterday’s announcement by the UK Government on health data and clinical trials.
Find out more: gsk.to/44fJGmn -
GSK
@GSK
Advances in technology are transforming cancer treatments – and the lives of patients with cancer. Here, Hesham Abdullah, GSK’s Global Head of Oncology R&D, discusses the leaps forward his team has made, and their ambitions for the future: gsk.to/3YcIyvY
-
GSK
@GSK
We understand the critical need for innovation and effective treatments in #copd.
Learn more about our progress and commitment to help patients breathe easier: gsk.to/4hRmgHh -
GSK
@GSK
As adults over 60 outnumber children under five for the first time in human history, the burden of vaccine-preventable disease among adults is increasing.
Find out why vaccinations are not just for children 👇
gsk.to/3FFTg86 -
GSK
@GSK
#news for #media and #investors: Today we announced that our oral antibiotic for uncomplicated urinary tract infections has been approved by US Food and Drug Administration (FDA).
🔗 Learn more: gsk.to/4l79DLg -
GSK
@GSK
#news for #investors and #media:
We are announcing a major new research collaboration with @UKDRI and @HDR_UK to advance our understanding of neurodegeneration.
🔗 Find out more: gsk.to/4hFnhCc -
GSK
@GSK
#news for #investors and #media: We're pleased to share the EMA has accepted for review the use of one of our biologics for chronic obstructive pulmonary disease (#copd).
Learn more: gsk.to/41Ub5aW -
GSK
@GSK
At #sgo2025, we’re sharing data from our ongoing research and advancing conversations around how we can address barriers to care for people with gynaecologic cancers.
Read more about how we’re delivering on this commitment to patients: gsk.me/4bHNsXs -
GSK
@GSK
While the flu is a moving target that evolves rapidly, RSV does not have the same variability. We’re committed to gaining a deeper understanding of RSV’s behaviour to improve education and prevention.
Learn more 👇
www.gsk.com/en-gb/behind-the-science-magazine/rsv-symptom… -
GSK
@GSK
#news for #investors and #media:
New data has been presented at #croi2025 on the innovative pipeline of our specialist HIV company, @ViiVHC.
🔗 Find out more: gsk.to/3DM3Fyf -
GSK
@GSK
The advent of long-acting options has truly been a game-changer for many people in the HIV community.
In this article, @ViiVHC's Head of R&D Dr Kimberley Smith explains how and why these innovations have made such an impact:
🔗 gsk.to/3QX0oPE -
GSK
@GSK
News for #investors and #media:
@ViiVHC, our specialist HIV company, is presenting more than 70 abstracts at #croi2025, reinforcing our leadership in long-acting innovation and supporting our ambition to end HIV and AIDS for good.
Find out more: gsk.to/4hhqFTt -
GSK
@GSK
#news for #investors and #media.
At @iRSVsociety #rsv2025, we're sharing our latest research with the global scientific community to help advance our understanding and help reduce the burden of RSV infection on our population.
Read more: www.gsk.com/en-gb/ -
GSK
@GSK
We are harnessing the latest science and technology to redefine the future of respiratory medicine.
We’re building on decades of pioneering work to deliver more ambitious treatment goals for hundreds of millions of people with respiratory diseases. -
GSK
@GSK
#news for #investors and #media: Our ultra-long-acting pipeline biologic has been accepted for review by the US FDA for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps (#crswnp).
Learn more: gsk.to/4bqlYFV -
GSK
@GSK
#news for #investors and #media: Our full phase III data in chronic rhinosinusitis with nasal polyps (#crswnp) for our ultra-long-acting pipeline biologic were published in The Lancet today and presented at #aaaai25. Learn more: gsk.to/4kqgMWD
-
GSK
@GSK
Our excellent performance in 2024 demonstrates the transformation of our business. Investors and media can read more about how we’re getting #aheadtogether in our latest Annual Report and Responsible Business Performance Report.
🔗 gsk.to/41x5OHm -
GSK
@GSK
. @IFAgeing and @MWHodin along with ambassadors from around the world join us this #shinglesawarenessweek to share their experience with shingles. #ourshinglesstories
-
GSK
@GSK
We have completed our acquisition of IDRx, Inc. a Boston based, clinical-stage biotech, to accelerate innovation for patients with gastrointestinal stromal tumours.
gsk.to/4bv6vEB -
GSK
@GSK
#news for #investors and #media:
Today we have announced the health authority in China has accepted for review our submission for the use of one of our biologics in chronic obstructive pulmonary disease (#copd).
Learn more here: gsk.to/41otUUL -
GSK
@GSK
The @US_FDA has approved one of our vaccines for an acute bacterial infection.
More information for media and investors: gsk.to/42XHsaP -
GSK
@GSK
Explore the key data from our strong 2024 performance.
More information for media and investors: gsk.to/42Hvr9e $GSK -
GSK
@GSK
#investors: Join GSK’s CEO Emma Walmsley and other members of our leadership team for our full year and fourth quarter 2024 results webcast at 10:45 GMT, 05:45 EST. $GSK
-
GSK
@GSK
Watch our CEO Emma Walmsley as she shares our strong 2024 performance and further improvement to our long-term growth outlook.
More information for media and investors: gsk.to/4aJneDF
$GSK #fyresultsThis media couldn't be displayed. See it on the original post.
GSK
@GSK
#investors and #media: Cautionary statement regarding forward-looking statements & the definitions & reconciliations for non-IFRS measures for our results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates. gsk.to/4hm1AI8
-
GSK
@GSK
We’re announcing our full year and fourth quarter 2024 results tomorrow at 0700 GMT, 0200 EST. $GSK
-
GSK
@GSK
#news for #investors and #media:
Submissions made to Chinese and Japanese health authorities for use of one of our pipeline biologics in two indications: asthma with type 2 inflammation and also CRSwNP.
Learn more here: gsk.to/3PRrwyW -
GSK
@GSK
#news for #investors and #media:
Today we have announced that the EMA has accepted the marketing authorisation application for use of one of our pipeline biologics in two indications: asthma with type 2 inflammation and also CRSwNP. Learn more here: gsk.me/4gmAChX -
GSK
@GSK
We’re announcing a collaboration with @UniofOxford to advance our understanding of how cancer develops, combining our expertise in the science of the immune system with Oxford’s cutting-edge research to explore the potential of cancer prevention.
🔗 gsk.to/4gdWsEj -
GSK
@GSK
#news for #investors and #media: The EMA has accepted our application for a new presentation for one of our vaccines.
Learn more: gsk.to/4jySk4Y -
GSK
@GSK
We’re proud of our CEO, Emma Walmsley, for being named Britain's Most Admired Leader 2024, in this annual survey run by @EchoResearch in partnership with the @LSEGplc.
#britainsmostadmired2024This media couldn't be displayed. See it on the original post. -
GSK
@GSK
#news for #investors and #media: The European Commission has approved an expanded indication of our immuno-oncology therapy. Learn more: gsk.me/3C5oc09
-
GSK
@GSK
As #jpm2025 comes to a close, we head into the year with strong and sustained momentum. We are very confident in our ability to deliver profitable growth through the decade with scale, health impact and attractive returns.
#aheadtogether #jpm25 -
GSK
@GSK
Today at #jpm25: Hesham Abdullah, Senior Vice President, Global Head Oncology, R&D, joins the #fiercejpmweek ‘Future of Oncology’ panel to explore how advanced research and innovative treatments are reimagining patient care.
For #investors and #media: gsk.to/4gSFLzq -
GSK
@GSK
Up next for #investors and #media: Watch Emma Walmsley speaking live at #jpm2025, followed by a Q&A with Tony Wood, Luke Miels and Deborah Waterhouse from our leadership team.
🔗 Watch live: gsk.to/4jaqtaU #jpm25 @ViiVHC -
GSK
@GSK
#news for #investors and #media: Today we announced the proposed acquisition of IDRx, Inc. aligned to our ambition to address the critical needs of patients with gastrointestinal cancers.
gsk.to/40yQJDB #jpm2025 -
GSK
@GSK
We look forward to joining the @jpmorgan Healthcare Conference next week, sharing how the breadth of our portfolio, positive pipeline data and focus on science tech, and culture are helping us deliver sustained profitable growth.
🔗 gsk.to/3PvSOef
#jpm2025 #jpm25 -
GSK
@GSK
#news for #investors and #media: The US FDA has accepted our application for a new presentation for one of our vaccines.
Learn more: gsk.to/40o75Ql -
GSK
@GSK
We’re excited to be recognised once again as top 5 in @Computerworld’s Best Places to Work in IT 2025 among large organisations.
🔗Find out more: gsk.to/4fUN3S2
#aheadtogether #gskproud
Computerworld
@Computerworld
Excited to share Computerworld’s 2025 Best Places to Work in IT! 🎉 Leaders like Adobe, FedEx, and Johns Hopkins Medicine are setting the standard in career growth, DEI, and innovation. Check out the full list! #bestplacestowork #itleadership
www.computerworld.com/article/3568480/computerworld-best-… -
GSK
@GSK
#news for #investors and #media: The FDA has granted Breakthrough Therapy Designation in a second indication for an investigational antibody-drug conjugate in our oncology pipeline. Learn more: gsk.me/41ZGuuh
-
GSK
@GSK
#news for #investors and #media:
Today we have announced that one of our biologics has been approved in China as a treatment option for people with chronic rhinosinusitis with nasal polyps (#crswnp).
Learn more here: www.gsk.com/en-gb/ -
GSK
@GSK
“We can reimagine what's possible for patients and society in new ways.”
Shobie Ramakrishnan, our Chief Data and Technology Officer, explains how data science and advanced tech drive progress and reduce inefficiencies across our business.
Learn more👇 gsk.to/4fnilRi -
GSK
@GSK
How can someone tell if they have a common cold, or a more serious virus like flu, COVID-19 or RSV?
Read our new Behind the Science article to find out more: gsk.to/4giGAS2 -
GSK
@GSK
For #investors: At the Meet the Management event, our leaders will discuss the next wave of R&D at GSK - showing how our deep expertise in immune science, advanced tech and strategic partnerships are paving the way for new and better innovation to deliver growth at scale.
-
GSK
@GSK
#news for #investors and #media: The FDA has granted Breakthrough Therapy Designation to one of our immuno-oncology treatments. Learn more: gsk.to/3VBQxli
-
GSK
@GSK
#news for #investors and #media:
The European Medicines Agency has granted Priority Medicines (PRIME) Designation for an investigational antibody-drug conjugate in our oncology pipeline.
Learn more: gsk.to/3ZwwMwB -
GSK
@GSK
#news for #investors and #media: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending an expanded indication of our immuno-oncology cancer therapy.
Learn more: gsk.to/4ffDnkV -
GSK
@GSK
We’re in the middle of a global outbreak of pertussis, or ‘whooping cough’, with several countries recording higher numbers of cases than they’ve seen in years.
So how did we get here? And how do we protect ourselves in the future?
Read our new article: gsk.to/3ZNedFA -
GSK
@GSK
#news for #investors and #media: Today at #ash24, we are excited to present positive results from our phase III clinical trial evaluating one of our #bloodcancer treatments. Learn more: gsk.to/4g5ip9z
-
GSK
@GSK
#news for #investors and #media: China’s National Medical Products Administration (NMPA) has accepted our application for one of our #bloodcancer therapies in combination with a standard of care. Learn more: gsk.to/3ZpMJVm
-
GSK
@GSK
#news for #investors and #media: Today we have announced the FDA has accepted the submission for one of our biologics in chronic obstructive pulmonary disease (#copd).
Learn more here: gsk.to/3D9FbyA -
GSK
@GSK
Advances in tech and a deeper understanding of cancer biology are shifting the ways the disease is diagnosed and treated.
We’ll be sharing more about how we’re innovating to help match the right treatment with the right patient at #ash24.
🔗 Learn more: gsk.to/3Dccalx -
GSK
@GSK
#news for #investors and #media: Today, the @WHO has prequalified tafenoquine and included this first single-dose medicine for P. vivax malaria in updated Guidelines for malaria, to help improve treatment for people most at risk.
Learn more gsk.to/4fWQCrP -
GSK
@GSK
#news for #investors and #media
The @EU_Commission has granted marketing approval for a single-vial, fully liquid presentation of one of our vaccines.
🔗 Learn more: gsk.to/498fUk0 -
GSK
@GSK
#news for #investors and #media: The US FDA has accepted our application for one of our #bloodcancer therapies in combination with standards of care. Learn more: gsk.to/4eK29sT
-
GSK
@GSK
News for #media and #investors: Today we announced an expanded indication for one of our vaccines.
🔗 Learn more: gsk.to/4i4mFaP -
GSK
@GSK
At GSK, we are working to prevent and change the course of respiratory diseases such as COPD and achieve more ambitious treatment goals for patients. David Brooks shares his thoughts.
#worldcopdday -
GSK
@GSK
This #worldcopdday, and every other day, we’re building on over 50 years of expertise in the field of respiratory health to change the course of the disease and improve the lives of people with COPD
#copdawareness
GSK
@GSK
Did you know that exacerbations in COPD can cause irreversible lung damage?
Exacerbations can cause damage to the lungs. Each COPD exacerbation can cause changes to the tissue which can accumulate over time.
GSK
@GSK
We want those affected to know that they’re not causing a fuss by asking if more can be done to help prevent further damage to their lungs.
Learn how we’re working to prevent cumulative lung damage and disease progression 👉
gsk.to/4eyyMd6 -
GSK
@GSK
We’re applying our decades of expertise in respiratory medicine to deliver ambitious treatment goals for the more than 391 million people globally with COPD. Aiming to go beyond optimal symptom control, to achieve disease stability and change the course of their disease.
#worldcopdday -
GSK
@GSK
#news for #investors and #media: Today we announced headline results from a phase III study in cholestatic pruritus of primary biliary cholangitis (PBC).
Learn more: gsk.to/3YUsMp9 -
GSK
@GSK
That’s a wrap on this year’s #mihealthsummit, where we’ve been discussing how we’re collaborating with partners to invest in prevention and other interventions that can transform patient care and improve health outcomes.
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
We’re at @ACRheum discussing early intervention for those living with #lupus.
When patients and doctors work together to treat lupus and lupus nephritis early with a goal of preserving kidney function, the risk of disease progression and organ damage can be reduced: www.gsk.com/en-gb/behind-the-science-magazine/intervening…
#acr24 -
GSK
@GSK
Hear from experts at #mihealthsummit, including our own James Strenner, SVP, Head of U.S. Commercial Strategy, about how we’re getting ahead of disease together by investing in prevention.
Milken Institute
@MilkenInstitute
We launched Project Prevent, with support from founding partner @GSK, to unite leaders across sectors to identify and expand solutions that shift the health care paradigm toward prevention.
Learn more here. youtu.be/1h19F3ROcZ4 -
GSK
@GSK
#news for #investors and #media: Today we announced positive headline results from a trial evaluating our #bloodcancer treatment. We’re looking forward to sharing full results at #ash24. Learn more: gsk.to/4fGh7Sl
-
GSK
@GSK
We’re excited to convene with global health experts and policymakers at the @MilkenInstitute 2024 #mihealthsummit, where we’ll share how we’re partnering to create scalable and sustainable programs that advance preventative health solutions.
Learn more about our focus on prevention:
www.gsk.com/en-gb/behind-the-science-magazine/prevention-…
GSK
@GSK
As our global population ages, and as science and technology continue to help us get ahead of disease, it’s our responsibility to reimagine healthcare – so that we’re not just treating sickness, but also investing in keeping people well.
Which of these actions are critical for prioritising prevention in our healthcare systems? -
GSK
@GSK
We’ve launched a new initiative to uncover gaps in care associated with gynaecologic cancers and create solutions to drive progress for patients. Learn more about Your Cancer Is Our Challenge and the @HarrisPoll survey that helped uncover these insights: gsk.me/48Kh3ya
-
GSK
@GSK
We're using tech to revolutionise the way we understand, prevent and treat disease – helping us reimagine what’s possible for patients.
🔗 Hear more from Shobie Ramakrishnan, Chief Digital and Technology Officer at GSK, on the TD Cowen Insights podcast: gsk.to/48HJRY3 -
GSK
@GSK
Our CEO, Emma Walmsley, spoke to @ArmstrongDrew, Executive Editor of Endpoints, at the @ftlive Global Pharma and Biotech Summit today. Their wide-ranging discussion covered crucial topics from building trust in pharma, to the importance of prevention and AI in healthcare.
-
GSK
@GSK
Our CEO, Emma Walmsley, will be giving a keynote interview at the @ftlive Global Pharma and Biotech Summit on 6 November at 10:20 AM GMT.
Register now: pharma.live.ft.com
#ftpharma -
GSK
@GSK
Discover the power of data in the fight against malaria with @malarianomoreuk's new "Zero Malaria Experience." This captivating journey shows how expanding current tools like bed nets and introducing next-generation vaccines will bring us closer to a malaria-free world.
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
AI analysis of ‘organoid’ recreations of NHS patients’ cancers could help to predict relapses and identify the most effective treatments, GSK scientists say.
Find out how tech like these ‘organoids’ and AI could transform lung cancer care 👇 (paywall)
gsk.to/3YunoZD -
GSK
@GSK
Today, we’re announcing our adoption of the first-ever #sciencebasedtargets for freshwater with the @SBT_Network. This is an important step in our plan to reduce our impact on nature at the same time as building business resilience.
Read more here: gsk.to/4htsr5h
#sbtn -
GSK
@GSK
News for #investors and #media
Explore our Q3 2024 highlights. www.gsk.com. $GSK -
GSK
@GSK
#investors: Join GSK’s CEO Emma Walmsley and other members of our leadership team for our Q3 2024 live results webcast at 12:00 BST, 07:00 EDT. $GSK
-
GSK
@GSK
News for #investors and #media
Watch our CEO Emma Walmsley as she shares our Q3 results. We are on track to deliver 2024 outlooks with further good progress made in R&D.
For more, visit gsk.to/48o7aGh
$GSK #news #q3results -
GSK
@GSK
#investors and #media Cautionary statement regarding forward-looking statements & the definitions & reconciliations for non-IFRS measures for our results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates.
For investors: gsk.to/4f3xEzl -
GSK
@GSK
We’re announcing our Q3 2024 results tomorrow at 0700 GMT, 0300 EDT. $GSK
-
GSK
@GSK
#news for #investors and #media: Today we announced an agreement to acquire an investigational medicine to potentially address continued unmet need in autoimmune diseases.
gsk.to/3YmlDhf -
GSK
@GSK
Early intervention and disease management is critical for patients with #lupus to reduce the risk of irreversible organ damage and/or #lupusnephritis. It’s important for doctors and patients to discuss ways to reduce this risk.
Watch to learn more.
@ASNKidney #kidneywk -
GSK
@GSK
Proud to be named in @ScienceMagazine’s Top Employers list for the 6th consecutive year.
#aheadtogether #gskproud #sctopemployers
Science Careers
@ScienceCareers
What makes the best places to work in #biotech, #pharma, and #biopharma? Nearly 6,500 scientists have spoken! Explore this year's @ScienceMagazine Top Employers survey results and discover the most innovative leaders in the industry. #sctopemployers 👉 www.science.org/content/article/top-20-2024-who-did-scien…
-
GSK
@GSK
We’re at @ASNKidney week. As long-standing leaders in the #lupusnephritis community, we know how critical early intervention and disease management is to reducing the risk of organ damage for patients.
Learn more: www.gsk.com/en-gb/innovation/therapeutic-areas/respirator…
#kidneywk -
GSK
@GSK
News for #investors and #media: Today we announced new positive clinical data on one of our vaccines.
Learn more: gsk.to/48mVbsA -
GSK
@GSK
News for #media and #investors:
We announced a new collaboration with Cambridge – the Cambridge-GSK Translational Immunology Collaboration (CG-TIC) – to further accelerate research and development in kidney and respiratory diseases.
Learn more: www.gsk.com/en-gb/ -
GSK
@GSK
We are excited to announce a new collaboration with the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center (BMC) to advance innovative research in the field of lung diseases.
-
GSK
@GSK
Thanks for joining us at #idweek2024, where we’ve been sharing scientific advances from our industry-leading, prevention-focused portfolio of infectious disease vaccines and medicines.
🔗 Find out more: gsk.to/3Ufs2cF 👈 -
GSK
@GSK
“There are three things necessary to ending the HIV/AIDS epidemic…and prevention is key”.
🔗 Find out what it means to change the course of disease through prevention and earlier intervention: gsk.to/408FXVG 👈
#idweek2024
@ViiVHC -
GSK
@GSK
We are excited to be at #idweek2024 to present research from across our broad and growing portfolio of vaccines and medicines aimed at getting ahead of infectious diseases.
🔗 Learn how are we developing new ways to prevent and treat infectious diseases: gsk.to/3A58Nfd -
GSK
@GSK
We’re excited to join experts from across the globe at #idweek2024! Together with @ViiVHC, we’re pioneering new technologies to advance the prevention and treatment of infectious diseases.
Learn more about our innovative research: gsk.to/3zWCCi1 -
GSK
@GSK
#news for #investors and #media: Today we announced that gepotidacin has been accepted for priority review by US FDA for treatment of uncomplicated urinary tract infections in female adults and adolescents.
Learn more: www.gsk.com/en-gb/ -
GSK
@GSK
We are proud to partner with @gaapporg to help amplify the conversation about the unmet needs of refractory chronic cough (RCC) patients on the first-ever #worldchroniccoughday.
Learn how we are shaping the future of RCC care: www.gsk.com/en-gb/behind-the-science-magazine/refractory-…
Global Allergy & Airways Patient Platform
@gaapporg
🎉🌍 Today is the first-ever World Chronic Cough Awareness Day! 🎉
Check out our website for the official proclamation and press release on this landmark event.
Visit 🔗 gaapp.org/wccd2024/ to learn more. @gaapporg #chroniccoughday -
GSK
@GSK
We’re aiming to support the European Network on Climate & Health Education to train 10,000 medical students, across 25 leading universities in Europe, to deliver sustainable healthcare: gsk.to/3Y4ww75
@TheSMIThis media couldn't be displayed. See it on the original post. -
GSK
@GSK
Are you attending #idweek2024? So are we! Join us as we convene with global experts, sharing the latest advancements in the prevention and treatment of infectious diseases.
🔗 Learn more: gsk.to/4h6WQWU
@ViiVHC -
GSK
@GSK
#news for #investors and #media: Today we announced positive phase III trial results of one of our pipeline biologics for chronic rhinosinusitis with nasal polyps (#crswnp).
Learn more here: gsk.to/402MhhG -
GSK
@GSK
News for #media and #investors: Together with @ViiVHC, we’re presenting 60 abstracts to showcase advances across our industry-leading infectious disease pipeline and portfolio at #idweek2024.
🔗 Learn more: gsk.to/3BB4lFw -
GSK
@GSK
News for #media and #investors: We have issued an important litigation update. Read more here: gsk.to/4eAeWiB
-
GSK
@GSK
Each year, there are around 5 million RSV infections in adults aged 60+ in high-income countries – yet, there is still a lot to discover about this virus.
Want to hear more about what scientists have learned about RSV? Read here! 👇 www.gsk.com/en-gb/behind-the-science-magazine/rsv-symptom… -
GSK
@GSK
We’re excited to be attending #chest2024 where we’re engaging with thought leaders and experts in pulmonary health. With approximately 177,000 US adults aged 65+ hospitalised due to RSV each year, it is crucial we unite our efforts to get ahead of this virus, together.
-
GSK
@GSK
#news for #investors and #media: Today we shared data at #chest2024 on one of our vaccines. Learn more: gsk.to/47WETpU
-
GSK
@GSK
News for #media and #investors from our specialist HIV company, @ViiVHC, on their commitment to increasing access to #hiv PrEP in low- and middle-income countries and Sub-Saharan Africa.
Find out more: www.gsk.com/en-gb/ -
GSK
@GSK
Around 1 in 5 invasive meningococcal disease survivors are left with severe long-term after-effects, such as permanent physical disabilities.
Hear Rodolpho’s powerful story: youtu.be/mVLG5X3FvEk
#worldmeningitisday -
GSK
@GSK
We’re extremely proud that our CEO Emma Walmsley, has been named to @FortuneMagazine's list of the 100 most powerful women, alongside other accomplished leaders in the Fortune 500 and Global 500.
-
GSK
@GSK
Huge congratulations to last night’s #wellchildaward winners. Your courageous stories inspired us all!
#aheadtogether -
GSK
@GSK
We’re so proud to meet all the incredible winners at this year’s #wellchild Awards.
Find out how together with community partners we’re making a positive impact on the health of vulnerable and marginalised people. www.gsk.com/en-gb/responsibility/charitable-partnerships-…
#aheadtogether
WellChild
@WellChild
Our incredible 2024 winners gather on stage for a photo with WellChild Patron Prince Harry, The Duke of Sussex, at the #wellchildawards, in association with @gsk.
-
GSK
@GSK
This #bloodcancerawarenessmonth, we are excited to share a sneak peek of our upcoming ‘Mapping Myelofibrosis: Our MF Journeys’ video series launching soon. Watch the clip below, and subscribe to our YouTube channel for more: gsk.me/3TK3SHc
-
GSK
@GSK
Join us on Monday as we come together to honour inspirational young people and healthcare professionals at the 2024 #wellchildawards
Tune in to watch the ceremony streamed live gsk.to/3ZEY8Cd -
GSK
@GSK
As co-founders of Energize, we're thrilled to announce the first deal, which includes four of our European suppliers. This marks an important step in our plan to achieve net zero impact on climate by 2045: gsk.to/4gG1Ilw
#climateweeknyc -
GSK
@GSK
We’re at #ims24, sharing the latest updates in our ongoing blood cancer research. Learn more here: gsk.to/3MYKLVS
-
GSK
@GSK
#news for #investors and #media: the @EMA_News CHMP has issued a positive scientific opinion on a single-vial, fully liquid presentation of one of our vaccines.
Learn more: gsk.to/4eyl9uV -
GSK
@GSK
By 2050, 1 death every 3 minutes could be due to antimicrobial resistance.
That's why this week, at #unga79, we must come together to prevent and get ahead of AMR.
Read on for more about the human cost of AMR – and how to stop it.
gsk.to/3MTQBb1 -
GSK
@GSK
At GSK, our work to advance oncology research is inspired by people like Alex. This #worldgoday, hear more about our ongoing commitment to bring innovative treatment options to people living with #endometrialcancer: gsk.me/3B7ld6z
-
GSK
@GSK
Most people with ovarian cancer are diagnosed at an advanced stage. Recognising the signs, symptoms and risk factors can help those affected seek care sooner.
Test your knowledge below – which of these is a common symptom of ovarian cancer:
GSK
@GSK
Learn more about our commitment to advancing research for people living with ovarian cancer: gsk.to/4ejZ1UW
-
GSK
@GSK
Today, our Worthing manufacturing site has become the first in the UK to achieve @BSI_UK Kitemark Certification for Minimized Risk of Antimicrobial Resistance! Responsible manufacturing of antibiotics is crucial to getting ahead of AMR.
gsk.to/3TyQq8Y
#unga79 -
GSK
@GSK
Breaking News: We’ve committed €4.5m over three years to @gardp_amr to ensure equitable access to antibiotics in lower-income countries.
Our funding aims to tackle the challenges that hinder critical antibiotics from reaching those in need. #powerof Antibiotics #unga79 -
GSK
@GSK
#news for #investors and #media: Japan’s MHLW has accepted our application for one of our #bloodcancer therapies in combination with standards of care. Learn more: gsk.to/3B8kNwy
-
GSK
@GSK
Precision medicine technologies like biomarker testing can help doctors match patients with the cancer treatment option that is likely to be most effective for them.
Learn about our #oncology research: gsk.to/4d0yQ4t #esmo24 -
GSK
@GSK
#news for #investors and #media: China’s National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation for one of our #bloodcancer therapies in combination with standards of care: gsk.to/4gr28MS
-
GSK
@GSK
Our focus on advancing innovation through #oncology research is driven by our commitment to extending and improving the lives of people with cancer.
Learn about the latest updates we’ll be sharing at #esmo24: gsk.to/3z5vtvv -
GSK
@GSK
We were thrilled to have been at #erscongress2024, sharing more about how we’re innovating to prevent and change the course of respiratory diseases. gsk.to/3Ba4WNU
-
GSK
@GSK
#news for #investors and #media: Today we announced positive headline data from a phase II vaccine programme.
Learn more here: gsk.to/3XEtwzi -
GSK
@GSK
At GSK, we’re redefining the future of respiratory care and are determined to help as many people as possible with asthma achieve clinical remission.
Learn more about achieving clinical remission in asthma regardless of disease severity here: gsk.to/3XlOUIj -
GSK
@GSK
In a new article, Dr David Lipson, GSK’s Vice President and Clinical Research Head, Respiratory and Immunology R&D, explains why a focus on the environmental impact of respiratory care is so essential.
Read more: gsk.to/3XA2Rng
#erscongress2024 -
GSK
@GSK
Join us at #unga79 as our VP of Global Health, Fiona Smith-Laittan and @Amref_Worldwide discuss how lower income countries can effectively respond to the challenge of Antimicrobial Resistance. Don't miss out on this insightful discussion hosted by @Devex. Find out more 👇
Devex
@devex
Join us for this event focused on scaling local solutions and partnerships to tackle the AMR challenge in Africa.
#devexevent @ #unga79 · In partnership with @GSK and @AMREF_Worldwide -
GSK
@GSK
Patients are at the heart of everything we do. Hear from one refractory chronic cough patient on her experience living with the condition and how it has impacted every aspect of her life. #refractorychroniccough #erscongress2024
Read more: gsk.to/3Zj0hTX -
GSK
@GSK
#news for #investors and #media: Today at #erscongress2024 we presented the phase III data in severe #asthma for our ultra-long-acting pipeline biologic. This was accompanied by simultaneous publication in in the #nejm. Learn more here: gsk.to/3z7Ks85
-
GSK
@GSK
We are talking to leaders, advocates and partners at #erscongress2024 about how we're innovating to change the course of respiratory disease, looking beyond symptom relief to keep people safe from infections and prevent diseases from getting worse.
Read more: -
GSK
@GSK
#refractorychroniccough (RCC) is a burden for both patients and the healthcare system, with a long diagnosis process, and it is poorly understood.
We’re looking forward to hearing more about RCC at #erscongress2024.
Read more: gsk.to/4ecIKkA -
GSK
@GSK
Did you know that exacerbations in asthma and COPD can cause irreversible lung damage?
GSK
@GSK
Exacerbations can cause damage to the lungs. Each attack can cause changes to the tissue which can accumulate over time. To find out more, here’s our latest article on preventing disease progression 👉 gsk.to/3ASX8QJ
-
GSK
@GSK
At GSK, we are working to prevent and change the course of respiratory diseases such as COPD and achieve more ambitious treatment goals for patients. Hear more about this from our leaders.
-
GSK
@GSK
With innovation comes more ambitious treatment goals. Our goal is to make clinical remission an achievable treatment outcome for people with certain types of severe asthma.
Discover what this means for those living with the condition 👇 -
GSK
@GSK
For decades we’ve researched the impact conditions like #asthma and #copd can have on a patient’s future.
Discover more about how we’re working to prevent cumulative lung damage and disease progression 👉 gsk.to/3AX03YM
#erscongress2024 -
GSK
@GSK
We are excited to be at #erscongress2024 where we will be showcasing our work to redefine the future of respiratory care and improve the lives of millions. We’re building on decades of innovation and turning science into solutions with the aim to free people from the constraints of respiratory conditions like asthma and COPD.
Check out this video and learn more. www.gsk.com/en-gb/innovation/therapeutic-areas/respirator… -
GSK
@GSK
Kaivan Khavandi shares his thoughts on how we can apply our expertise to deliver the next generation standard of care and help millions of patients with respiratory conditions improve their lives in a way that has never been possible before 👉 gsk.to/4dTjjVu
-
GSK
@GSK
We believe every breath matters.
This #erscongress2024, see how we’re building on decades of expertise in respiratory vaccines and medicines to go beyond symptom relief to protect people from infections & prevent deterioration, exacerbations, lung damage and disease progression 👇
gsk.to/4grHHiT -
GSK
@GSK
Climate change and air pollution negatively impact the health of patients with respiratory conditions– yet some treatments used for those same conditions contribute to greenhouse gas emissions. It’s time to break the cycle.
Learn more: gsk.to/3XvnTU1
#erscongress2024 -
GSK
@GSK
#news for #investors and #media: Today we have announced positive phase III trial results of one of our biologics in chronic obstructive pulmonary disease (#copd). Learn more here: gsk.to/47cqs0J
-
GSK
@GSK
This #bloodcancerawarenessmonth 🩸, we are grateful to those in the #bloodcancer advocacy and clinical communities who help us drive progress for those living with complex cancers, like #myelofibrosis and #multiplemyeloma
-
GSK
@GSK
In a GSK funded online RSV survey of 3,516 respondents in 4 countries, over 50% of adults >50 years were worried about missing out on family occasions or holidays due to respiratory infections.
#globalrsvawarenessweek -
GSK
@GSK
Did you know that older adults (60+) and those with certain underlying health conditions are at increased risk of complications due to RSV? Join us in raising awareness of the disease to help prevent RSV.
Learn more about RSV: gsk.me/4g91pzp 👈
#globalrsvawarenessweek -
GSK
@GSK
#news for #investors and #media: At #erscongress2024 we’ll be sharing our latest research across 56 abstracts including a late breaking alert session as we continue in our aim to redefine the future of respiratory medicine. Learn more here: gsk.to/4eqGgPV
-
GSK
@GSK
Respiratory syncytial virus (RSV) causes ~5 million infections in adults every year.
However, new data shows 6 in 10 adults over 50 have never heard of the virus – despite some being most at risk.
Find out more here:
gsk.to/3X7T5HO -
GSK
@GSK
Today, we proudly launch #globalrsvawarenessweek alongside the @COPDFoundation, @gaapporg and @IFAgeing, to raise global awareness of RSV, a virus that may affect millions annually.
Learn more about the risks of RSV: gsk.me/3MAOFUF 👈 -
GSK
@GSK
High-quality healthcare should be accessible to all of us, regardless of who we are or where we come from.
Find out how GSK is helping to close the health equity gap here:
gsk.to/4cAphJt -
GSK
@GSK
News for #investors and #media: Today the EU Commission has approved an expanded indication for one of our vaccines. gsk.to/4dMnPVJ
-
GSK
@GSK
Progress to achieving universal access to healthcare has slowed.
Here, Thomas Breuer, our Chief Global Health Officer, explains how to speed things up again:
gsk.to/4dx98Wx -
GSK
@GSK
#news for #investors and #media: Today we announced that one of our investigational medicines has been granted SENKU designation by the Japanese Ministry of Health, Labour and Welfare (MHLW). Find out more gsk.to/3MIECgJ
-
GSK
@GSK
#news for #investors and #media: Today we have announced that Japan has approved the use of one of our biologics as a treatment option for people with chronic rhinosinusitis and nasal polyps (#crswnp). Learn more here: gsk.to/3Xpbi52
-
GSK
@GSK
Many groups are disproportionately affected by disease, yet still face barriers to access the healthcare they need.
Read more about GSK's collaborative efforts to reduce the health equity gap here:
gsk.to/4dTDmCJ -
GSK
@GSK
100 years ago today, we launched Ostelin, the world’s first Vitamin D supplement.
Step back to 1924 with us to explore the history of our first pharmaceutical product.
Read more about our heritage of innovation 👉 gsk.to/4fOD0iy
#aheadtogether -
GSK
@GSK
Rising antimicrobial resistance and the threat of "superbugs" is exacerbated by global warming.
Find out why - and how vaccines could help mitigate the risk of AMR - here:
gsk.to/3AyoX0p -
GSK
@GSK
Climate change doesn’t just affect the planet - but the health of populations, too.
Here’s how – and what we can do to reduce the risk of disease:
gsk.to/3AyLRFb -
GSK
@GSK
“Now I feel happier for my children and I see the better health on their faces.”
Vaccinating her children changed Asli’s life.
We’re supporting local innovators in Africa with @SavetheChildren to improve access to immunisation for families like Asli's
gsk.to/3MhyZ8U -
GSK
@GSK
“AMR is like rising sea levels. It will keep rising. It will not stop, and suddenly we’ll be standing there with water around our knees.”
Read more about the crisis of antimicrobial resistance and why the world urgently needs novel antibiotics:
gsk.to/46LEUww -
GSK
@GSK
#news for #investors and #media: The FDA has granted Breakthrough Therapy Designation to an investigational antibody-drug conjugate in our oncology portfolio. Learn more: gsk.to/4dstxMt
-
GSK
@GSK
Data helps us make smart decisions with greater precision and speed. But it must be handled with care.
Read more about how we ensure we use it responsibly here:
gsk.to/3WXjzg2 -
GSK
@GSK
In 1944, we produced 80% of the UK’s penicillin, increasing the chances of survival for hundreds of WW2 soldiers.
Today, we remain on a mission to develop new antibiotics to fight the rising tide of AMR:
gsk.to/4fJUCfI -
GSK
@GSK
Behind each data point is a real person with a delicate history and a right to privacy.
Learn more about how we safely access and share data from our Senior Vice President of Research Technologies, Chris Austin: gsk.to/4dICZLn -
GSK
@GSK
AI and machine learning are integrated into every stage of drug development, from selecting molecules for early testing, to identifying suitable drugs for the right patient groups.
Learn more here:
gsk.to/3WBVRVd -
GSK
@GSK
Not only does the use of AI and robots promise greater efficiency, but it reduces our reliance on essential resources, making us greener.
Read our article to learn more: gsk.to/4ccUan6 -
GSK
@GSK
Biomarkers are key, it provides information about a patient’s biological condition, indicating the most effective treatments for patients.
Learn more about biomarkers here:
gsk.to/4fDH0Ta -
GSK
@GSK
Robots, AI and machine learning are helping to deliver medicine to patients faster.
Learn more about our advanced manufacturing hubs: gsk.to/4cicVoY -
GSK
@GSK
#news for #investors and #media: The FDA has approved an expanded indication of our immuno-oncology cancer therapy in the US.
Learn more: gsk.to/46x4N31 -
GSK
@GSK
315 million people around the world are thought to be affected by COPD - chronic obstructive pulmonary disease. Recognise the symptoms and open up to a healthcare professional today.
#copd #aheadtogether -
GSK
@GSK
News for #investors and #media
Take a look at key highlights from our Q2 2024 performance. For more insights, visit us at gsk.to/3ylCLe0. $GSK -
GSK
@GSK
News for #investors and #media
Explore our Q2 2024 figures at a glance. www.gsk.com/en-gb/. $GSK -
GSK
@GSK
#investors: Join GSK’s CEO Emma Walmsley and other members of our leadership team for our Q2 2024 live results webcast at 12:00 BST, 07:00 EDT. $GSK
-
GSK
@GSK
News for #investors and #media
Watch our CEO Emma Walmsley as she shares our Q2 results, with continued strong performance and upgraded full-year guidance for 2024.
For more, visit gsk.to/46wvZim
$GSK #news #q2results -
GSK
@GSK
#investors and #media Cautionary statement regarding forward-looking statements & the definitions & reconciliations for non-IFRS measures for our results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates.
For investors: gsk.to/3A5DTmv -
GSK
@GSK
We’re announcing our Q2 2024 results tomorrow at 0700 BST, 0200 EDT. $GSK
-
GSK
@GSK
#news for #investors and #media: Today we announced that we have entered into an agreement with Flagship Pioneering to discover future medicines and vaccines for patients.
Find out more: gsk.to/3WmmZHH -
GSK
@GSK
We’re proud to support @Hep_Alliance this #worldhepatitisday and are using science, technology and talent to help meet the needs of the generation of people living with chronic hepatitis B (CHB).
-
GSK
@GSK
HIV remains one of the world’s biggest health epidemics, with 1.3 million new diagnoses annually. Our goal is to minimise the impact of HIV on people’s lives by treating and preventing the disease, and tackling HIV-related stigma.
🔗Find out more: gsk.to/3Yk84Ra
#aids2024 -
GSK
@GSK
HIV remains one of the world’s biggest health threats and while great strides have been made in HIV treatment, with people living with HIV on effective treatment able to live long and full lives, stigma remains a challenge.
Find out how we are committed to changing that, by minimising the impact of HIV on people’s lives through treatment, prevention and ultimately cure: gsk.to/3YgObu5 👈
#aids2024 -
GSK
@GSK
Find out more: gsk.to/4deCHvg
-
GSK
@GSK
#news for #investors and #media: new data shared today at #aids2024 by our specialist HIV company, @ViiVHC, include updates from our pipeline that reinforce our leadership in HIV innovation and supporting the community.
🔗 Find out more: gsk.to/4d4g50M -
GSK
@GSK
“There are three things necessary to ending the HIV/AIDS epidemic…and prevention is key”.
Find out what it means to change the course of disease through prevention and earlier intervention 👇
#aids2024 gsk.me/4f9W7mX -
GSK
@GSK
#news for #investors and #media: Our marketing authorisation application for potential new indications for one of our #bloodcancer therapies, in combination with standards of care, has been accepted by the EMA. Learn more: gsk.to/4bKiLPW
-
GSK
@GSK
Speaking with @BloombergTV, our CEO, Emma Walmsley, and Lord Darzi discuss the urgent need to tackle #antimicrobialresistance through cross-sectoral partnership, innovative treatments and vaccines, and improved public awareness.
Watch the interview: gsk.to/3xTuLRo
GSK
@GSK
#amr is a global health issue that threatens millions of lives every year. We’re proud to be partnering with #fleminginitiative in our continued efforts to get ahead of AMR @FlemingCentre
-
GSK
@GSK
Together with our global health partners, we’re helping strengthen healthcare systems in lower income countries.
Guided by local communities and experts, we’re contributing towards helping #changethetrajectory of high burden infectious diseases: gsk.to/4bKkWmoThis media couldn't be displayed. See it on the original post. -
GSK
@GSK
#news for #investors and #media: @ViiVHC, our specialist HIV company, are presenting over 20 abstracts from our innovative pipeline and portfolio of medicines at #aids2024.
Find out more: www.gsk.com/en-gb/ -
GSK reposted
ViiV Healthcare
@ViiVHC
Our data at #aids2024 will reinforce the need to create new #hiv treatment and prevention options that may allow for less frequent dosing intervals.
Find out more about our presence in Munich here: viivhealthcare.com/hiv-news-and-media/medical-conferences…
@iasociety #putpeoplefirst #wewontstop -
GSK reposted
-
GSK
@GSK
“Women need freedom and empowerment over what happens to them.” In partnership with @devex, @ViiVHC CEO and president of GSK Global Health, Deborah Waterhouse, discusses why a gender lens is vital if we’re to help end the HIV and TB epidemics 👉 gsk.to/3Wh7d1T
-
GSK
@GSK
As for many people living with #myelofibrosis (MF), Andrew’s journey was not straightforward. MF can present unique symptoms for each patient, making diagnosis and treatment challenging. Read more about how he lives life to the fullest @WebMD: gsk.me/4cl5xtq
-
GSK
@GSK
#news for #media and #investors: Brazil and Thailand become the first malaria-endemic countries to launch new single-dose medicine to help prevent relapse of P. vivax malaria, developed in partnership with @MedsforMalaria: gsk.to/3xLaUUa
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
#news for #investors and #media: Today we announced a new licensing agreement with CureVac. This is our latest investment in vaccine platform technologies, allowing us to match the best platform to each pathogen and help prevent illness in more people around the world.
Read more: www.gsk.com/en-gb/ -
GSK
@GSK
Global experts encourage early intervention with evidence-based treatments to help reduce the risk of organ damage in people with lupus, including tapering the use of oral corticosteroids.
Learn more at our dedicated GSK site: gsk.to/3XZXPBp -
GSK
@GSK
We’ve signed a 10-year energy deal for our manufacturing sites in Singapore which is set to increase our global purchased renewable electricity usage by 9%.
Read more about our action on climate: gsk.to/4cuzQhA
#lcaw2024 -
GSK
@GSK
"Can we end epidemics?" is a new podcast from @ViiVHC, in partnership with @ForeignPolicy.
In episode 5, GSK’s Fiona Smith-Laittan and @Amref_Worldwide’s Dr Mercy Mwangangi, discuss partnerships and health system strengthening. gsk.to/4eGoskr -
GSK
@GSK
Meet Zack, GSK chemist, early riser and planet protector working on #greenchemistry solutions to help make more sustainable medicines and vaccines that benefit patients and the planet. Watch his inspiring story and find out more about life at GSK #wearegsk #lcaw2024 #gskcareers
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
Did you know that #antimicrobialresistance could lead to approximately 6.9 million extra hospital days a year by 2050?
Learn more about how we can get ahead of #amr 👉 gsk.to/455q6Yx -
GSK
@GSK
We’re highlighting the importance and evidence of early action to target drivers of irreversible organ damage in lupus, an inflammatory disease where the immune system attacks its own tissues, such as the kidneys.
Learn more: gsk.to/45zHZz7 -
GSK
@GSK
It’s #lcaw2024 and we’re sharing how we’re working together with partners to develop more sustainable medicines and vaccines. It’s part of how we’re supporting healthcare systems that are better for patients and the planet.
Find out more: gsk.to/45G0Ngc -
GSK
@GSK
#news for #investors and #media: The Ministry of Health, Labour and Welfare of Japan has granted approval for our blood cancer therapy. Learn more: gsk.to/3KXmqPp
-
GSK
@GSK
#news for #investors and #media: Our marketing authorisation application for a potential expanded indication for our immuno-oncology therapy has been validated by the EMA.
Learn more: gsk.to/4cCkvM1 -
GSK
@GSK
At the #timesceosummit, our CEO, Emma Walmsley, shared how, through partnership across NHS, life sciences sector and government, there’s huge opportunity to build on UK’s strengths with a new healthcare model that moves from treating sickness to getting ahead of disease @thetimes
-
GSK
@GSK
We're proud to be included in the Times Top 50 Employers for Gender Equality.
Hear from Shobie Ramakrishnan, our Chief Digital & Technology Officer, about how we support women at GSK to thrive. 👇
#timestop50 -
GSK
@GSK
Congratulations to #longitudeprize on #amr winners @AstregoDx. Preventing the spread of #superbugs is essential in protecting global health and, alongside vaccination and good sanitation, rapid diagnostics are a key component in the prevention toolbox.
@longitude_prize
Longitude Prize on ALS
@longitude_prize
We are thrilled to reveal that the #longitudeprize on AMR has been won by @AstregoDx with their PA-100 AST System 🎉Congratulations to the team, this technology is a gamechanger in the fight against #superbugs. Learn more about it here: amr.longitudeprize.org/winners
GSK
@GSK
As a proud supporter of @Challenge_Works #longitudeprize, we believe the impact of innovative technologies like @AstregoDX's PA-100 AST System could be transformative in our collective efforts to get ahead of #amr
-
GSK
@GSK
In #endometrialcancer, early diagnoses and individualised testing could lead to better long-term outcomes for patients. Hear from Sharon about her journey with this type of #uterinecancer.
-
GSK
@GSK
This Pride Month, we’re highlighting people who work at GSK and ViiV from the LGBTQ+ community and allies in STEM roles who are committed to making a positive impact on patients’ lives.
Find out more from Kaylia, Ana and Ethan. -
GSK
@GSK
At GSK, we’re revolutionising our supply chain. Using data tech, robotics and automation to increase the speed, quality and scale of product supply, we are driving performance to reach patients and people, better and faster. This is smart manufacturing.
#londontechweek #ltw24This media couldn't be displayed. See it on the original post. -
GSK
@GSK
📣 We’re excited to announce the recipients of the Gender Equality Fund, in collaboration with @GlobalFund and @ViiVHC.
Together, we are working towards gender equality for girls, women and gender-diverse communities across Africa.
#changethetrajectory gsk.to/4epm0PpThis media couldn't be displayed. See it on the original post. -
GSK
@GSK
We are getting ahead of #bloodcancer at #eha2024, as we share our research in #multiplemyeloma and #myelofibrosis. Discover more about our progress in oncology: gsk.me/4b1LkYT
-
GSK
@GSK
We're partnering with UK biotech @ochrebio through a multi-year agreement, generating new data to deepen our understanding of #liverdiseases and potentially accelerate the development of innovative therapies. Read more: www.ochre-bio.com/2024/06/12/gsk-enters-into-a-multi-year…
Ochre Bio
@OchreBio
🚀 Announcing our new multi-year data license agreement with @GSK to investigate the drivers of #liverdisease!
Read the announcement ➡️
www.ochre-bio.com/2024/06/12/gsk-enters-into-a-multi-year… -
GSK
@GSK
The key to leading an organisation through a period of change? Resilience and empathy 🙏
London Tech Week
@LDNTechWeek
“You can’t change what you don’t care about.”
@GSK Chief Digital and Technology Officer Shobie Ramakrishnan drops gem after gem 💎 in this insightful conversation with @OliBarrett about healthcare, impact, and resilience. 👇🏥✨ #londontechweek #ltw24This media couldn't be displayed. See it on the original post. -
GSK
@GSK
Thanks for having us #londontechweek! We’ve had a blast connecting with the tech community here in London and beyond.
We’re at a transformational moment in health. With science and tech, we can prevent and change the course of disease better and faster than ever before. #ltw24This media couldn't be displayed. See it on the original post. -
GSK
@GSK
We believe tech-powered science will transform what’s possible for patients. That’s why we’re using data tech to get ahead of disease faster and better than ever before.
🔗 Find out what we're up to at #londontechweek: gsk.to/4aZFyqk -
GSK
@GSK
We’re at this year’s @eular_org congress presenting our latest research to support the global #lupus community and emphasizing the importance of taking early action.
#eular2024 -
GSK
@GSK
On day 3 of #londontechweek, we’re asking 👇
What’s the most important personal quality for a leader of disruptive tech innovation? -
GSK
@GSK
We’re excited to be at #londontechweek exchanging ideas with some of the biggest names in tech.
From AI and Digital Twins to greener supply chains, we can’t wait to see where tech can take us next.
🔗 Read more about GSK at #ltw24: gsk.to/3Vlqyxi -
GSK
@GSK
We’re at #londontechweek asking participants to add their perspective to our award-winning #gskdata visualisation wall. Have your say 👇
What's the biggest opportunity for AI impact in your organisation?
GSK
@GSK
Read more about GSK at #ltw24: gsk.to/3Vh8lRK
-
GSK
@GSK
On day 2 of #londontechweek, we’re asking…aside from malicious use, what is the biggest risk with #ai?
GSK
@GSK
Read more about GSK at #ltw24: gsk.to/3Vh8lRK
-
GSK
@GSK
By combining deep expertise in artificial intelligence (#ai) and machine learning with access to rich troves of genetic, genomic and health data, scientists are unlocking new discoveries about disease that could change the face of healthcare 👇
#ltw24 www.gsk.com/en-gb/behind-the-science-magazine/ai-ml-data-… -
GSK
@GSK
We’re delighted to be at #londontechweek spending time meeting, collaborating, and listening. Visit us at booth 501 to add your perspective to our award-winning #gskdata visualisation wall, or take part in our online polls.
🔗 Read about GSK at #ltw24: gsk.to/45ivJ60 -
GSK
@GSK
Giving researchers access to rich biological data at scale is crucial to accelerating drug discovery.
Here, Chris Austin, SVP, Research Technologies at GSK, explains why – and why a diverse skillset is needed to do this well and responsibly 👇
#ltw24 www.gsk.com/en-gb/behind-the-science-magazine/chris-austi… -
GSK
@GSK
RSV is one of the most common seasonal respiratory viruses – yet until recently, its role in adult disease was not well known. Here are 3 key facts, shared by our Head of Vaccines R&D & Infectious Disease Research, to help increase understanding of RSV 👇
www.gsk.com/en-gb/behind-the-science-magazine/rsv-symptom… -
GSK
@GSK
RSV infection is not only an illness that affects children: for some adults, getting sick with RSV can mean not being able to do what they love, shortness of breath, intense coughing or fatigue – and even being hospitalised. Our goal is to help people enjoy life at its fullest.
-
GSK
@GSK
81% of people living with primary biliary cholangitis (#pbc) are also living with cholestatic pruritus, a persistent itch that may impact sleep, daily activities, and relationships. We’re committed to advancing science to change that.
#easlcongress -
GSK
@GSK
News for #investors and #media: Today @US_FDA has approved an expanded indication for one of our vaccines. gsk.to/3XefEfn
-
GSK
@GSK
Heading to #londontechweek? We are! Join our colleagues at featured panel sessions, check out our Learning Lab and visit booth 501 to have your say on the future of tech at our award-winning #gskdata visualisation wall.
🔗 Learn more about GSK at #ltw24: gsk.to/4bP3Epg -
GSK
@GSK
At GSK, we’re committed to advancing cancer care through innovation.
Discover how we’re harnessing the power of biomarker testing and precision medicine to have a positive impact on patient lives: gsk.to/4bEWovY
#asco24 -
GSK
@GSK
#news for #investors and #media: Today we announced that we have acquired Elsie Biotechnologies to further enhance and advance our capabilities in the discovery and development of novel oligonucleotide therapeutics. gsk.to/3KwxKSj
-
GSK
@GSK
We’re excited to be at #easlcongress 2024 to connect with and share the stories of those living with chronic #hepatitisb. Visit us at stand I1 to get a glimpse into the challenges faced by people living with CHB 👇
-
GSK
@GSK
This Uterine Cancer Awareness Month, we’re raising awareness of disparities in diagnosis of this often-overlooked cancer. Early detection can improve outcomes in #uterinecancer, including #endometrialcancer. Visit @IGCSociety for ways to get involved: gsk.me/3yOGy3u
-
GSK
@GSK
Want to know the leading response to our #gskdata wall exhibit question at #asco24: What is the main benefit of oncology R&D collaborations to get ahead of cancer?
Discover more insights from #gskdata: gsk.to/3Kv0ue5 -
GSK
@GSK
DYK that 40% of #asco24 delegates told us that focusing on precision medicine and personalised treatment options is the most important step we can take to improve patient outcomes in cancer.
Discover more insights from #gskdata: gsk.to/3wOJeO0 -
GSK
@GSK
#news for #investors and #media: We’re pleased to share the latest research from a trial evaluating our immuno-oncology therapy at ASCO24.
Learn more: gsk.to/45aEX4c -
GSK
@GSK
#news for #investors and #media: At ASCO24, we shared late-breaking research from a phase III clinical trial evaluating one of our #bloodcancer therapies.
Learn more: gsk.to/3yG4DJM -
GSK
@GSK
We're at the #gskdata wall learning what our ASCO24 conference-goers think: What scientific innovation is best placed to advance new cancer therapies to patients?
See what they think below.
Discover more insights from #gskdata: gsk.to/3UYDQQ4 -
GSK
@GSK
We’re at #asco24 in Chicago, the most significant gathering of oncology professionals worldwide. Our Senior Vice President, Global Head Oncology R&D, Hesham Abdullah, is here and shares his perspective from day 1.
Learn more: gsk.to/3V4G7JQ -
GSK
@GSK
We're at #eaaci2024 where we bring together deep understanding of the immune system and ongoing innovation in the field of respiratory medicine.
Eduardo Genofre, VP of Global Medical Affairs, shares the focus of our research: Learn more here: gsk.to/4aJ1TZn
GSK
@GSK
For people living with chronic rhinosinusitis with #nasalpolyps, their symptoms don’t just take a physical toll on things like breathing, sleeping and taste. But an emotional toll too.
-
GSK
@GSK
We’re committed to getting ahead of #bloodcancer for patients living with #multiplemyeloma, like Lou. At this year’s @ASCO Annual Meeting, we’ll share our latest advances in oncology research. Learn more: gsk.to/4bZdrsi
#asco24 -
GSK
@GSK
The impact of climate change on health alongside AMR are two huge challenges hindering global health progress. Our chief global health officer @ThomasBreuer_MD reflects what we can do in the face of these challenges in our latest Behind the gsk.to/3ViFgXi
#wha77 -
GSK
@GSK
More than 1 million people worldwide are diagnosed with a blood cancer annually. At GSK, we’re committed to advancing research for people living with #bloodcancer. This #worldbloodcancerday, watch to learn more about two types of blood cancer.
-
GSK
@GSK
Did you know that #antimicrobialresistance could result in millions of deaths every year by 2050?
Learn more about how we’re forging ahead against #amr through research and coordinated action: gsk.to/4blJVNx -
GSK
@GSK
We’re at this year’s @ERAkidney congress, sharing the latest in our ongoing research to support the global #lupus community and encouraging people living with lupus to act early and speak with their doctors about how to slow their disease progression. #era24
-
GSK
@GSK
#news for #investors and #media: We’re pleased to present new data from our oncology portfolio at ASCO24, including two late-breakers. Read more: gsk.to/3yv6wsy
-
GSK
@GSK
We are thrilled to have been at #ats2024 and our presence has further highlighted the importance of the work we are doing to prevent and change the course of respiratory diseases.
gsk.to/3QZjYex -
GSK
@GSK
“We need nature to tackle climate change and we can’t halt and reverse nature loss without a stable climate”
Check out this FT article, in partnership with GSK, and discover why healthy people need healthy ecosystems. gsk.to/3wLMAB4 -
GSK
@GSK
As #ats2024 comes to a close, read about why our timely implementation of evidence-based treatment plans are important in preventing deterioration in health, preventing exacerbations and disease progression.
gsk.to/3wLER6a -
GSK
@GSK
We are proud to be a leader in the field of asthma research and of the ongoing contribution we are making to deliver next generation treatment goals and help ease the burden of asthma on millions of people with asthma. #ats2024
Learn more here: gsk.to/3KaR07J -
GSK
@GSK
Today, our #naturestrategy has been recognized by @BfNCoalition as part of ‘#nowfornature’, which calls on businesses to act on nature and boost resilience to nature related risks.
Find out more about why nature it not only fundamental for human health, but it’s also critical for long-term business success: gsk.to/4bN6pqF
Business for Nature
@BfNCoalition
🔊 🌱 The first business #naturestrategies have been published as part of ‘It’s #nowfornature’!
A nature-positive, net zero and equitable future is possible and businesses can contribute by setting a credible nature strategy 👇
Read more: nowfornature.org/news/first-nature-strategies/
#partoftheplan #fornature
@GSK @KeringGroup @ENGIEgroup Taiwan Cement Corporation @AnneVeck -
GSK
@GSK
Our CEO, Emma Walmsley, attended the @royalsociety event on #antimicrobialresistance alongside HRH Prince William, @UKAMREnvoy & other leaders.
The event reinforced the need for collective action, like our #fleminginitiative partnership, in tackling #amr: gsk.to/3Kp9FwV -
GSK
@GSK
Kaivan Khavandi, Senior Vice President of Respiratory and Immunology R&D is focused on research that targets the underlying cause of respiratory diseases, aiming to modify the specific biological pathways, deliver optimal symptom relief and prevent disease progression #ats2024
GSK
@GSK
What percentage of severe asthma patients require hospitalisation due to exacerbations every year?
GSK
@GSK
We are proud to be a leader in the field of asthma research and of the ongoing contribution we are making to deliver next generation treatment goals and help ease the burden of asthma on millions of people with asthma. #ats2024
Learn more here gsk.to/3wz90FT -
GSK
@GSK
Our understanding of asthma has advanced and treatment options are helping to achieve ambitious goals. We are proud to be a leader in this field and the ongoing contribution we are making to deliver next generation treatment goals for the millions of people with asthma.
-
GSK
@GSK
This World Day for Cultural Diversity, we’re highlighting the importance of ensuring people most impacted by a particular disease are included in clinical research.
Watch @Maimah's story to learn how we’re working with @tigerlilycares to help achieve equitable health outcomes.This media couldn't be displayed. See it on the original post. -
GSK
@GSK
#news for #investors and #media: Today we have announced positive results for the first phase III trials in #asthma of one of our pipeline biologics.
Learn more here: gsk.to/3KgCKKx -
GSK
@GSK
We’re aiming for people with severe asthma to achieve clinical remission, freeing them from exacerbations or the need for oral corticosteroids ─ achieving symptom control and stabilising lung function.
Find out who could achieve remission ☟
gsk.to/3wwgYPX -
GSK
@GSK
#asthma management is evolving. A simple blood test can identify the underlying pathology driving an individual’s asthma and help to optimise their treatment.
#ats2024 learn how biomarkers aid treatment decisions.
gsk.to/3UXGs21 -
GSK
@GSK
Timely intervention with the right management strategy can help to prevent exacerbations which can lead to cumulative lung damage and disease progression in #asthma and #copd.
Discover more in our latest article: gsk.to/3wxZ3bD -
GSK
@GSK
We are sharing our industry-leading respiratory portfolio by talking to leaders, advocates and partners about respiratory and prevention to change the course of disease #ats2024
gsk.to/3WTeLcd -
GSK
@GSK
People with #refractorychroniccough experience a persistent cough lasting for over 8 weeks despite treatment for an identified underlying medical condition or when one isn’t identified despite appropriate evaluation.
At #ats2024, experts will discuss this unmet need. -
GSK
@GSK
We are excited to be at #ats2024, where we will be showcasing our work to redefine the future of respiratory care and improve the lives of millions.
Follow us for more. gsk.to/3ReVApF -
GSK
@GSK
We look beyond the visible symptoms of #asthma and #copd. With an eye on the longer-term impact these conditions can have on a patient’s future, we aim to target the underlying drivers to prevent cumulative lung damage and disease progression. #ats2024
gsk.to/3UJo7Ex -
GSK
@GSK
For more than 50 years, inhalers have helped millions of people manage their asthma, but they also contribute to greenhouse gas emissions.
Discover why low carbon inhalers could help patients while reducing our environmental impact. #ats2024
gsk.to/3wyzQO7 -
GSK
@GSK
One the first day of #ats2024 Kaivan Khavandi, Senior Vice President of Respiratory and Immunology R&D shares his thoughts on how we’re determined to apply our expertise to deliver ambitious treatment goals for patients and redefine the future of #respiratory medicine.
-
GSK
@GSK
We’re looking forward to #ats2024, where we’ll be presenting real-world data on clinical remission in #severeasthma.
In the meantime, find out more about why we are aspiring to achieve clinical remission in severe #asthma: www.gsk.com/en-gb/behind-the-science-magazine/remission-s… -
GSK
@GSK
Our pledge will support projects to harness new technology, such as AI, to better utilise data to develop novel solutions and improve understanding of how drug-resistant infections can be tracked and prevented.
#amr #antimicrobialresistance #fleminginitiative @FlemingCentre
Imperial NHS 💙
@ImperialNHS
.@GSK has pledged £45 million to the Fleming Initiative to help fight against drug resistant infections ➡️ www.imperial.nhs.uk/about-us/news/gsk-backs-fleming-initi…
The @FlemingCentre is a collaborative partnership between @ImperialNHS and @imperialcollege to tackle anti-microbial resistance around the world. 1/ -
GSK
@GSK
By uniting our leadership in prevention and treatment of infectious diseases with @imperialcollege and @imperialNHS’s world-class clinical and research expertise, we’re addressing the global health impact of #antimicrobialresistance, together.
#fleminginitiative @FlemingCentre
Fleming Initiative
@FlemingCentre
We’re proud to announce our partnership with @GSK as we continue to tackle #antimicrobialresistance by driving innovation, public engagement, multi-disciplinary research and policy.
Together we can get ahead of #amr
Read more ⤵️
gsk.to/3yjyV4T -
GSK
@GSK
We’re excited to be partnering with the #fleminginitiative on this innovative approach to tackling #amr, and grateful to His Royal Highness the Prince of Wales for his ongoing support #aheadtogether #antimicrobialresistance
The Prince and Princess of Wales
@KensingtonRoyal
The Fleming Initiative is dedicated to combating antimicrobial resistance, and is at the forefront of research and innovation.
Proud to be Patron of the appeal for its creation 👇 -
GSK
@GSK
Getting ahead of #antimicrobialresistance is critical to protecting modern medicine as we know it. But we can’t do it alone.
Our CEO, Emma Walmsley, spoke with @Ara_Darzi on how we will be the founding partner of the global @FlemingCentre - tackling #amr, together: -
GSK
@GSK
Our CEO, Emma Walmsley, is at an event with @RoyalSociety today celebrating global efforts and initiatives to tackle #antimicrobialresistance, including our new partnership with #fleminginitiative shared earlier today: gsk.to/44HroZD
-
GSK
@GSK
We’re building on decades of innovation and turning science into solutions with the aim free people from the constraints of respiratory conditions like asthma and COPD.
Check out this video in the lead up to #ats2024.This media couldn't be displayed. See it on the original post. -
GSK
@GSK
We’re proud that we will be the first founding partner of the global #fleminginitiative – an innovative and collaborative approach to tackle #antimicrobialresistance around the world.
Together we can get ahead of #amr @FlemingCentre
Read more: gsk.to/3yjyV4T
GSK
@GSK
The #fleminginitiative is a partnership between @imperialcollege and @ImperialNHS. Learn more: www.fleminginitiative.org
-
GSK
@GSK
We are excited to be attending the upcoming #ats2024 Congress. Hear from Dr. Imran Satia about the significant impact of refractory chronic cough on patients and healthcare professionals. #refractorychroniccough
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
At GSK respiratory innovation looks beyond short-term symptom control, to a patient’s future too. We aim to protect people from infections, prevent deterioration, exacerbations, lung damage and disease progression. #ats2024
Find out more 👇
gsk.to/3QFTw9G -
GSK
@GSK
Nearly 5 million people worldwide have lupus. If left unmanaged, this chronic autoimmune condition can progress and lead to severe disease flares.
This #worldlupusday, find tips for talking with your doctor: lupusbutterflyeffect.com/important-questions-to-ask-your-…
#makelupusvisible #lupusawareness -
GSK
@GSK
Everyday we’re working to push the frontiers of respiratory medicine. We’re committed to deliver the next generation standard of care in asthma treat the symptoms and the underlying cause of inflammation, exacerbations and cumulative lung damage.
-
GSK
@GSK
This World Ovarian Cancer Day, we are raising awareness for the tens of thousands of women diagnosed with #ovariancancer each year. Hear from Carmen about navigating her diagnosis. #wocd2024 #nowomanleftbehind
-
GSK
@GSK
Our CEO Emma Walmsley has been at #miglobal sharing how we’re using science and tech to prevent and change the course of disease – and why we’re partnering with @MilkenInsitute to help health systems invest in prevention and earlier intervention: gsk.to/4bnNeDA
-
GSK
@GSK
For more than 50 years, inhalers have helped millions of people manage their asthma, but they also contribute to greenhouse gas emissions.
Discover why low carbon inhalers could help patients while reducing our environmental impact. #worldasthmaday
gsk.to/3wb2Mf8 -
GSK
@GSK
#worldasthmaday is a day when we ask, ‘can more be achieved for people with #asthma?’
Joelle had life-threatening asthma attacks before being diagnosed with a specific type of #severeasthma. Check out her story: gsk.to/3xZNPgd.
GSK
@GSK
Globally, how many people have asthma?
-
GSK
@GSK
On #worldasthmaday we say thank you to the patients in our clinical trials or share their experiences, the experts and patient organisations who partner with us and GSK employees who are working tirelessly to deliver the next generation of #asthma care.
-
GSK
@GSK
From vaccines to help protect all stages of life to working to change the course of diseases like asthma and hepatitis B, we’re innovating to get ahead of disease, together. Read more 👉 gsk.to/3Wt2dI2
-
GSK
@GSK
We’re pleased to be the founding partner of Project Prevent, a new initiative from @MilkenInstitute bringing together cross-sector experts to accelerate investment in, and access and uptake of, preventative healthcare. #miglobal
Find out more:
gsk.to/4bnNeDA -
GSK
@GSK
Looking forward to our CEO Emma being part of the conversation on shaping our shared future at #miglobal this weekend.
Milken Institute
@MilkenInstitute
Join us LIVE from May 5-8 for Global Conference 2024 to hear how @KGeorgieva , David Beckham, @ValerieJarrett, @fedex CEO Raj Subramaniam, @GSK CEO Emma Walmsley, @IvanDuque, and many more will be shaping a shared future!
Explore our full lineup here: milkeninstitute.org/events/global-conference-2024
#miglobal #future #innovation #leadership -
GSK
@GSK
Get to know our #targetthefuture grant recipient: @CancerSupportHQ! Learn more about how their programme is connecting #multiplemyeloma patients and caregivers with vital resources: gsk.to/4aY7Z9i #aheadtogether
-
GSK
@GSK
Do you have #asthma or nasal polyps?
You are the experts on these conditions and your voice is important. We’re delighted to have partnered with @gaapporg on this survey to help improve understanding of these conditions.
Complete the survey here by 12 May
Global Allergy & Airways Patient Platform
@gaapporg
🌐 Have asthma or nasal polyps? Reside in the US, Canada, UK, Germany, Italy, France, or Spain? Your feedback on biologics can revolutionize patient education.
Take our short survey! 📊 #gaapp #healthsurvey #patientexperience
👉 Survey Link: www.surveymonkey.com/survey-closed/?sm=PbcqOYkG9JgXMGaT3p… -
GSK
@GSK
News for #investors and #media
We’ve announced our Q1 2024 results. Review our key highlights. For more insights, visit us at gsk.to/44kqCSf. $GSK -
GSK
@GSK
News for #investors and #media
Explore our Q1 2024 figures at a glance. gsk.to/4aUgYZ5. $GSK -
GSK
@GSK
#investors: Join GSK’s CEO Emma Walmsley and other members of our leadership team for our Q1 2024 live results webcast at 12:00 BST, 07:00 EDT. $GSK
-
GSK
@GSK
News for #investors and #media
Hear our CEO Emma Walmsley talk about our strong Q1 performance and learn more about our upgraded outlooks for the year.
For more, see gsk.to/3wgznQu
$GSK #news #q1results -
GSK
@GSK
#investors and #mediaplease read our cautionary statement regarding forward-looking statements and the definitions and reconciliations for non-IFRS measures for our Q1 2024 results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates. $GSK For investors: www.gsk.com/en-gb/investors/cautionary-statement/
-
GSK
@GSK
We’re announcing our Q1 2024 results tomorrow at 0700 BST, 0200 EDT. $GSK
-
GSK
@GSK
As people’s immune systems weaken with age, the burden of vaccine-preventable diseases rises. That’s what motivates us to work towards making adult immunisation the standard of care across the globe. #wiw2024 gsk.me/3JI28Jc
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
Did you know there are an estimated 82 million new gonorrhoea cases globally each year?
Go Behind the Science to learn more about disease prevention 👇 gsk.me/3JDJOkr -
GSK
@GSK
Nine projects have been funded through #projectafricagradient, a collaboration between GSK, @Novartis and @MRCza. Among them, Dr. Tekete and Dr. Ouédraogo are leading two important studies, looking at the impact of genetic diversity on malaria treatment #zeromalaria
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
Discover how we are leading the fight against #infectiousdiseases. Our ground-breaking research and development efforts are aimed at protecting communities worldwide. Learn more 👇
-
GSK
@GSK
#vaccination plays a crucial role in adult health and productivity. A recent report from @OHENews highlights the investment case for #adultvaccination, demonstrating its broader societal returns beyond individual health benefits.
IFPMA
@IFPMA
Investing in adult vaccination programmes can help protect lives, our healthcare systems and our economies. New study from @OHENews looks at data from across ten countries. Read more at www.ifpma.org/initiatives/vaccinesforlife #vaccinesforlife
-
GSK
@GSK
Today, Liberia introduces RTS,S into its routine immunisation programme. To support this, our partner @lastmilehealth is supporting the training of community health workers on delivering malaria vaccines as part of routine vaccination protocols in Liberia #worldmalariaday
-
GSK
@GSK
Our £1bn investment in global health R&D over 10 yrs will help get ahead of #malaria in lower income countries. From the world’s 1st malaria vaccine to novel antimalarials we support the global elimination of malaria by helping improve prevention and treatment. #worldmalariaday
-
GSK
@GSK
Investing in adult vaccination programmes plays a crucial role in protecting lives, healthcare systems and economies. The new report from @OHENews evidences the Socio-Economic Value of Adult Immunisation Programmes. Check it out 👇
IFPMA
@IFPMA
New study from @OHENews demonstrates the role vaccines play in supporting our healthcare systems and economies. Read “The Socio-Economic Value of Adult Immunisation Programmes” at www.ifpma.org/initiatives/vaccinesforlife #vaccinesforlife
-
GSK
@GSK
For the past two years, 100% of our Phase III clinical trials have had diversity plans to reflect the people most impacted by a particular disease. Find out more: gsk.to/4aNG1Nk
-
GSK
@GSK
#news for #investors and #media: Our application for a potential expanded indication for our immuno-oncology therapy has been accepted by the @US_FDA with Priority Review status. Learn more here: gsk.to/3xPNPzv
-
GSK
@GSK
Today @savechildrenuk is launching a new 'Immunisation Accelerator' to find innovations that address the barriers that exist for children receiving vaccinations. Here's Save the Children’s Dr Tewodros Gebremichael to explain more 👇 gsk.to/44abLtu
-
GSK
@GSK
Margaret’s family has been deeply affected #malaria, but thanks to the support of Gaudenciah, a community health promoter trained by @Amref_Worldwide through our partnership, she is now able to access the healthcare she needs. #worldmalariaday gsk.to/3xJRKOj
-
GSK
@GSK
#news for #investors and #media: Today we have announced phase III data in uncomplicated urogenital gonorrhoea (GC).
Find out more gsk.to/4aAlU5a -
GSK
@GSK
For #investors and #media: Today we announced new positive long-term follow-up trial data in shingles.
Find out more: gsk.to/4aXTRvY -
GSK
@GSK
#news for #media and #investors: Today, we announced that the Biologics License Application for our vaccine candidate has been accepted by the @US_FDA.
Find out more: gsk.to/49FPPrl -
GSK
@GSK
Closing the health equity gap is better for everyone, not just those who face barriers to accessing high quality healthcare.
This is how companies like GSK are working with partners to find solutions:
gsk.to/43RijNj -
GSK
@GSK
All patients deserve access to high quality healthcare, yet the needs of many go unmet due to preventable factors.
This is why closing the health equity gap not only benefits those facing barriers to access, but society as a whole: gsk.to/43ZlvGP -
GSK
@GSK
“A disease that was once almost uniformly fatal is now a disease that can be controlled with treatment” – getting ahead of HIV is one way we’re innovating to help prevent and change the course of disease.
Find out more 👇
@ViiVHC gsk.to/3xk3iHH -
GSK
@GSK
So far, 75 health systems around the world have committed to lowering their carbon footprint.
Read the latest FT article, in partnership with GSK, to discover how low carbon inhalers could be key to reducing their emissions. gsk.to/3TMhRLR -
GSK
@GSK
Biomarker testing is helping doctors find precision treatments for patients that could dramatically improve health outcomes for everything from cancer to respiratory disease: gsk.to/4ap5cFu
-
GSK
@GSK
Meet Lou – a patient with #multiplemyeloma who shares what life can be like for those living with this blood cancer. This #myelomaactionmonth we are inspired to keep driving progress for patients like Lou. Get to know her story here: gsk.to/3xcUjbf
-
GSK
@GSK
Modern medicine has revolutionised the way we live, but the challenges to our health are evolving. We believe prevention is the best medicine – for patients, societies and our economy.
This is why: gsk.to/43JFUj1 -
GSK
@GSK
Our Mapping myelofibrosis podcast allows us to sit down with myelofibrosis experts, to learn more and discuss how we can collectively work together to close the gaps in complex #bloodcancers.
Watch it here: gsk.to/4am8xoM
#mappingmf -
GSK
@GSK
Frustrated by lack of awareness of #myelofibrosis, Thomas educated himself and identified a care team to better navigate his cancer journey. His story sheds light on challenges people with complex #bloodcancers face.
Read more in @ReutersPlus: gsk.to/3TqEJA8 -
GSK
@GSK
On #worldtbday, we stand with the global TB community, reaffirming our commitment to help #changethetrajectory of this disease in lower income countries by investing in innovative partnerships and working with communities at the heart of the epidemic. #yeswecanendtb
-
GSK
@GSK
TB is a complex disease, making it challenging to prevent and treat. As drug-resistant strains continue to emerge, its vital we work with partners to find new and innovative ways to get ahead of TB and contribute to ending the epidemic.
#yeswecanendtb #worldtbday -
GSK
@GSK
Patients are at the centre of everything we do. In episode 2 of our Mapping myelofibrosis podcast, we sat down with Kapila Viges, CEO of @MPN_RF to better understand the unmet needs in research & care for the #myelofibrosis community. Watch here: gsk.to/4a3yxVX
-
GSK
@GSK
As #worldtbday approaches, we’re delighted to share a new episode of TB Voices featuring Pamella. Her story highlights the importance of understanding TB and advocating for yourself to get the right diagnosis and treatment. gsk.to/3xbwrVk #yeswecanendtb
-
GSK
@GSK
Dr. Veron Ramsuran from @UKZN shares his groundbreaking work as part of #projectafricagradient.
By studying human genes and their response to TB drugs among African populations, he's on a mission to find better ways to diagnose and treat TB patients. -
GSK
@GSK
When Betty’s daughter, Rebecca, became unwell, her determination to help her get the right diagnosis of TB was unwavering. With the support of community nurse Daisy, they've been working together to ensure Rebecca's recovery. #worldtbday #yeswecanendtb
-
GSK
@GSK
#news for #investors and #media:
Together with the clinical community, we’ve been advancing #gynaecologic cancer research. We’re pleased to share our latest findings at the 2024 #sgomtg.
Learn more: gsk.to/3IFroPK -
GSK
@GSK
We’re excited to be at #isppd in Cape Town from March 17-20 to engage with the global pneumonia and pneumococcal community.
Learn how we want to innovate in this area - and continue to advance science against these diseases together 👇 gsk.me/49T8HUF -
GSK
@GSK
What an incredible and inspiring day meeting @ghettokidstfug from Uganda. We were privileged to hear their stories and share with them how our science and innovation are making a difference in the fight against malaria. #zeromalaria
Zero Malaria
@ZeroMalaria
.@ghettokidstfug are in London to turbocharge the fight to end malaria. Their positive energy and hope is contagious. Yesterday they met a British scientist working on the malaria vaccines @GSK, then UK Foreign Secretary, @David_Cameron. They don’t hang about #zeromalaria
-
GSK
@GSK
This #myelomaactionmonth, @IMFmyeloma is empowering the #multiplemyeloma community to take actions that support patients. Follow along as we raise awareness by highlighting perspectives from patients and advocates this month.
-
GSK
@GSK
Through #projectafricagradient, an initiative we support with @Novartis and @MRCza, scientists are studying genetic variation amongst African populations. Carene Ndong Sima from @StellenboschUni is looking at understanding how people’s genes affect their responses to TB drugs.
-
GSK
@GSK
Colorectal cancer can be hard to diagnose because symptoms often don’t present during its early stages—that’s why regular screenings are so important to help increase early detection.
This #colorectalcancerawarenessmonth, get informed about testing: gsk.to/3v1F4RM -
GSK
@GSK
This International Women’s Day, we’re celebrating GSK people who #inspireinclusion by making a positive impact on women’s health and helping to forge a more inclusive world for women. Find out more 👇
#iwd2024 -
GSK
@GSK
HIV remains one of the world’s biggest health threats and while great strides have been made in HIV treatment, stigma remains a challenge.
We are committed to changing that, by minimising the impact of HIV on people’s lives through treatment, prevention and ultimately cure. -
GSK
@GSK
#news for #investors and #media:
Today we announced positive headline results from a phase III clinical trial evaluating one of our #bloodcancer therapies.
Learn more: gsk.to/3V5As7K -
GSK
@GSK
News for #investors and #media: Today @ViiVHC, our specialist HIV company, have announced an update on the LATITUDE study evaluating adherence challenges faced by people living with #hiv.
Find out more: gsk.to/49X29E3 -
GSK
@GSK
With the support of @Novartis and @MRCza, we’re proud to contribute to #projectafricagradient which funds research on genetic diversity in Africa. One project, led by Professor Collen Masimirembwa from @WitsUniversity, is looking at certain patients’ reactions to TB drugs 🔬
-
GSK
@GSK
#investors and #media
As well as our #gskannualreport we have published our #esg Performance Report 2023, summarising our progress on our ESG focus areas. See some of our highlights here.
More: gsk.to/7187 -
GSK
@GSK
A new app could help in the quest to develop new HIV treatments designed with quality of life in mind. Long-acting medicines, for example, give patients the option of doing away with daily routines that are challenging for some. Read more in our article 👇
gsk.me/43k15rX -
GSK
@GSK
News for #investors and #media: Phase I findings presented today at #croi2024 by our specialist HIV company, @ViiVHC, set the stage for the next generation of medicines.
Find out more: www.gsk.com/en-gb/ -
GSK
@GSK
To positively impact the health of 2.5 billion people, we need exceptional talent. Cynthia's story highlights how diverse teams offer unique insights, helping us to better understand the needs of diverse patients: gsk.to/3wHG3Y0
-
GSK
@GSK
#investors and #media
We’ve published our 2023 #gskannualreport and #esg Performance Report. See how we are living up to our commitments to get ahead of issues that matter for society, company sustainability and GSK people.
More: gsk.to/3ThcdCh -
GSK
@GSK
#investors and #media
In our 2023 #gskannualreport, CEO Emma Walmsley, reflects on our progress. With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide. -
GSK
@GSK
#investors and #media
We’ve published our 2023 #gskannualreport and
#esg Performance Report. Learn how we are uniting science, technology and talent to get ahead of disease together for health impact, shareholder returns and thriving people
More: gsk.to/3IlY40g -
GSK
@GSK
#investors and #media:
Read our cautionary statement regarding forward-looking statements and the definitions and reconciliations for non-IFRS measures in our 2023 Annual Report #gskannualreport.
gsk.to/49WPHnB -
GSK
@GSK
Today is #rarediseaseday. From the rare to the more common, we’re striving to improve outcomes for people with a range of immune-mediated diseases.
Read more about how biologic therapies are advancing our care ambitions for people with rare conditions.
gsk.to/3P252ey
GSK
@GSK
Do you know what a biologic medicine is or their role in the treatment of a range of conditions such as #egpa, #hes, #asthma or #lupus?
This #rarediseaseday learn more about the role of biologics in immune-mediated conditions.
gsk.to/3P252ey -
GSK
@GSK
#investors and #media
We’re publishing our Annual Report tomorrow. At GSK we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade. #gskannualreport. -
GSK
@GSK
The study of immunology has advanced the management of immune-mediated diseases from more common conditions like #asthma & lupus to rare conditions like EGPA or HES.
This #rarediseaseday learn about how biologics are advancing treatment in this field. gsk.to/4bU0D7l -
GSK
@GSK
News for #investors and #media: @ViiVHC, our specialist HIV company, are presenting 64 abstracts from our innovative pipeline and portfolio of medicines at #croi2024
Find out more: gsk.to/3SNUaCk -
GSK
@GSK
Antibiotics were one of the most significant medical discoveries of the 20th century.
Go Behind the Science to learn more about the need for antibiotics: gsk.to/4a6wr7B -
GSK
@GSK
We’re proud to have @ViiVHC, our specialist HIV company, presenting at #croi2024
ViiV Healthcare
@ViiVHC
At #croi2024, we will be showcasing our commitment to producing the next generation of treatment and prevention options for people living with #hiv
More here: viivhealthcare.com/hiv-news-and-media/medical-conferences…
#wewontstop -
GSK
@GSK
We think about HIV every day so people like Warren won't have to.
Read about our work in HIV: gsk.me/3uKUyJV 🔬
@ViiVHC -
GSK
@GSK
Welcome to Shingles Awareness Week 🎉
Shingles is a painful disease with potentially long-lasting complications.
Tune in and learn more about Shingles with Lionel, @IFAgeing, @ILCUK, @EFIC_org and GCOA👇
gsk.me/4bPmDjS -
GSK
@GSK
Hear Prof Ian Pavord, Professor of Respiratory Medicine at the University of Oxford, discussing the possibility of achieving clinical remission in certain types of #asthma 👇
Learn more gsk.to/3uNbU8U
#aaaai24 #respiratory -
GSK
@GSK
#news for #investors and #media: Today we have announced positive headline results from our phase III clinical trial evaluating our antibiotic in development. Find out more here. gsk.to/4301rDJ
-
GSK
@GSK
#news for #investors and #media: We have completed the acquisition of Aiolos Bio. We look forward to building on our expertise in respiratory medicines.
gsk.to/3uK91pc -
GSK
@GSK
#news for #investors and #media: Today we announced that the @US_FDA has granted Fast Track designation for our investigational medicine. Learn more: gsk.to/49wtmgx
-
GSK
@GSK
We’ll be at @ReSViNET in Mumbai from February 13-16 sharing knowledge as well as the latest results of our research.
Read this article below to find out more about RSV: gsk.to/49lvecc gsk.to/3OCxPXa -
GSK
@GSK
Do you have a game-changing data-driven idea to protect the power of antibiotics, focussing on low- and middle-income countries? The #trinitychallenge is welcoming applications.
Submit your solution by 29 February: gsk.to/3HRGRf3 -
GSK
@GSK
We’re pleased that our action on sustainability has been recognised by @CDP, scoring us an A- for tackling Climate Change, an A- for Water Security and Bs for Forests.
Learn more about our climate and nature goals: gsk.to/3UxCn50
#healthyplanethealthypeople -
GSK
@GSK
#news for #investors and #media: Tomorrow at the #ascoplenaryseries, we look forward to presenting positive results from our phase III clinical trial evaluating our blood cancer therapy. Learn more: gsk.to/42wrYIM
-
GSK
@GSK
On #worldcancerday, we’re inspired by the strength of the patient community. Today and every day, we strive to provide treatment options that can help patients get ahead of their disease.
#closethecaregap -
GSK
@GSK
Cancer is the second leading cause of death worldwide. As #worldcancerday approaches, our focus remains on driving research and innovation to bring novel treatment options to people living with cancer so we can #closethecaregap.
-
GSK
@GSK
“With knowledge comes empowerment.”
Our Head of Vaccines R&D Phil Dormitzer shares three key facts scientists have learned about RSV - and explains why they could help us protect those most at risk.
Read his article here: gsk.to/3OuH8bA -
GSK
@GSK
News for #investors and #media
We’ve announced our strong full year 2023 results. Swipe through our key highlights. For more insights, visit us at www.gsk.com. $GSK -
GSK
@GSK
News for #investors and #media
Explore our full year 2023 figures at a glance. Dive into the data: www.gsk.com. $GSK -
GSK
@GSK
#investors: Join GSK’s CEO Emma Walmsley and other members of our leadership team for our full year and Q4 2023 live results webcast at 11:00 GMT, 06:00 EST. $GSK
-
GSK
@GSK
News for #investors and #media
Watch our CEO, Emma Walmsley, share strong full year and Q4 2023 results and upgrades to our growth outlooks.
For more, see gsk.com
$GSK #news -
GSK
@GSK
#investors and #media Cautionary statement regarding forward-looking statements & the definitions & reconciliations for non-IFRS measures for our results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates.
For investors: gsk.to/47Woznl -
GSK
@GSK
We’re announcing our full year and Q4 results tomorrow at 0700 GMT, 0200 EST. $GSK
-
GSK
@GSK
On #worldntdday, we stand united with @WHO and the global NTD community to eliminate and control NTDs. Our targeted R&D and medicine donations are making strides in eliminating lymphatic filariasis and treating soil-transmitted helminths. #beatntds
-
GSK
@GSK
#news for #investors and #media: Today the European Commission granted authorisation for our blood cancer therapy.
Learn more: gsk.to/47NZZoV -
GSK
@GSK
We welcome this new initiative from the government. Read what Emma Walmsley, our CEO, has to say about it 👇
“We’re very optimistic about the opportunities for positive impact from AI, not just for GSK but for the UK’s short and long-term economic growth, innovation and skills development. The UK has the potential and talent to exploit these transformative technologies, but faster adoption is key. This new forum brings together businesses large and small with AI developers to develop practical ideas and support and we look forward to contributing.”
Department for Science, Innovation and Technology
@SciTechgovuk
Adopting AI means greater productivity for businesses, accelerated growth, and new high-paid jobs.
Read more on the new AI Opportunity Forum which has been launched today 👇
www.gov.uk/government/news/business-and-tech-heavyweights… -
GSK
@GSK
Robots, #ai, machine learning and other technological advances are transforming the factory floor and ultimately enabling us to get our medicines and products to the people who need them faster.
Read our article on #smartmanufacturing to find out more:
gsk.to/4b53NVo -
GSK
@GSK
Congratulations, Cameroon!
It’s a proud day for us at GSK, seeing the official launch of our groundbreaking malaria vaccine – the world's first – as a routine vaccination in malaria endemic countries.
WHO African Region
@WHOAFRO
It's official!
Cameroon🇨🇲 has now introduced the RTS,S malaria vaccine into its expanded vaccination programme, following a 4-dose schedule.
Baby Daniella is the first baby to be vaccinated!
#vaccineswork -
GSK
@GSK
Robots, #ai, machine learning and other technological advances are transforming the factory floor – and for the biopharma industry, this is just the start.
Read our article to find out more: gsk.to/3Hqkhdc
#smartmanufacturing #digitaltransformation -
GSK
@GSK
Breaking news! Cameroon is the first country outside of the WHO-coordinated pilot to roll out our groundbreaking malaria vaccine, Mosquirix. After 35 years of hard work, we're incredibly proud of our team for developing this vaccine and making it accessible to those who need it.
-
GSK
@GSK
Do you know how many under 18s missed out on one or more vaccinations between 2019 and 2021?
GSK
@GSK
Disruptions to immunisation services between 2019 and 2021 resulted in 67 million under 18s missing out on vaccines.
This continues to have serious consequences – including recent outbreaks of preventable disease.
Read our article to find out more:
www.gsk.com/en-gb/behind-the-science-magazine/child-immun… -
GSK
@GSK
We believe prevention is the best medicine – for patients, societies, and our economy.
Here’s why: gsk.to/4aLSLUO
#aheadtogether #jpm24 #jpm2024 -
GSK
@GSK
#news for #investors and #media: Today we announced positive news that our medicine has been approved in China for the treatment of severe asthma with an eosinophilic phenotype in certain patients. Learn more 👉 gsk.to/3TV1U7I
-
GSK
@GSK
#investors and #media: Hear Emma Walmsley, our CEO, talk live today at #jpm2024 about our exciting year ahead, at 1030 EST / 0730 PT / 1530 GMT. Her presentation will be followed by a Q&A.
Tune in here: gsk.to/4aHkciK -
GSK
@GSK
We believe prevention is the best medicine. It’s why we’ve built one of the broadest vaccine portfolios in the world to help protect all stages of life. #aheadtogether #jpm24 #jpm2024
-
GSK
@GSK
#news for #investors and #media: Today we announced that we have entered into an agreement to acquire Aiolos Bio to build on our expertise in respiratory medicines
Link: gsk.to/3H9xzdY -
GSK
@GSK
We believe the bigger the challenge, the bigger the need for collaboration. We have long been committed to partnering with the world's best minds - like Wave Life Sciences - at the intersection of science & tech. #aheadtogether #jpm24 #jpm2024
More: gsk.to/48urF39
1/2
GSK
@GSK
Our acquisition of Affinivax.
Find out more about our collaborations: gsk.to/48urF39
2/2 -
GSK
@GSK
#investors and #media can listen to Emma Walmsley, our CEO, speaking live at #jpm2024 at 1030 EST / 0730 PT / 1530 GMT tomorrow, followed by a Q&A.
Tune in here: gsk.to/41KIRPq -
GSK
@GSK
#investors and #media: On Tuesday 9 January our CEO, Emma Walmsley and Chief Scientific Officer and President, R&D, Tony Wood will be joining the annual JP Morgan Healthcare Conference as we kick off another exciting year for GSK. #jpm2024 #jpm24
gsk.to/3S9Fy18 -
GSK
@GSK
We’re looking forward to meeting investors & industry colleagues at next week’s JP Morgan Healthcare Conference in San Francisco and sharing more about our focus on prevention to get ahead of disease. #jpm2024 #aheadtogether #jpm24
gsk.to/3H7LnWg -
GSK
@GSK
Do you know what percentage of total health spending is dedicated to #prevention across wealthy countries?
GSK
@GSK
Only around 3% of total health spending is dedicated to #prevention across wealthy countries, resulting in people living with diseases that could have been prevented or managed sooner.
Read our article for more on why we believe prevention is the best medicine 👇 -
GSK
@GSK
Wishing you a happy and healthy 2024!
#happynewyear -
GSK
@GSK
A patient-centred approach is key to transforming #respiratory care and relieving struggling services. Read our article to find out how our scientists are helping to make that a reality 👇
gsk.to/3NAHkpd -
GSK
@GSK
Investing in adult vaccine programs is not only beneficial for individuals but also for society as a whole. CEO of the Global Coalition on Aging, @MWHodin, calls for collective action to make adult immunisation the new standard of care 👇 #gcoa
gsk.to/3TyAKTX -
GSK
@GSK
The ‘tripledemic’ will hit older people hard this winter – but there are things we can all do to reduce the impact. Read our article to find out more 👇
gsk.to/3vb3N5Y -
GSK
@GSK
By responsibly harnessing #ai, we can transform healthcare and deliver better outcomes for patients. Below, our AI experts discuss how we can embrace this powerful technology to accelerate delivery of new medicines and vaccines 👇 gsk.to/3TElIvV
-
GSK
@GSK
Achieving clinical remission for severe asthma patients could significantly improve their quality of life and minimise the risk of attacks. Read our article about the solutions we're developing to get there 👇 gsk.to/3trRn9i
-
GSK
@GSK
Wishing you a holiday season filled with joy and peace!
-
GSK
@GSK
We're committed to help raise awareness among those who are most at risk of RSV, especially older adults and those with health conditions. Safeguard yourself and your loved ones this holiday season by consulting your healthcare professional and learning how to reduce risk.
-
GSK
@GSK
We’re thrilled to announce the next #targetthefuture grant recipient: @CancerSupportHQ! Its Multiple Myeloma Digital Engagement Program provides resources that bridge the digital divide for patients. Learn more: gsk.to/3NAsKy1
-
GSK
@GSK
#news for #investors and #media: Today we announced that we have entered into another agreement with Hansoh Pharma to further expand our portfolio of clinical-stage antibody-drug conjugates.
Learn more: gsk.to/3TtM3wL -
GSK
@GSK
#news for #investors and #media: Today we announced new positive headline results from our trial exploring the combination of two of our #cancer therapies. Learn more: gsk.to/3GLZZKR
-
GSK
@GSK
People don’t have to look, feel, or act their age, but the fact is that as the human body ages, the immune system declines in strength, increasing the risk of infection.
Read our article to find out what can be done about it 👇
gsk.to/4agcgVx -
GSK
@GSK
As we age, our immune systems undergo a series of changes that lowers their effectiveness.
Read our article to find out why this matters – and what can be done about it 👇
gsk.to/46VP8sC -
GSK
@GSK
Proudly partnering with @Amref_Worldwide for 35 years, we've impacted around 10m people in 17 African countries. As we enter 2024, we're excited to launch two new programmes on AMR and malaria.
Together, we're driving lasting health change in Africa. gsk.to/4ajOeca -
GSK
@GSK
Partnerships are key to helping #changethetrajectory of diseases impacting children in lower income countries. Together with @FT we've examined the critical role of partnerships with @savechildrenuk, @PATHtweets, and @EGPAF.
Learn more: gsk.to/46ZEdOk -
GSK
@GSK
We believe it’s important to have a greater understanding of the complex relationship between climate change, asthma care and the environment.
Take a look at a new report from @economistimpact and sponsored by GSK, with actions we can make: gsk.to/3RDHjTG -
GSK
@GSK
Innovation and collaboration are key elements in our work to improve #cancer care globally. The Middle East’s R&D capabilities are growing and hold promise for addressing unmet patient needs.
Read about it in @Forbes_MENA_: gsk.to/3t3Q0NX -
GSK
@GSK
#news for #investors and #media: Today, the European Commission granted authorisation for a new indication for our immuno-oncology therapy.
Learn more here: gsk.to/3thFmmA -
GSK
@GSK
The @ASH_hematology Annual Meeting provides an important forum for researchers and members of the #bloodcancer community to gather and discuss scientific advances in #myelofibrosis and #multiplemyeloma.
Learn more: gsk.to/3RfNsEl
#ash23 -
GSK
@GSK
Medical treatments for respiratory conditions are moving beyond a one-size-fits-all model to take aim at underlying causes in individual patients.
Here, our experts explain why this patient-centred approach is so transformative: www.gsk.com/en-gb/behind-the-science-magazine/patient-cen… -
GSK
@GSK
We all have a role to play to #changethetrajectory of the impact of climate change on human health. At #cop28uae, we hosted an insightful discussion with climate and health experts, reflecting on Health Day and the importance of turning conversation into action.
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
Thanks to @Forbes for including our CEO Emma Walmsley on the 2023 World's Most Powerful Women list, representing the most dynamic female business leaders making an impact on the world today. #aheadtogether
Forbes
@Forbes
The World’s Most Powerful Women
This year’s list represents the most dynamic female business leaders, entrepreneurs, investors, philanthropists, and politicians making an impact on the world today.
SEE LIST: www.forbes.com/lists/power-women/
#powerwomen -
GSK
@GSK
Climate change & nature loss are changing the spread and burden of disease with the most vulnerable communities bearing the brunt. Our CEO Emma & WHO's Vanessa Kerry discuss how we’re getting ahead of the health impacts of climate change together #cop28uae gsk.to/4ab9pNu
-
GSK
@GSK
Together with our partners, we work in lower income countries where children’s health is affected by climate change. Routine immunisations can offer a first line in defence against disease outbreaks and is at the heart of our partnerships with @gavi and @savechildrenuk #cop28uae
-
GSK
@GSK
“Respiratory disease is certainly on the rise, acute and chronic, keeping people from breathing freely and fully," says @Tonya_Winders, CEO of @gaapporg.
Here's why she agrees that a patient-centred approach is key to solving the crisis: www.gsk.com/en-gb/behind-the-science-magazine/patient-cen… -
GSK
@GSK
Climate change is creating new health threats. In this article, created in partnership with the @FT, we explain why, with our partners, we’re in the race to eradicate infectious diseases in the face of climate change. gsk.to/3sWJBUL #cop28uae
-
GSK
@GSK
Symptoms of #myelofibrosis can present and progress differently for everyone. Through our ongoing research, we are working to improve the outcomes and quality of life for people living with this #bloodcancer.
Find out more: gsk.to/3uLldG0
#ash23 -
GSK
@GSK
“This is an investment, not an expense.” Climate change is impacting the spread and burden of disease and accelerating anti-microbial resistance. Vaccines can help protect people’s health but are under-recognised and under-resourced. Read more: gsk.to/4a7DUnl #cop28uae
-
GSK
@GSK
News for #investors and #media: Today, in collaboration with @IQVIA_Institute and #gcoa, we shared new data funded by GSK uncovering inequities in adult vaccine uptake.
Read more about “Trends in Global Adult Vaccination: A View from Five Global Cities”: gsk.to/46Kyzj9 -
GSK
@GSK
People all over the world are struggling to breathe because of respiratory infections and chronic diseases. But further damage may be prevented taking a patient-centred approach. In this article, our experts explain why: www.gsk.com/en-gb/behind-the-science-magazine/patient-cen…
-
GSK
@GSK
🌍 A new global survey, commissioned and funded by GSK, uncovers important misconceptions about what causes shingles disease.
The data highlights the importance of accessing health information from HCPs or reliable online sources 🩺
Find out more: gsk.to/3sRaIR6 -
GSK
@GSK
This #idpwd, we're sharing how we embrace diversity to positively impact the health of people with disabilities. Chiko describes how we include the voices of diverse patients, helping us to design and develop more inclusive medicines and devices. gsk.to/3N43vDX
-
GSK
@GSK
It’s #healthday at #cop28uae, and we’re sharing more about the tangible action we are taking to get ahead of climate change and nature loss.
Follow us to find out more.
#healthyplanethealthypeople -
GSK
@GSK
Congratulations to our #targetthefuture finalists! 🏅
Their ideas to bring positive change to the multiple myeloma patient community are so inspiring.
Stay tuned to find out who will receive our $100,000 grant to bring their idea to life.
Learn more: gsk.to/3RpIO8c -
GSK
@GSK
Our VP Sustainability, Claire Lund, is at #cop28uae. This Sunday she'll be joining a panel to discuss net-zero and resilient healthcare systems, in honour of Health Day. Join online at: ftcop.live.ft.com
Financial Times Live
@ftlive
What actions are healthcare leaders taking to reduce their carbon emissions?
Join the conversation on 3 December at COP28.
In person and online at: ftcop.live.ft.com -
GSK
@GSK
Four decades of innovation in HIV treatment has transformed the lives of patients. Now, a new app could improve things further by helping clinicians to identify hidden factors that impact their quality of life.
Read our article here: gsk.to/3RjDJOG
#worldaidsday2023 -
GSK reposted
ViiV Healthcare
@ViiVHC
On #worldaidsday, we continue to partner with the HIV community to in the fight to #endhivstigma 💪
Our #hivinview partners @BexDeHavilland, @AxelRBautista, @VictoriaRoscow, @Inad_Rie, and @D_Moraa share why it's important to #letcommunitieslead. -
GSK
@GSK
We are proud to be a part of the consortium for @UK_Biobank that today unveiled data from whole genome sequencing of 500,000 participants. This data is important in deepening our understanding of disease and patients.
#aheadtogether #500kgenomes -
GSK
@GSK
We’re part of @TheSMI Health Systems Task Force. Together, we’re helping our suppliers source renewable power to decarbonise the healthcare supply chain.
Learn about our joint actions to make more sustainable healthcare systems: gsk.to/46AokxU
The Sustainable Markets Initiative
@TheSMI
Members of our Health Systems Task Force are collaborating to scale renewable power in China & India. Learn about our joint actions and commitments to accelerate the delivery of net zero health systems: smi.netlify.app/editor/?token=CmP4YC3GJfhyymQNOv4VWgtt&pa…
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
Excited to be ranked #2 among large organisations in @Computerworld’s annual list of Best Places to Work in IT. Find out more 👇
#aheadtogether #gskproud #bestplacesit gsk.to/46xCboE -
GSK
@GSK
We’re getting ready for #cop28uae 🌍 which will include the first ever #healthday. Together, we have a chance to get ahead of this threat and stop disease in its tracks.
-
GSK
@GSK
📣 Applications for this year’s #africaopenlab are now open! This global health initiative supports early career African scientists’ research projects into infectious diseases that disproportionately affect sub-Saharan Africa.
Learn more: www.gsk.com/AfricaOpenLab #cphia2023 -
GSK
@GSK
Tune in on 29 Nov. to @EconomistEvents’ Insight Hour to hear from Ali Çimen, our Head of Medical Affairs, Europe, on the innovations we are advancing in oncology research to provide transformational therapies for people with cancer.
Learn more: gsk.to/40ODnCP -
GSK
@GSK
As part of #theclimateandus series, we embark on a journey to Nepal to explore the impact of climate change on typhoid and learn why partnership is vital in helping protect children from the disease #cop28uae
-
GSK
@GSK
#news for #investors and #media: Today we announced positive headline results from a trial evaluating our #cancer treatment.
Learn more: gsk.to/3QVch8j -
GSK
@GSK
Optimising adult immunisation uptake can support healthy ageing and drive a healthy economy.
Join us in getting #aheadtogether to protect the health of our ageing society: gsk.to/3MYOXpj -
GSK
@GSK
Do you know how many drug candidates - potential medicines - fail at some point during testing using traditional methods?
GSK
@GSK
90% of drug candidates fail.
Luckily, our scientists harness the power of technology to make more efficient progress. Find out how we’re using modern technologies to double the odds of making medical discoveries: gsk.to/3MVzF4k -
GSK
@GSK
“It’s about opening the eyes of young people to know they’ve got options.”
At GSK, we are committed to supporting diversity in STEM. Read our article to find out more about our new funding scheme: gsk.to/3RbMLgm -
GSK
@GSK
There has always been fear about new technologies, argue GSK’s leading AI experts, but that shouldn’t hold us back from realising the incredible potential of artificial intelligence.
Read their article here: gsk.to/3GeXv7s -
GSK
@GSK
As we think about how to help people live healthier lives, there is a clear opportunity to shift from funding 'sickness systems' to investing in earlier action to prevent, diagnose and treat disease.
Here's why we think that's important: www.gsk.com/en-gb/behind-the-science-magazine/prevention-… -
GSK
@GSK
Adult vaccination can help to reduce morbidity, mortality, and healthcare costs.
Find out how we can get #aheadtogether in improving rates of adult immunisation: gsk.to/3sNExln -
GSK
@GSK
#dyk that by 2050, Antimicrobial Resistance (#amr) could lead to 10 million deaths every year globally? #vaccination could have a role in helping prevent some infections and ensuring a healthier future for our societies. Find out more 👇
#waaw gsk.to/3MWBcav -
GSK
@GSK
We’re part of #theclimateandus series that draws links between climate and health. Join us at our manufacturing site in Nashik, India where we’re reducing our water impact and working with local partners to increase water security. For more: gsk.to/47nAifv
#cop28uaeThis media couldn't be displayed. See it on the original post. -
GSK
@GSK
When Cheryl’s late husband was diagnosed with #myelofibrosis, she was driven to learn as much as possible about the #bloodcancer and inspired to support the community.
Listen to our first episode of #mappingmf to hear Cheryl’s experience: gsk.to/3G88EHp
#aheadtogether -
GSK
@GSK
News for #media and #investors: We’re announcing a major step towards our sustainability ambitions with advancement to phase III trials for our metered dose inhaler. Find out more: gsk.to/40NPEY4
-
GSK
@GSK
DYK myelofibrosis signs and symptoms can be different for each patient? To increase understanding of this complex blood cancer, we’re introducing the #mappingmf podcast. #aheadtogether
Tune into our first episode, A Caregiver’s Journey, to learn more: www.youtube.com/watch?v=g4_lXUdsaN8 -
GSK
@GSK
Too often, our health systems are focused on reactive treatment, treating the symptoms of diseases rather than stopping them in the first place.
Here's why we think that's a problem: gsk.to/3QZFxvX -
GSK
@GSK
Modern medicine has revolutionised the way we live, but the challenges to our health are evolving. We believe prevention is the best medicine – for patients, societies, and our economy.
This is why: gsk.to/40DrNu0 -
GSK
@GSK
During this year’s @EconomistEvents’ #econworldcancerseries Europe, we shared the latest on how we are applying innovative technologies to improve outcomes for people with cancer, including our focus on advancing precision medicine in #oncology.
Watch some of the highlights. 👇 -
GSK
@GSK
#unionconf2023 focuses on one of the world’s most significant public health threats – TB. Our third episode of TB Voices offers a candid view from a team of dedicated healthcare professionals in Uganda, who are working to help prevent and treat TB. #endtb
-
GSK
@GSK
We’re investing in making STEM education more equitable to inspire and empower the next generation of diverse innovators who can help us discover and develop future medicines and vaccines. Find out more 👇
#gskstemuk -
GSK
@GSK
Ahead of #cop28uae, we’re excited to announce our #netzero targets have been approved by @sciencetargets. Delivery towards this target is part of how we’re working to get ahead of the health impacts of climate change.
Read more: gsk.to/40DK1LT
#sciencebasedtargets -
GSK
@GSK
The 2023 Lancet Countdown report on health and climate change is out, and it's clear that urgent action is needed. At GSK, we're getting ahead of the health impacts of climate change. As #cop28uae approaches stay tuned for more updates on our work related to climate and health.
The Lancet Countdown on Health and Climate Change
@LancetCountdown
OUT NOW: The Lancet Countdown 2023 Report
Drawing on the expertise of 114 scientists & health practitioners worldwide, this report provides our most comprehensive assessment of the links between climate change and health yet.
Read more: www.lancetcountdown.org/2023-report/ #lancetclimate23 -
GSK
@GSK
Biologics are helping to question what can be achieved in the treatment of immune-mediated conditions like EGPA, types of severe #asthma or #lupus.
Learn more about how we are working to target the root cause of immune-mediated conditions:gsk.to/47mbP9G
#acr23 -
GSK
@GSK
We’re in Paris for #unionconf2023 to join the important discussions around #tuberculosis. Come and see us at booth B663317 to find out how, with our partners, we’re aiming to #changethetrajectory of TB in lower income countries. Thanks, @TheUnion_TBLH for having us!
-
GSK
@GSK
The impact of RSV on adults is not always known as it is often under-diagnosed and under-reported. Hear from the COPD Foundation on the risks RSV can represent, especially for adults at increased risk due to medical conditions affecting the lungs.
#worldcopdday -
GSK
@GSK
At GSK, we want people to be able to live free from the constraints of respiratory disease. We welcome the updated @GOLD_COPD Strategy for 2024 and will continue to innovate to shape the future so we can get ahead of respiratory disease together.
-
GSK
@GSK
We’re striving to achieve clinical remission for people with a range of immune-mediated diseases.
Read about advances in the management of conditions like severe asthma, rheumatoid arthritis or EGPA that mean we aim for ambitious treatment goals: gsk.to/3uaw7ou
#acr23 -
GSK
@GSK
Get ready for #unionconf2023 with episode 2 of our TB Voices series. This is Kevin’s powerful story. Through our partnership with @Amref_Worldwide, we've made a difference in Western Kenya, enhancing the prevention, diagnosis and treatment of TB.
gsk.to/3QFZ6YX
#endtbThis media couldn't be displayed. See it on the original post. -
GSK
@GSK
We’re working with @KingsCollegeLon to build digital and biological replicas of patients’ tumours and then using AI and ML on the data to help us match cancer patients to the best treatment for them. Find out more: gsk.to/3SBe1Gf
-
GSK
@GSK
Together, we continue to listen and learn from people living with chronic #hepatitisb (CHB) to better understand the disease and improve patient outcomes. We were honoured to speak with, Jacki and Natalia, CHB patient advocates, to learn more. #tlm23
gsk.to/3FUXdCs -
GSK
@GSK
Get ready for episode 2 of #malariavoices! Hear from inspiring healthcare professionals working tirelessly in malaria-endemic regions to prevent and treat the disease, and about the real life impact the RTS,S malaria vaccine has had in their communities.
-
GSK
@GSK
“When our communities see us coming together, they understand that we are all working together to improve their quality of life” – we could not say it better. Thanks @COPDFoundation , @IFAgeing and @gaapporg for joining forces to raise awareness of RSV! #rsvawarenessweek
-
GSK
@GSK
#news for #investors and #media: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending approval of our blood cancer therapy.
Learn more: gsk.to/46g0bwa -
GSK
@GSK
Organ damage in #lupus occurs when the immune system attacks and inflames organs. This could be prevented for some patients if timely action is taken. Take a look at our GSK website dedicated to lupus to learn more: gsk.to/3SAnjCk
#acr23 -
GSK
@GSK
At #acr23, our 20 abstracts aim to advance the management of immune-mediated conditions.
Read more about how we’re uniting science, technology and talent to leverage the power of the immune system to develop pioneering treatments: gsk.to/3Qyfbjp -
GSK
@GSK
#rsv typically produces mild symptoms, but infants and older adults may be at further increased risk to severe disease due to age underlying medical conditions such as diabetes, chronic lung and heart diseases, and those with weakened immune systems.
#rsvawarenessweek -
GSK
@GSK
Community activism drives health innovation. Let's harness the lessons learned from #hiv and amplify our voices for #tuberculosis. Together, we can help address the needs of those living with both. Watch our #scienceonthesofa episode for more. #hivstigma
-
GSK
@GSK
RSV can seriously hinder your independence. Find out from the @COPDFoundation the impact RSV can have on adults at increased risk.
-
GSK
@GSK
Peak RSV season is approaching in many countries and affects more than 5 million older adults each year, which is why on this #rsvawarenessweek we’re joining forces with the @COPDFoundation, @IFAgeing and @gaapporg to raise awareness of the risks of RSV in adults.
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
Science has a diversity problem. Black people, women, and those from lower socio-economic backgrounds are under-represented in the scientific workforce.
Find out why diversity in STEM is key to greater medical innovation: gsk.to/49kABsH -
GSK
@GSK
#investors: Join GSK CEO Emma Walmsley and other members of our leadership team for our Q3 2023 live results webcast at 12:00 GMT, 08:00 EDT. $GSK gsk.to/3SuJ1aO
-
GSK
@GSK
News for #investors and #media
See our Q3 Results highlights gsk.to/3SnpoBt. $GSK -
GSK
@GSK
News for #investors and #media
Explore our Q3 2023 figures at a glance. gsk.to/3tWJcSc. $GSK -
GSK
@GSK
News for #investors and #media
Watch our CEO, Emma Walmsley, as she announces our results for Q3 2023.
For more, see gsk.to/3SjfEbH
$GSK #news #financialresults -
GSK
@GSK
#investors and #media Cautionary statement regarding forward-looking statements & the definitions & reconciliations for non-IFRS measures for our results. CER% represents constant exchange rates. £% or AER% represents actual exchange rates.
For investors: gsk.to/45TtSmG -
GSK
@GSK
We’re announcing our Q3 results tomorrow at 0700 GMT, 0300 EDT. $GSK
-
GSK
@GSK
We were proud to join our partners at the @sciencemuseum to launch our nationwide STEM mentoring programme last week and the beginning of our 10-year commitment to UK STEM equity-focused initiatives, to inspire the next generation of diverse innovators: gsk.to/3QhUsQD
-
GSK
@GSK
#news for #investors and #media: Today we announced that we have reached an agreement with @ArrowheadPharma and @JanssenUS to expand our approach to address chronic hepatitis B.
gsk.to/3sfTqwy -
GSK
@GSK
#news for #investors and #media: Today we announced positive headline results evaluating our cancer therapy.
Learn more: gsk.to/49bwJKy -
GSK
@GSK
Honoured to be ranked as a Top Employer on @ScienceMagazine's annual list for the 5th consecutive year
#aheadtogether #gskproud #sctopemployers
Science Careers
@ScienceCareers
The verdict is out! The 2023 Top Employers survey has captured insights from 6,800 professionals in #biotech, #pharma & #biopharma, revealing their priorities when choosing an employer. Click to explore the results! #sctopemployers
www.science.org/content/article/making-happy-workplace-em… -
GSK
@GSK
Breaking news: We’re proud to announce a new 10-year UK STEM equity programme designed to inspire and invest in the next generation of STEM talent from under-represented groups, starting with a nationwide mentoring programme.
Learn more: gsk.to/3s9fvwI -
GSK
@GSK
Despite progress in oncology treatments, cancer is a leading cause of death worldwide, reflecting a clear need to bring new therapies to patients. Read how we are using technology to get ahead of cancer in @washingtonpost: gsk.to/3FyPFW2
#esmo23 -
GSK
@GSK
Proud to be included in TIME’s Best Inventions of 2023 list!
-
GSK
@GSK
News for #investors and #media: Today we have shared new data on one of our vaccines.
Find out more: gsk.to/45H2d8l -
GSK
@GSK
Our dedication to advancing gynaecologic cancer research is rooted in making a difference for patients like Gudrun, Carmen, Andrea, and their families. #esmo23
Learn how we drive innovation to support patients: gsk.to/40bhZHi -
GSK
@GSK
Tech powers everything we do at GSK, and cutting-edge AI is one way we're working to provide patients with better medicines and vaccines faster.
Read more about London’s Knowledge Quarter, home to our global AI hub (paywall): gsk.to/3s22hSk -
GSK
@GSK
There has always been fear about new technologies, argue GSK’s leading AI experts Kim Branson, Robert Vandersluis and Jeremy England (@lifelikephysics), but that shouldn’t stop us from realising its incredible potential.
gsk.to/46UIhzR -
GSK
@GSK
#news for #investors and #media: Today we announced that we have entered an agreement to obtain a license from Hansoh Pharma for a novel antibody-drug conjugate underscoring our approach to addressing gynaecologic cancers.
Read more: gsk.to/402OEPo -
GSK
@GSK
Delighted to see @ViiVHC, our specialist HIV company, representing at #eacs2023
ViiV Healthcare
@ViiVHC
The #eacs2023 guidelines, suggesting that Patient Reported Outcomes (PROs) should be used for ALL people living with #hiv. Hear why this is such an important step in our commitment to prioritising quality of life!
@EACSociety #wewontstop #prosThis media couldn't be displayed. See it on the original post. -
GSK
@GSK
It's essential we address the stigma faced by people living with #hivandtb. Joining forces with @ViiVHC on their latest #scienceonthesofa episode, we talk about the need for holistic care in changing the trajectory for people living with HIV and TB.
-
GSK reposted
GSK US
@GSKUS
Thanks @STATnews @pharmalot @EdSilverman for hosting an engaging #statsummit discussion with CEO Emma Walmsley about “GSK’s New Groove”, our story of transformation and our strong focus on vaccination and prevention.
-
GSK
@GSK
We’re in Chicago for #tropmed23 to discuss the important topics and issues in #globalhealth - come and see us at booth 221 to find out how, with our partners, we’re aiming to change the trajectory of infectious diseases in lower income countries. Thanks, @ASTMH for having us!
-
GSK
@GSK
We look forward to gathering with others in the oncology community at @myESMO 2023, to share our progress in advancing research to address unmet needs and deliver new options for patients. #esmo23
Read about our ongoing commitment to cancer patients: gsk.to/3tIOv7y -
GSK
@GSK
Dr. Kimberly Smith will join @STATnews tomorrow in a compelling session called “We Can End the HIV Epidemic – Why Haven’t We?” at this week’s #statsummit.
-
GSK
@GSK
Our CEO Emma Walmsley will join @EdSilverman @STATnews at the #statsummit tomorrow to talk about “GSK’s New Groove” – the transformation story of how we got here and where we’re going. gsk.to/3M5lpWB
-
GSK
@GSK
News for #investors and #media: As part of our ongoing commitment to advancing patient outcomes, we’re pleased to present new data from our #oncology portfolio at #esmo23.
Learn more about our presentations: gsk.to/49919NE -
GSK
@GSK
#news for #investors and #media: Today, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency [@EMA_News] issued a positive opinion recommending approval of our #cancer therapy.
Learn more: gsk.to/3RWclHd -
GSK
@GSK
#multiplemyeloma is a complex blood cancer that affects the Black community 2x more than other populations. It’s critical for patients, especially those at risk of recurrence, to understand how to navigate this disease.
Read more from @RealHealthMag 👇 gsk.to/46kAk7f -
GSK
@GSK
In the face of great challenges, we can and must learn from the past.
Together with @ViiVHC we're exploring ways that our deep experience in HIV can inform new approaches to treating TB.
Watch the latest #scienceonthesofa now. -
GSK
@GSK
Prevention is the best medicine. It is all about innovating to change the course of disease.
Find out how our innovative R&D approach helps us get #aheadtogether: gsk.to/3ZPmKX3 🔬
#idweek2023 -
GSK
@GSK
By bringing together the power of data and platform technology, we expand what's possible for patients.
Learn more about our partnerships, including our innovative work with @WaveLifeSci: gsk.to/3tsOrca 🔬
#hlth2023 -
GSK
@GSK
“The folks who need the most are getting access to the least.”
That’s why @ViiVHC’s head of R&D, Dr Kimberly Smith, spoke about #healthequity at yesterday's “Healthcare, Policy & Advocacy Walk into a Bar” panel.
Find out more: gsk.to/3LTLgAo
#hlth2023 -
GSK
@GSK
It’s the final day of #hlth2023 and we’ve had a blast connecting with the innovation community here in Las Vegas and beyond. Thanks for joining us! 🙏
Discover what we’ve learned: gsk.to/3Fczgq5 -
GSK
@GSK
Great to see Lisa Banks, our VP Global Head Digital Health & Innovation, sharing her wisdom at #hlth2023 👏
HLTH
@HLTHEVENT
"It's a team sport. Digital health is a team sport."
#hlth2023 #digitalhealth #healthinnovation -
GSK
@GSK
News for #investors and #media: We are committed to improving outcomes in hepatology and look forward to sharing new data with the broader hepatology community at #tlm23.
Find out more: gsk.to/3tqlDB0 -
GSK
@GSK
DYK that 34% of #hlth2023 delegates told us that if they could modify one aspect of healthcare collaborations to drive innovation, they would be more open to working with unexpected relationships.
Discover more insights from #gskdata: gsk.to/3PPt8Jh 🔍 -
GSK
@GSK
We’re proud of our commitment to improving gender equality in Africa. Earlier this year we teamed up with @ViiVHC and @GlobalFund to launch the Gender Equality Fund. Now, the Request for Information is live! 👉gsk.to/3ZQH9ek
GSK
@GSK
In collaboration with our partners @ViiVHC and @GlobalFund we are launching a new, multi-year fund focused on advancing community engagement for gender equality in Africa.
Find out more: gsk.to/44w21sK
#aheadtogether #wd2023 -
GSK
@GSK
Lisa Banks joined pharma #innovation leaders from @Pfizer, @AstraZeneca, @JNJInnovation & @GeneralCatalyst on stage at @HLTHEVENT to discuss what technologies are exciting them, and how they are envisioning the future of #lifescience and #digitalhealth collaborations.
#hlth2023 -
GSK
@GSK
#hiv medicines are getting better all the time, but stigma is still a major issue that many people experience.
Learn how @ViiVHC 's “Chapters of Stigma” #virtualreality experience teaches empathy and better understanding of patients’ needs: gsk.to/3F8QODB 👈 -
GSK
@GSK
Live from the #hlth2023 floor, Mike Montello joined @ChitraNawbatt on the @HLTHEVENT Daily Show to talk everything from how digital and tech powers all that we do at GSK, to his own personal leadership journey. #healthtech
-
GSK
@GSK
Yesterday we discussed “How digital health can advance #healthequity: From research to patient healthcare access” with @DrIvorHorn, Director of Health Equity and Product Inclusion @GoogleHealth.
See what else we have planned at #hlth2023: gsk.to/45n82I4 📆
@ViiVHC -
GSK
@GSK
The results are in! 24% of #hlth2023 conference go-ers have told us that the use of cutting-edge tech best demonstrates a #biopharma company is at the forefront of #innovation.
More daily insights: gsk.to/46Hw1m7 -
GSK
@GSK
Infectious diseases affect everyone, everywhere, and this is a major concern for society. That’s why we’re in #boston for @IDWeekmtg.
Our #infectiousdisease portfolio is one of the broadest in the industry and represents two-thirds of our pipeline.
#idweek2023. -
GSK
@GSK
Our team, including Lisa Banks and Maggie Czarnogorski, spoke about digital health innovations at the @HLTHEVENT Global Health Connector Village yesterday.
View our #hlth2023 speaker schedule: gsk.to/3FcccI5 📣 -
GSK
@GSK
Lisa Banks [VP, Global Head Digital Health & Innovation] draws on her experience of leading a biotech start-up to advise how best to land a collaboration with a global biopharma
#hlth2023 👇 gsk.to/3ZUOr0D -
GSK
@GSK
Yesterday at #hlth2023 we joined Mike Montello, SVP, R&D Digital & Tech, at the Pharma & Life Sciences Forum talking about the groundbreaking technologies reshaping #biopharma.
Find out what else we’re up to: gsk.to/46l04Aw
@HLTHEVENT @FiercePharma -
GSK
@GSK
We’re live at #hlth2023 connecting, engaging, and exchanging ideas with the brightest in #healthtech #innovation!
Watch our highlights video from day one and see what else we have planned: gsk.to/3rFFMmb 🎬This media couldn't be displayed. See it on the original post. -
GSK
@GSK
News for #media and #investors: Today we announced an exclusive strategic vaccines partnership in China, which will significantly extend availability of our innovative vaccines & help protect China’s rapidly growing population of older adults.
Read more: gsk.to/46m1r1A -
GSK reposted
GSK careers
@GSK_careers
Joining us at #hlth2023? Over the next few days you’ll hear us share our expertise and discover new ways to get ahead of disease together.
Can't make it? Explore our opportunities here: gsk.to/3PNBLUM
#aheadtogether -
GSK
@GSK
We believe innovation starts when we stop to listen.
Visit us at Booth 4424 at #hlth2023 to add your perspective to our #gskdata visualisation wall and help shape the future of healthcare #innovation.
Find out more: gsk.to/48HvwKI -
GSK
@GSK
We believe the bigger the challenge, the bigger the need for #collaboration.
We have long been committed to partnering with the world's best minds at the intersection of science & tech, while continuing to invest in our own capabilities: gsk.to/45ALCDn 🤝
#hlth2023 -
GSK
@GSK
Heading to #hlth2023? We are!
Be sure to join our colleagues featured on panel sessions and visit booth 4424 to let us know what you think about the impact of technology across the healthcare ecosystem at our #gskdata visualisation wall.
Learn more: gsk.to/46Fts3U -
GSK
@GSK
Later this week we’ll be at @HLTHEVENT 2023. We’re looking forward to spending some time meeting, collaborating, and listening!
We’ve got a number of speakers lined up – see them all here and what they’ll be talking about: gsk.to/3tlUori 📣
#hlth2023 -
GSK
@GSK
Congratulations to our CEO Emma Walmsley and all of the other accomplished women named to @FortuneMagazine’s list of the 100 most powerful women.
Check out the full list here: gsk.to/46junY6 (Paywall) -
GSK
@GSK
Approximately how many people are diagnosed with meningitis worldwide each year?
#aheadtogether #worldmeningitisday #defeatmeningitis -
GSK
@GSK
On #worldmeningitisday, we are sharing Ludovic’s story. #meningitis left Ludovic in a coma but he hasn’t let the disease get in the way of his dream career in motorsports. He is truly racing to #defeatmeningitis
Find out more: gsk.to/3LPi9hF
#aheadtogether -
GSK reposted
Climate Group
@ClimateGroup
Hear from @Transform_Zero members, including @GSK, in the latest #climateweeknyc article on how to work with suppliers to measure, manage and reduce Scope 3 emissions. Read now: www.climateweeknyc.org/news/four-actions-businesses-can-t…
-
GSK
@GSK
We’re proud that our Chief Scientific Officer, Tony Wood, has been named a Fierce 50 Breakthrough honoree by @FiercePharma, celebrating healthcare and biopharma trailblazers and visionaries fighting for patient care. 👏 🔬
-
GSK
@GSK
We’re committed to extending the health span of adults. When we help prevent disease, we get #aheadtogether. Hear more from our leaders Francesco Berlando Scorza and Christi Kelsey about healthy ageing.
-
GSK
@GSK
#dyk that #myelofibrosis is a complex blood cancer? It can impact the body’s production of blood cells and lead to anaemia. September is #bloodcancerawarenessmonth. Visit @LLSusa 🩸🎗️ to learn about their work to get ahead of #bloodcancer together with the myelofibrosis community
-
GSK
@GSK
"It’s like a life sentence of just being uncomfortable.” Kristen Butcher explains the reality of living with cholestatic pruritus of primary biliary cholangitis.
This #pbcawarenessmonth we’re highlighting how #pbc is relentless in affecting people’s quality of life. -
GSK
@GSK
Take part in our Mile for Meningitis challenge and help raise awareness of #meningitis. 🏃♀️🏊♀️🚣♀️🚴♂️
Get your friends involved and spread the word!
#aheadtogether #worldmeningitisday -
GSK
@GSK
Let's give #tb the attention it deserves! Vincent's story is a powerful reminder of the harsh reality of this disease - the stigma, treatment challenges, and impact on families.
If we truly want to change the trajectory and #endtb, collaboration is key: gsk.to/48yldZi -
GSK
@GSK
News for #investors and #media: Today the Ministry of Health, Labour and Welfare of Japan has approved our RSV vaccine.
Find out more: gsk.to/3ZtITde -
GSK
@GSK
Adult immunisation, like good diet and exercise, can help protect against disease and benefit overall health. Hear more about how we can get #aheadtogether to support turning vaccine innovations into vaccinations.
This media couldn't be displayed. See it on the original post. -
GSK
@GSK
Is #multiplemyeloma curable? September is #bloodcancerawarenessmonth. Learn more about this #bloodcancer 🩸🎗️ and the organisations that provide important support to patients and their families.
-
GSK
@GSK
This week at #unga our Chief Global Health Officer has been talking about the work GSK is doing to change the trajectory of #tb through our candidate vaccine, M72 and why partnership is key to unlocking new innovation. Read @ThomasBreuer_MD’s latest blog gsk.to/3ZpBETH
-
GSK
@GSK
This #worldgoday, we’re shining a light on the importance of advancing care for people living with gynaecologic cancers. Through precision medicine technologies like biomarker testing, innovative research can help us get ahead of gynaecologic cancers. #gofortesting
-
GSK
@GSK
TB accounts for a third of all deaths of people living with HIV. Recognising this intersection of HIV and TB is crucial for targeted healthcare solutions as care is often siloed.
Together, we're trying to change the trajectory of #hivandtb #scienceonthesofa -
GSK
@GSK
Missed yesterday's panel discussions featuring GSK's @ThomasBreuer_MD and Sabena Solomon, head of impact partnerships? Don't worry, we've got you covered! You can catch up on their insightful conversations at #unga78 right here 👇
#devexevent
Devex
@devex
LIVE · Unlocking the power of prevention: Delivering global health impact for all through partnerships #devexevent @ #unga78 · In partnership with @GSK x.com/i/broadcasts/1RDGllEkAyqGL
-
GSK
@GSK
At 11am EDT today, @ThomasBreuer_MD and head of impact partnerships Sabena Solomon will be joining @devex for a panel with @gavi, @sabinvaccine and @savechildrenuk. There’s still time to register! gsk.to/3PxBpCC
-
GSK
@GSK
Converging global challenges of health, climate and #nature need collaborative and urgent action!
We’ll be at the #gcleaderssummit today to help inspire and challenge organisations to accelerate progress. Register now: gsk.to/3Rnu1LD -
GSK
@GSK
To protect human health and get ahead of disease, we need to take action on #nature. That’s why we worked with leading experts to develop practical guidance to help ensure human health is a central outcome of global efforts to protect and restore nature: gsk.to/3RnxdqB
-
GSK
@GSK
News for #investors and #media regarding our HIV medicine in Europe, received today by @ViiVHC, our specialist HIV company. More at gsk.to/3PIPb5x.
-
GSK reposted
TNFD
@TNFD_
We're delighted that @GSK has announced its intention to start adopting @TNFD_ Recommendations and will publish its first nature disclosures in 2026 based on 2025 data.
We look forward to others joining as early TNFD Adopters: tnfd.global #tnfd -
GSK
@GSK
Protecting nature makes our business more resilient and helps us deliver for patients, ensuring the continued supply of raw materials needed to manufacture medicines and vaccines. That’s why we’ve committed to publish our first #tnfd disclosures from 2026, based on 2025 data.
TNFD
@TNFD_
Business and finance are entirely dependent on nature🌍
Our Recommendations were designed with extensive market engagement and help organisations report and take action on nature-related issues.
It’s time for business and finance to step forward: tnfd.global #tnfd -
GSK
@GSK
It's #unga78 and we’ve got a date for your diary!
This Wednesday, @ThomasBreuer_MD and head of impact partnerships, Sabena Solomon, talk with @devex on the importance of partnerships and our new #zerodose commitment with @savechildrenuk: gsk.to/3PxBpCC #devexevent -
GSK
@GSK
Dr Tania Small was a guest on the @DownThereAware podcast to discuss the urgent need to improve outcomes for patients of colour with #endometrialcancer, and how to increase representation in clinical trials for #gynaecologiccancers 💜.
Listen to her here: gsk.to/3sXy2MA -
GSK
@GSK
#news for #investors and #media: The @US_FDA has approved our new treatment for #myelofibrosis that may address key manifestations of the disease, namely anaemia, constitutional symptoms and splenomegaly.
-
GSK
@GSK
67 million under 18s globally missed out on one or more vaccinations between 2019 to 2021, creating an immunity gap that has already had grave consequences. gsk.to/3sW82RO
-
GSK
@GSK
Partnerships lie at the heart of our mission to improve #healthforall. @ThomasBreuer_MD talks with @devex at #unga78 about how partnerships are changing the trajectory of infectious diseases in lower income countries: gsk.to/3PxBpCC
🗓️ 20 September
🕚11am EDT -
GSK
@GSK
News for #investors and #media
Explore our Q2 2023 figures at a glance. gsk.com
$GSK -
GSK
@GSK
The scientific community didn't believe an agent could be found which would have activity against HIV. But Marty St Clair, a virologist working at a GSK legacy company in the 1980s, proved them wrong with a life-saving discovery: gsk.to/3Q4vQMI
-
GSK
@GSK
In collaboration with our partners @ViiVHC and @GlobalFund we are launching a new, multi-year fund focused on advancing community engagement for gender equality in Africa.
Find out more: gsk.to/44w21sK
#aheadtogether #wd2023 -
GSK
@GSK
We're so proud of the GSK people who are part of SPECTRUM, our employee network group for LGBTQ+ employees and allies, who marched at #prideinlondon.🌈
We want GSK to be a workplace where everyone can feel a sense of belonging and thrive. Find out more: gsk.to/43h2MVk -
GSK
@GSK
Calling all global health researchers! #niro has just launched – your new one-stop-shop for information on #funding opportunities, with a focus on #malaria, neglected tropical diseases, #tuberculosis and #amr
EFPIA
@EFPIA
We're thrilled to announce the launch of #niro, a new navigation tool for R&I funding programmes🚀 This platform will make it easier for organizations to access info on #funding opportunities to continue to advance health #research: niroglobal.com
#wewontrest -
GSK
@GSK
Unconscious biases are the attitudes or stereotypes that people hold in the unconscious part of their brain.
Go #behindthescince to find out how that can affect the outcome of clinical trials - and what our scientists are doing to overcome it 👇 #dei
www.gsk.com/en-gb/behind-the-science-magazine/men-women-g… -
GSK
@GSK
.@wellcometrust and @gatesfoundation announce funding to advance M72/AS01E, a candidate vaccine against #tb. We’re proud to have led on its early development. If successful in Phase 3, it'll be the first new vaccine against active TB in over a century in lower income countries.
-
GSK
@GSK
#vaccines are global health’s biggest success, helping people of all ages live longer, healthier lives. Judy Stewart, SVP US Vaccines, shared at today’s #bio2023 session how we’re turning up the dial on adult #immunization.
-
GSK
@GSK
At GSK our fight against HIV started over 40 years ago. Today we continue to innovate and unite science, technology and talent so patients like Jorge can live long, healthy and full lives. 👇
Watch the full conversation: gsk.to/3qeQpLv -
GSK
@GSK
News for #investors and #media
We’ve announced a strong start to 2023. Swipe through for the highlights and see more on our website. $GSK -
GSK
@GSK
News for #investors and #media
Watch our CEO, Emma Walmsley, as she outlines a strong start to 2023.
For more, see www.gsk.com
$GSK #news -
GSK
@GSK
An estimated 3.5 to 5 million lives are saved every year thanks to #immunisation. Help protect future generations from vaccine-preventable diseases. #wiw2023 #thebigcatchup
-
GSK
@GSK
Did you know that #antimicrobialresistance could result in 10 million deaths every year by 2050?
Go Behind the Science to learn more about #amr 👇 gsk.to/41b2SNS -
GSK
@GSK
Until recently, medicines and vaccines were mainly tested on men. This has had a detrimental effect on the health outcomes of women around the world. However, attitudes are shifting: gsk.to/3LvMQcD
-
GSK
@GSK
For #investors and #media
Our CEO, Emma Walmsley, reflects on our progress in 2022 and looks ahead to 2023 in the #gskannualreport
Read more in our Annual Report: www.gsk.com/en-gb/investors/financial-reports/annual-repo… -
GSK
@GSK
For #investors and #media
We’ve published our 2022 #gskannualreport and ESG Performance Report detailing our progress in getting ahead of disease together: www.gsk.com/en-gb/investors/financial-reports/annual-repo… -
GSK
@GSK
The combination of three prominent respiratory viruses this winter – Covid, flu, and RSV – continues to raise the risk for older and at-risk adults. But what can we all do to reduce the impact? #behindthescience gsk.to/3DMnsdZ
-
GSK
@GSK
News for #investors and #media
We’ve announced a strong set of full year results for 2022. Swipe through for the highlights and see more on our website. $GSK -
GSK
@GSK
News for #investors and #media
Watch our CEO, Emma Walmsley, as she discusses our strong performance in 2022.
For more, see gsk.com
$GSK #news -
GSK
@GSK
Researchers are testing innovative new ways to protect people against infectious disease – and pursuing effective vaccines to fight bacteria and viruses that have eluded them for decades. #behindthescience
gsk.to/3WobUDY -
GSK
@GSK
The combination of #flu, #covid19 and #rsv has become known as the #tripledemic. What are the things we can all do to reduce the impact? Find out: gsk.to/3Zb0tlW
-
GSK
@GSK
It’s been a long fight against #hiv – but we, and @ViiVHC, will not stop now.
Go #behindthescience with us #aheadtogether www.gsk.com/en-gb/behind-the-science-magazine/the-40-year… -
GSK
@GSK
How can we help avoid #amr becoming the next pandemic? Find out when you go #behindthescience www.gsk.com/en-gb/behind-the-science-magazine/antibiotic-…
-
GSK
@GSK
#news for #investors and #media: Today we announced a new collaboration with @WaveLifeSci to drive discovery and development of oligonucleotide therapeutics leveraging our expertise in genetics and genomics
-
GSK
@GSK
Exciting things are happening at #ash22! 🤳
Learn how we’re getting #aheadtogether to improve the lives of blood cancer patients at our selfie station and hear from Rebecca Russell, Global Congress Director, Oncology, for more on the sponsored #ashrunwalk. -
GSK
@GSK
P.J. has been raising awareness around HIV issues within the Black Queer Community since he was in college. Following his own HIV diagnosis, he’s continued to inspire his community in his role as Senior External Affairs Manager at @ViiVHC.
Hear his story 👇 #worldaidsdayThis media couldn't be displayed. See it on the original post. -
GSK
@GSK
In 2011, GSK launched Trust in Science in Latin America. The public-private partnership model focuses on peer-to-peer scientific collaboration. Earlier this week, the first licensing agreement was signed out of this public-private partnership model. @CONICETDialoga @FilmusDaniel
-
GSK
@GSK
Access is core to our ambition to positively impact more than 2.5 billion lives. That’s why we’re delighted to be top of the @ATMIndex again in 2022.
📺CEO Emma Walmsley and President of Global Health and CEO of @ViiVHC Deborah Waterhouse discuss the news: youtu.be/FvP0RfK4zCU -
GSK
@GSK
At GSK, we know #antimicrobialresistance is not a future problem, it’s a problem now. That’s why we are committed to uniting science, technology and talent to get ahead of #amr together.
-
GSK
@GSK
News for #investors and #media
We’ve announced a strong set of Q3 results. Swipe through for the highlights and see more on our website. -
GSK
@GSK
News for #investors and #media
Watch our CEO, Emma Walmsley, as she discusses our strong performance in Q3.
For more, see gsk.com
$GSK #news -
GSK
@GSK
Honoured to be ranked as a Top Employer on @ScienceMagazine annual list.
#aheadtogether #gskproud #sciencetopemployer
Science Careers
@ScienceCareers
The results are in: the 2022 #sctopemployer survey gathered the voices of over 6,000 scientists in #biotech & #pharma to uncover what they value in #industry employers. Click to find out! www.science.org/content/article/2022-s-top-employers-prov…
-
GSK
@GSK
#news for #investors and #media: Today’s new collaboration announcement with Halozyme, Inc. keeps us at the forefront of developing innovative new options for HIV treatment and prevention. More information on www.gsk.com
-
GSK
@GSK
From innovation to helping prevent infection, students debate how to #fightmalaria with @Dr_JamesLogan @ComicRelief at @McLarenGroup centre
-
GSK
@GSK
We take on some of the world’s biggest healthcare challenges. Today, we’re inviting 100 students to help #fightmalaria with @ComicRelief
-
GSK
@GSK
We’re at @TheManufacturer #tmalc discussing 'Driving Continuous Improvement’ with our partner @McLarenGroup: gsk.to/1yTCSEj
-
GSK
@GSK
Wishing @McLarenGroup all the best as race day kicks off at @F1NightRace in Singapore!
-
GSK
@GSK
As the @F1NightRace in Singapore revvs up, we celebrate our unique five-year partnership with @McLarenGroup.
-
GSK
@GSK
Introducing Galvani Bioelectronics – a new company we’re establishing with Verily to develop #bioelectronic meds!
-
GSK
@GSK
How has working with @JensonButton and the @McLarenF1 team helped production at GSK?
amp.twimg.com/v/ae9bfc90-730d-4c63-92ed-98b6262aa245 -
GSK
@GSK
Working with academia is key to discovering new meds. Excited to be recognised as most collaborative pharma in 2015! gsk.to/1TMCjYZ
-
GSK
@GSK
Pleased to work with @VBIVaccines on an innovative approach to improve stability of our vaccines #leadingscience gsk.to/20Vomt7
-
GSK US
@GSKUS
#news for #investors and #media: At #tlm26 we’re unveiling our latest advancements across our hepatology pipeline for chronic hepatitis B (CHB), metabolic dysfunction-associated steatohepatitis (MASH), and alcohol-related liver disease (ALD).
Find out more in the press release: gsk.to/4egVmcZ
#tlm26 -
GSK US reposted
GSK
@GSK
News for #investors and #media
Watch our CEO, Luke Miels, as he delivers news of our strong Q3 performance and continued momentum ⤵️
Find out more: gsk.to/4zggYib
#gskresults #earnings -
GSK US
@GSKUS
#news for #investors and #media: Today @US_FDA has approved our first-in-class treatment for chronic hepatitis B (CHB).
This approval reflects our commitment to innovation in liver disease, where significant unmet need remains.
Learn more: gsk.to/4z5NgfC -
GSK US
@GSKUS
#news for #investors and #media:
The US Food and Drug Administration (FDA) has approved a new indication for one of our immunotherapies. Read more: gsk.to/4zCl4Rf -
GSK US
@GSKUS
Building on our $30 billion commitment to US innovation, R&D and manufacturing, today we are celebrating the development of our Upper Merion Flex Factory. By expanding our presence in Pennsylvania, this factory will deliver best-in-class new medicines for respiratory disease and cancer.
@GovernorShapiro @PAChamber @TradeGov @montco_pa @ChamberPHL @SelectUSA -
GSK US
@GSKUS
#news for #investors and #media:
Today, we announced the US FDA accepted the application for one of our immuno-oncology therapies for priority review. Learn more: gsk.to/4gO7q71 -
GSK US
@GSKUS
On World Hepatitis Day, we’re raising awareness of viral hepatitis and recognizing the importance of early and more complete testing in hepatitis B.
Learn more about complete testing at: www.hepatitisbtesting.com
#worldhepatitisday #hepb #hepatitisb #liverhealth #testingmattersThis media couldn't be displayed. See it on the original post. -
GSK US reposted
GSK
@GSK
Today, we’re announcing a £400 million investment in UK life sciences, including plans to establish a new flagship R&D centre in Cambridge. The new site on the city’s Biomedical Campus, one of the world’s leading life sciences ecosystems, will be a catalyst to fuel collaboration and accelerate GSK R&D.
-
GSK US reposted
GSK
@GSK
News for #investors and #media
Watch our CEO Luke Miels as he shares our strong Q2 core performance, continued momentum and plans to accelerate our R&D, including a new flagship R&D centre in Cambridge.
Find out more: gsk.to/4pG56BQ
#q2results $GSK -
GSK US reposted
GSK
@GSK
#news for #investors and #media: We’ll be at #aids2026 with @ViiVHC, our specialist HIV company, presenting research and insights from our innovative portfolio and integrase strand transfer inhibitor (INSTI)-powered pipeline.
Find out more in the press release: gsk.to/4fdROcs
Our mission: to leave no person living with HIV behind. -
GSK US
@GSKUS
#news for #media and #investors: Today @US_FDA has approved our oral anti-infective for complicated urinary tract infections (cUTIs).
With three million cUTIs treated annually in the US, this approval reflects our commitment to innovation in anti-infectives.
Learn more: -
GSK US
@GSKUS
#news for #investors and #media: Today, we announced that the US FDA has granted regulatory designations for one of our therapies for the treatment of VEXAS syndrome.
Learn more: gsk.to/4eoSdHf -
GSK US reposted
GSK
@GSK
#news for #investors and #media:
We have entered an agreement to acquire clinical-stage precision oncology company Nuvalent, Inc., bringing in multiple lung cancer assets to our existing oncology portfolio.
Find out more: gsk.to/4ooHOjy -
GSK US
@GSKUS
#news for #investors and #media:
We're excited to be at #asco26 and #eha2026, where we will share data on how we're delivering a meaningful impact for cancer patients today while innovating for tomorrow.
Learn more: gsk.to/4dQBSLg. -
GSK US
@GSKUS
Getting ahead of respiratory disease means relentless innovation, moving beyond just symptom management.
At #ats2026, we're sharing 33 abstracts across our respiratory portfolio. Our focus: targeting underlying drivers of conditions like asthma, COPD, and refractory chronic cough to improve patient outcomes. Explore our science – a meaningful investment for patients, health systems, and societies. -
GSK US reposted
GSK
@GSK
News for #investors and #media
Explore the key highlights from our Q1 2026 results announcement ⤵️
Find out more: gsk.to/4uelV7Y $GSK -
GSK US reposted
GSK
@GSK
News for #investors and #media
Watch our CEO Luke Miels as he shares our strong Q1 performance and start to 2026.
Find out more: gsk.to/3OA31JU
$GSK #q1results -
GSK US
@GSKUS
News for #investors and #media: Today, we announced the US Food and Drug Administration accepted our application for a potential first-in-class treatment for chronic hepatitis B. Learn more: gsk.to/4darMFN
-
GSK US
@GSKUS
Current treatments for #cutis caused by drug-resistant organisms often require hospitalization. The lack of oral treatments can result in extended hospital stays, ultimately having a negative impact on patients’ quality of life.
We remain focused to address the growing issue of antimicrobial resistance.
#escmidglobal2026 -
GSK US
@GSKUS
#news for #investors and #media: At #sgo2026, we presented new data on an investigational antibody-drug conjugate from our oncology pipeline. Learn more: gsk.to/47V3hJO.
-
GSK US
@GSKUS
Our partnership with the lupus community has always been fueled by a clear purpose: to improve the outcomes for people living with lupus.
This dedication to advancing breakthroughs continues to drive our work as we look ahead to the future of lupus care.
#lupus #aheadtogether -
GSK US
@GSKUS
We‘ve topped the Access to Medicine Index's 2026 Antimicrobial Resistance Benchmark, reflecting our continuous focus on delivering innovative antibiotic medicines and vaccines for patients with significant unmet medical need.
Check out our #amr podcast: gsk.to/4rj3UUt -
GSK US reposted
GSK
@GSK
Our latest Annual Report and Responsible Business Report show our progress in creating value for patients and shareholders.
Take a look at the highlights ⤵️
🔗 Investors and media can read more: gsk.to/4ubX9pQ -
GSK US
@GSKUS
We’re on the ground at #aaaai26, sharing our latest #respiratoryhealth research this week. Stop by Booth 1137 to learn more. If you can’t attend, you can learn more about our work here: gsk.me/4tYOfvR 🫁
-
GSK US reposted
GSK
@GSK
Explore the key highlights from our Q4 and full year 2025 results announcement ⤵️
More information for media and investors: gsk.to/4a2WXQw $GSK -
GSK US reposted
GSK
@GSK
Watch our CEO Luke Miels as he shares our strong 2025 performance and reaffirms our long-term outlooks.
More insights and information for media and investors: gsk.to/4ti5YOs $GSK #fyresults -
GSK US reposted
GSK
@GSK
#news for #investors and #media: We’ve announced an agreement to acquire RAPT Therapeutics.
Find out more: gsk.to/3NuAT9Z -
GSK US
@GSKUS
We're leaving #jpm2026 inspired and confident in our R&D momentum & future pipeline impact. Our approach, built on cutting-edge innovation and industry-leading partnerships, is driving us to get ahead of disease together.
#aheadtogether -
GSK US
@GSKUS
We’re excited to announce Court Horncastle's selection as a Life Sciences Voice Top Industry Leader, a testament to his 30+ years leading teams and redefining the future of specialty medicine to help get ahead of disease. Congratulations, Court!
#aheadtogether #gskproud -
GSK US
@GSKUS
Yesterday at #jpm2026: our CSO Tony Wood joined Endpoint News to share how our focused R&D approach – driven by science, advanced tech, and strategic partnerships – is accelerating pipeline momentum and our ambition to transform health.
🔗 Learn more: gsk.to/4qRrt6X -
GSK US
@GSKUS
#news for #media and #investors:
The US Food and Drug Administration (FDA) has approved our new, long-acting biologic therapy for people living with severe asthma.
For more information, visit: gsk.to/457P6PZ -
GSK US
@GSKUS
#news for #investors and #media: Today we announced that the Food and Drug Administration (FDA) has granted Orphan Drug Designation to an investigational antibody-drug conjugate in our oncology pipeline.
Learn more here: gsk.to/4pynQma -
GSK US
@GSKUS
#news for #investors and #media: At #ash25, we’ll be presenting new data from our hematology portfolio. Learn more: gsk.to/4pRVdAa
-
GSK US
@GSKUS
Big news for U.S. innovation!
We've officially opened our new Vaccine & Infectious Disease R&D HQ in Boston's Cambridge Park Drive. This expanded space is central to our 5-year investment in the U.S., driving faster, better innovation for patients globally. -
GSK US reposted
GSK
@GSK
Take a look at the highlights from our Q3 2025 performance 👇
More information for media and investors: gsk.to/3JzxOnq
$GSK #q3results #earnings -
GSK US reposted
GSK
@GSK
Today we announce our Q3 2025 results, with another quarter of strong performance and upgraded guidance for 2025.
Hear more from our CEO Emma Walmsley ⤵️
More information for media and investors: gsk.to/4ns8cXo
$GSK #q3resultsThis media couldn't be displayed. See it on the original post. -
GSK US reposted
GSK
@GSK
7 years strong! GSK has again been named a @ScienceMagazine Top Employer, driven by our purpose to unite science, tech & talent to get ahead of disease, together.
Find out more here: gsk.to/47jG6HR
#aheadtogether #gskproud #sctopemployersThis media couldn't be displayed. See it on the original post. -
GSK US reposted
GSK
@GSK
Our Chief Digital & Technology Officer, Shobie Ramakrishnan, spoke at #bloombergtech this week about how an integrated use of tech across everything we do is helping us get ahead of disease. Here, Shobie shares why it's so critical to drive innovation - bringing science, tech and talent together to innovate in R&D 👇
Bloomberg Live
@BloombergLive
"It takes over 10-12 years to bring a really big medicine to market - being able to change - by engineering biology - [will have] a massive impact on patients."
@GSK's Shobie Ramakrishnan explores the intersection between tech and medicine at #bloombergtech.This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
#news for #media and #investors: Today, we announced that our treatment for #multiplemyeloma has been approved by the US Food and Drug Administration (FDA). Learn more: gsk.to/4o90eno
-
GSK US
@GSKUS
We’re at #idweek2025 in Atlanta, joining global experts and leaders to tackle one of the most urgent health challenges: infectious diseases.
For more than 70 years, GSK has pioneered innovation in this field. Our portfolio today spans both vaccines and medicines, with over 30 projects in development – many targeting serious infectious pathogens.
#aheadtogether -
GSK US
@GSKUS
Inspiring to see our CEO Emma Walmsley alongside so many trailblazing women at today’s #fortunempw summit. From discoveries in cancer treatments to leveraging AI, Emma shared her vision for the future of healthcare and reflected on the significant transformation she has led as a change agent for GSK over the past nine years.
-
GSK US reposted
GSK
@GSK
Luke Miels has been appointed CEO Designate. He assumes full responsibility as CEO on 1 Jan. Luke joined GSK in 2017 and is currently CCO. He succeeds Dame Emma Walmsley, who delivered a step-change in GSK’s performance, portfolio & pipeline.
-
GSK US
@GSKUS
We are investing $30 billion in R&D and manufacturing in the US over the next 5 years. This will create hundreds of new highly skilled jobs and builds on GSK’s strong innovation and manufacturing footprint in the US, developing and making products in the US for the US.
-
GSK US reposted
GSK
@GSK
Take a look at the highlights from our strong Q2 2025 performance 👇
More information for media and investors: gsk.to/3UDdbZo. $GSK -
GSK US
@GSKUS
#news for #media and #investors: Today we announced we have started shipping our #influenza vaccines in anticipation of the 2025-26 #flu season in the US. Learn more: gsk.to/4lErfOt
-
GSK US
@GSKUS
#news for #investors and #media: At #asco2025 in Chicago, IL and #eha2025 in Milan, Italy we will be presenting findings across our oncology pipeline and portfolio in more than 60 abstracts. Learn more: gsk.to/43jGx4j
-
GSK US
@GSKUS
At the @WSJ's "The Future of Everything", our CEO Emma Walmsley joined leaders across business, tech, sports, and style to tackle tomorrow's challenges, including the future of drug discovery using cutting-edge tech and the impact of prevention on disease.
#thefutureofeverything -
GSK US
@GSKUS
#news for #investors and #media: Today we announced our anti IL-5 biologic treatment for people living with COPD has been approved by the US Food and Drug Administration (FDA). Learn more: gsk.to/4jk9KRx
-
GSK US
@GSKUS
With over 40 abstracts, including 4 late-breaker submissions, this data line-up is a testament to our long-term focus on a broad range of areas where we can help improve outcomes for patients suffering from complex respiratory diseases.
Precil Varghese shares more about our presence at #ats2025 this year. Watch to learn more. -
GSK US
@GSKUS
#news for #media and #investors: Today we announced our sponsorship of “Pretty Hurts” a new Lifetime Original Movie and the latest extension of our Ask2BSure public health campaign.
Learn more: gsk.me/3YCxeK9This media couldn't be displayed. See it on the original post. -
GSK US reposted
GSK
@GSK
Explore the key highlights from our Q1 2025 performance.
More information for media and investors: gsk.to/42TtzIS. $GSK -
GSK US reposted
GSK
@GSK
Our CEO Emma Walmsley announces our strong Q1 2025 performance, demonstrating the quality, strength and resilience of our portfolio.
More information for media and investors: gsk.to/4iE8HLC
$GSK #fyresults -
GSK US
@GSKUS
#news for #media and #investors
Two of our vaccines have received new recommendations from the US Advisory Committee on Immunization Practices (ACIP). These recommendations will be reviewed for official adoption.
Learn more at: gsk.to/4ltr4pf -
GSK US
@GSKUS
Construction has begun to expand our Pennsylvania site where we’re using smart manufacturing to reach people who need our medicines and vaccines better and faster. Thank you for joining us today, @DCEDSecretary!
🏭Read about our largest US manufacturing investment to date:
PA Department of Community & Economic Development
@PADCEDnews
We love a groundbreaking! 🎉Today, @DCEDSecretary Siger attended a groundbreaking ceremony for @GSKUS’ $800M expansion in Lancaster County. With $21M in state investment, PA is leading the way in biotech growth & vaccine manufacturing. #paproud dced.pa.gov/newsroom/spurring-innovation-shapiro-administ…
-
GSK US
@GSKUS
#news for #media and #investors: Today we announced that our oral antibiotic for uncomplicated urinary tract infections has been approved by US Food and Drug Administration (FDA).
Learn more: gsk.to/3QNxYaP -
GSK US
@GSKUS
Our commitment to advancing new treatment options is inspired by patients like Andrea, who was diagnosed with #endometrialcancer in 2017. Watch to learn more about her story and stay tuned as we share our latest innovations in gynecologic cancer research at this year's #sgomtg.
-
GSK US reposted
GSK
@GSK
#news for #investors and #media:
New data has been presented at #croi2025 on the innovative pipeline of our specialist HIV company, @ViiVHC.
🔗 Find out more: gsk.to/3DM3Fyf -
GSK US reposted
GSK
@GSK
News for #investors and #media:
@ViiVHC, our specialist HIV company, is presenting more than 70 abstracts at #croi2025, reinforcing our leadership in long-acting innovation and supporting our ambition to end HIV and AIDS for good.
Find out more: gsk.to/4hhqFTt -
GSK US
@GSKUS
#news for #media and #investors: Today, we announced that the @US_FDA has approved our meningococcal vaccine. Find out more here: gsk.to/4hA4CIP
-
GSK US reposted
GSK
@GSK
Watch our CEO Emma Walmsley as she shares our strong 2024 performance and further improvement to our long-term growth outlook.
More information for media and investors: gsk.to/4aJneDF
$GSK #fyresultsThis media couldn't be displayed. See it on the original post. -
GSK US reposted
GSK
@GSK
Explore the key data from our strong 2024 performance.
More information for media and investors: gsk.to/42Hvr9e $GSK -
GSK US
@GSKUS
As #jpm2025 comes to a close, we head into the year with strong and sustained momentum. We are very confident in our ability to deliver profitable growth through the decade with scale, health impact and attractive returns.
#aheadtogether #jpm25 -
GSK US
@GSKUS
Today at #jpm25: Hesham Abdullah, Senior Vice President, Global Head Oncology, R&D, joins the #fiercejpmweek ‘Future of Oncology’ panel to explore how advanced research and innovative treatments are reimagining patient care.
For #investors and #media: gsk.to/3WcqBNl -
GSK US
@GSKUS
Up next for #investors and #media: Watch Emma Walmsley speaking live at #jpm2025, followed by a Q&A with Tony Wood, Luke Miels and Deborah Waterhouse from our leadership team.
🔗 Watch live: gsk.to/4jbpkQu
#jpm25 @ViiVHC -
GSK US reposted
GSK
@GSK
#news for #investors and #media: Today we announced the proposed acquisition of IDRx, Inc. aligned to our ambition to address the critical needs of patients with gastrointestinal cancers.
gsk.to/40yQJDB #jpm2025 -
GSK US
@GSKUS
We look forward to joining the @jpmorgan Healthcare Conference next week, sharing how the breadth of our portfolio, positive pipeline data and focus on science tech, and culture are helping us deliver sustained profitable growth.
🔗 gsk.to/3C3SZu4
#jpm2025 #jpm25 -
GSK US
@GSKUS
News for #media and #investors: The FDA has accepted for review our application for a new presentation of SHINGRIX: gsk.to/4aaPdfa
-
GSK US reposted
The Economic Club of New York
@EconClubNY
As part of the Club's Women in Business Series, we’re honored to host Emma Walmsley, CEO of @GSK, tomorrow for our first Signature Luncheon of the year! 👏
In a conversation led by Club Chair Bob Steel, Emma will discuss the transformative power of investing in health, exploring everything from advancements in science and technology to the pivotal role of preventative healthcare and examine what keeps this industry building healthier societies and stronger economies.
Follow along for live updates and join the conversation using #ecnywalmsley! 💬
#ecny #econclubny #ecnyevents #economicclub #nyc #economics #biopharma #healthcare #innovation #womeninbusiness -
GSK US reposted
GSK
@GSK
“We can reimagine what's possible for patients and society in new ways.”
Shobie Ramakrishnan, our Chief Data and Technology Officer, explains how data science and advanced tech drive progress and reduce inefficiencies across our business.
Learn more👇 gsk.to/4fnilRi -
GSK US
@GSKUS
#news for #investors and #media: The FDA has granted Breakthrough Therapy Designation to one of our immuno-oncology treatments. Learn more: gsk.to/41vZfVT
-
GSK US
@GSKUS
#news for #investors and #media: Today at #ash24, we presented positive results from our phase III clinical trial evaluating one of our #bloodcancer treatments. Learn more: gsk.to/4g7Z9bq
-
GSK US
@GSKUS
#news for #investors and #media: Today we have announced the FDA has accepted the submission for one of our biologics in chronic obstructive pulmonary disease (#copd).
Learn more here: gsk.to/49vodGN -
GSK US
@GSKUS
We are pleased to share that our own Dr. Hesham A. Abdullah, Senior Vice President, Global Head #oncology, Research & Development will be joining this year’s @statnews @ASH_hematology panel to discuss the biggest opportunities and challenges ahead in #hematology.
#ash24 -
GSK US
@GSKUS
#news for #investors and #media: The @US_FDA has accepted our application for one of our #bloodcancer therapies in combination with standards of care. Learn more: gsk.to/3ZjoZmS
-
GSK US
@GSKUS
We’re proud of our commitment to improving access to medicines and vaccines, which sees us rank second as one of two leading companies in the @AtMIndex. By continuing to make progress, we will get ahead of high burden diseases in lower-income countries. #atmi24
This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Social factors can majorly impact a person’s health, especially for people from racial & ethnic minority groups living with #lupus. GSK is addressing these challenges & encouraging early intervention for those living with this condition: gsk.to/4exFgsy @ACRheum #acr24
-
GSK US
@GSKUS
We’re excited to be at this year’s GOLD International COPD Conference. We’ll be listening and learning from colleagues and experts in the field to translate the latest COPD research into meaningful improvements for patients. #goldcopd2024
-
GSK US reposted
GSK
@GSK
News for #investors and #media
Explore our Q3 2024 highlights. www.gsk.com. $GSK -
GSK US reposted
GSK
@GSK
News for #investors and #media
Watch our CEO Emma Walmsley as she shares our Q3 results. We are on track to deliver 2024 outlooks with further good progress made in R&D.
For more, visit gsk.to/48o7aGh
$GSK #news #q3results -
GSK US
@GSKUS
For people living with #lupus, disease management is critical to try to help reduce the risk of organ damage progression. It’s important for doctors and patients to work together and have discussions about this. Watch to learn more.
@ASNKidney #kidneywk -
GSK US
@GSKUS
We’re excited to be at @ASNKidney week. As long-standing leaders in the #lupus community, we know how critical disease management is to try to help reduce organ damage progression for patients.
Learn more: www.gsk.com/en-gb/innovation/therapeutic-areas/respirator…
#kidneywk -
GSK US
@GSKUS
We’re proud to be investing in US manufacturing to bring products and innovation to patients faster. Thanks to @GovernorShapiro, @DCEDSecretary, @SenatorAument and PA Rep Tom Jones for helping to make our Marietta Pennsylvania site expansion possible!
gsk.to/40nFQWJ -
GSK US
@GSKUS
Breaking #news: We are making our largest US manufacturing investment to date: $800 million in our Pennsylvania site, able to manufacture both medicines and vaccines, double the size of the site and over 200 new jobs.
Read more here: gsk.to/3UoHvqZ -
GSK US
@GSKUS
#news for #investors and #media: Today we shared data on our RSV vaccine.
Learn more: gsk.to/48hqyoj -
GSK US
@GSKUS
Thanks for joining us at #idweek2024, where we’ve been sharing scientific advances from our industry-leading, prevention-focused portfolio of infectious disease vaccines and medicines.
🔗 Find out more: gsk.to/40tOlzB 👈 -
GSK US
@GSKUS
We are excited to be at #idweek2024 to present research from across our broad and growing portfolio of vaccines and medicines aimed at getting ahead of infectious diseases.
🔗 Learn how are we developing new ways to prevent and treat infectious diseases: gsk.to/3zRMUA3 -
GSK US
@GSKUS
Are you attending #idweek2024? So are we! Join us as we convene with global experts, sharing the latest advancements in the prevention and treatment of infectious diseases.
🔗 Learn more: gsk.to/4h8eZnt -
GSK US
@GSKUS
News for #media and #investors: Together with @ViiVHC, we’re presenting 60 abstracts to showcase advances across our industry-leading infectious disease pipeline and portfolio at #idweek2024.
🔗 Learn more: gsk.to/3U3RW2Z -
GSK US
@GSKUS
#news for #investors and #media: Today we shared data at #chest2024 on one of our vaccines. Learn more: gsk.to/47WElAm
-
GSK US
@GSKUS
COPD and asthma can co-occur, with almost a fourth of asthma patients presenting with COPD symptoms. At #chest2024, we’re sharing our latest research in #asthma and concurrent #copd. Learn more: gsk.me/3BylxeB
-
GSK US
@GSKUS
We’re committed to serving the needs of respiratory patients and look forward to sharing our latest research and insights at #chest2024.
-
GSK US
@GSKUS
We’re extremely proud that our CEO Emma Walmsley, has been named to @FortuneMagazine's list of the 100 most powerful women, alongside other accomplished leaders in the Fortune 500 and Global 500.
-
GSK US
@GSKUS
In the spirit of supporting the communities where we live and work, GSK is providing funding to support #hurricanehelene recovery and relief efforts in the southeast region of the US. #communitysupport #disasterrelief
👉 Learn more: gsk.to/4eGvchu -
GSK US
@GSKUS
Thank you to all advocacy groups for your tireless work in educating, empowering & advocating for women’s health during #gynecologiccancerawarenessmonth and #ovariancancerawarenessmonth including @ECANAwomen, @GYNCancer, @FacingOurRisk, @NOCC_National, and @ocrahope.
-
GSK US
@GSKUS
Each year, thousands in the U.S. are diagnosed with #multiplemyeloma, the second most common blood cancer. It starts in bone marrow when plasma cells mutate. Learn more: us.gsk.com/en-us/company/oncology/multiple-myeloma/
#bloodcancerawarenessmonth -
GSK US
@GSKUS
Genetic characteristics can help you understand how your body’s cells, or genes, are programmed and your risk for certain diseases, such as cancer.
Take five minutes to familiarize yourself with related questions you can ask your health care provider following a diagnosis. -
GSK US
@GSKUS
We’re in New York for #unga79 and #climateweeknyc.
Watch Claire Lund, our VP, Sustainability, as she shares how we’re working to create more sustainable healthcare that benefits both patients and the planet. -
GSK US
@GSKUS
This #bloodcancerawarenessmonth, we want to thank @HealthTree, @IMFmyeloma, @mpnadvocacy, @myMPNRF, @theMMRF, and @LLSusa for their work in raising awareness, advancing research and providing essential resources to the blood cancer community.
-
GSK US
@GSKUS
By 2050, 1 death every 3 minutes could be due to antimicrobial resistance.
That's why this week, at #unga79, we must come together to prevent and get ahead of AMR.
Read on for more about the human cost of AMR – and how to stop it:
gsk.to/47Q45P3 -
GSK US
@GSKUS
Kia found her exercise routine helped her reduce stress and build a community that reminded her she was not alone on her #lupus journey. Learn ways to build healthy habits and help manage your lupus: www.usinlupus.com/living-with-lupus/exercise/
#rheumaticdiseaseawarenessmonth -
GSK US
@GSKUS
Breaking News: We’ve committed €4.5m over three years to @gardp_amr to ensure equitable access to antibiotics in lower-income countries.
Our funding aims to tackle the challenges that hinder critical antibiotics from reaching those in need. #powerof Antibiotics #unga79 -
GSK US
@GSKUS
Staying informed and prioritizing your well-being is important for taking control of your #endometrialcancer experience. Take five minutes to get informed about the five most common symptoms of EC: www.us.gsk.com/5for5.
#gynecologiccancerawarnessmonth #gcam #5for5 -
GSK US
@GSKUS
Sharing openly about #lupus symptoms can feel scary, but it doesn’t have to be when you’re connected with a care team and loved ones you can trust. Curtisha spoke up to advocate for herself and so can you. Learn how: www.usinlupus.com/talking-about-lupus/
#rheumaticdiseaseawarenessmonth -
GSK US
@GSKUS
#news for #investors and #media: today we announced data on two of our vaccines. Read more here: gsk.to/4d6CZ6Z
-
GSK US
@GSKUS
September is #bloodcancerawarenessmonth, a global effort to raise awareness about various types of blood cancers like #myelofibrosis (MF) and #multiplemyeloma. Learn about our commitment to the #oncology community: us.gsk.com/en-us/company/oncology/.
-
GSK US reposted
MPN Research Foundation
@MPN_RF
Uncovering unmet needs in our MPN community inspires us. Thanks to @GSK, we shared our efforts on #mappingmyelofibrosis. 🎧 www.youtube.com/watch?v=Da5ZQNOSobo&t=53s
Join us to empower those with ET, PV, and MF. We're aiming for 600 donors. Donate now: mpnrf.info/3XlFX2U -
GSK US reposted
ViiV Healthcare
@ViiVHC
#wewontstop until a functional cure for HIV is a reality.
It's a bold goal, but we're working towards a future where people living with HIV can achieve long-term remission without medication.
Tune in to #scienceonthesofa to learn about the road ahead: youtu.be/EIWNqCeJ9zQ -
GSK US
@GSKUS
Take five minutes to learn about some of the most common symptoms of #ovariancancer. Since symptoms can mimic other common conditions, listen to your body and note any irregularities that may arise. Learn more: www.us.gsk.com/5for5.
#ovariancancerawarenessmonth #5for5 -
GSK US
@GSKUS
Join one of the two webinars on the 12th of September to hear directly from our current Commercial Development Program associates.
Don't miss this chance to learn more about developing your career in the commercial space.
Register now 👉 gsk.to/47jwUD6 -
GSK US
@GSKUS
We are proud to host our Annual Frontiers in Gynecological Cancer Roundtable on September 10th. At GSK, we value collaboration with our patient advocate partners to understand and address the unmet needs of the #gynecologiccancer community. #gynecologiccancerawarenessmonth.
-
GSK US
@GSKUS
We’re reminiscing about the lively event we hosted in February with Sideline RSV spokesperson @MagicJohnson at the @LakeHighlandsY in Dallas. We love going into communities to help spark important health conversations about #rsv.
Go #behindthescience: gsk.me/3WMDWN8 -
GSK US
@GSKUS
We’ve spent the summer teaching future innovators to be space scientists. Check out students designing spacesuits to protect astronauts 👩🚀.
In collaboration with @TheFranklin, #gsksis inspires students about #stem. Find this activity and more here 👉 gsk.to/4easVe6 -
GSK US
@GSKUS
For #gynecologiccancerawarenessmonth and #ovariancancerawarenessmonth, take five minutes to learn more about the risks, symptoms, and the importance of raising awareness.
Learn more here: gsk.me/4dZQtCy.
#5for5 #gcam #ocam -
GSK US
@GSKUS
Inspiring the next generation of future innovators is what GSK Science in the Summer™ strives to do!
Meet David Cornejo who shares his experience taking part in the program as a child.
Read more here 👉 gsk.to/3MtwDnB -
GSK US
@GSKUS
For nearly 40 years, our GSK Science in the Summer™ program has introduced children to STEM subjects.
By creating light bulb moments, we want to nurture the next generation of scientists - this includes current colleagues and GSK volunteers. -
GSK US
@GSKUS
Congratulations to GSK colleague, Giovan Lane on her appointment as Chairperson of the #deib Expert Panel for @USPharmacopeia. Learn about Giovan and how she will be leading global change within the industry: gsk.to/4dY53dE
-
GSK US
@GSKUS
#backtoschool season is an important time for everyone – especially for parents and caregivers of children living with lupus in the U.S. Learn ways to intervene early and help your child start their new school year off right: www.usinlupus.com/for-caregivers/parenting-a-child-with-l…
This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
100 years ago today, we launched Ostelin, the world’s first Vitamin D supplement.
Step back to 1924 with us to explore the history of our first pharmaceutical product.
Read more about our heritage of innovation 👉 gsk.to/4fZzAti -
GSK US
@GSKUS
It’s #internseason!
Meet Shreya, a major in Molecular Biology and Computer Science from @JohnsHopkins. A Cell Biology intern with extensive community engagement, bringing a unique set of skills to our R&D team.
Our programs 👉 gsk.to/3YZLmhl
#careersstarthere -
GSK US
@GSKUS
It’s #throwbackthursday!
Meet Stephen! He began his journey at GSK as an Enterprise Operations Intern from the University of North Carolina, ultimately paving his way for exciting opportunities in ViiV Healthcare
Discover more 👉 gsk.to/3WWZeGx
#careersstarthere -
GSK US reposted
GSK
@GSK
“AMR is like rising sea levels. It will keep rising. It will not stop, and suddenly we’ll be standing there with water around our knees.”
Read more about the crisis of antimicrobial resistance and why the world urgently needs novel antibiotics:
gsk.to/46LEUww -
GSK US
@GSKUS
Check out these future innovators!
In collaboration with @TheFranklin, students are taking on the role of rocket engineers and designing rockets that soar to new heights 🚀
Find this and more #gsksis activities 👉 gsk.to/3yMIPwi
#stem #stemkids -
GSK US
@GSKUS
It’s #internseason!
Avishek, a Chemical and Molecular Engineering student from @stonybrooku. Through valuable R&D experience, he is acquiring the essential engineering skills to contribute to his career goals.
Discover here 👉 gsk.to/3XcDI1Q
#careersstarthere -
GSK US
@GSKUS
Join us in conversation with 2023 COiMMUNITY grant recipients sharing their #adultimmunization work, including advocacy efforts, culturally relevant education, and community delivery approaches.
RSVP now! 👉 gsk.to/3yNJJsm
#niam -
GSK US
@GSKUS
It’s #internseason!
Erbol, a Biomedical Engineering student from @FIU is interning with our Precision Medicine department. He’s aspired to make a direct and positive impact on human health.
Discover career opportunities here 👉 gsk.to/46VxCpP
#careersstarthere -
GSK US reposted
GSK
@GSK
#news for #investors and #media: The FDA has granted Breakthrough Therapy Designation to an investigational antibody-drug conjugate in our oncology portfolio. Learn more: gsk.to/4dstxMt
-
GSK US
@GSKUS
Our GSK Chemistry team will be at the @AmerChemSociety Fall conference this week talking all things chemistry!
Join our chemists Joseph, Cuthbert, Nicole and Ray as they present their science.
Find out more about their presentations 👉 gsk.to/3YTmBUc
#acsfall2024 -
GSK US
@GSKUS
It’s #internseason! Shannon, a Biostatistics PhD student from @ColoradoSPH, is interning with our development biostatistics department. We're excited to have her contribute to our team!
#careersstarthere -
GSK US
@GSKUS
Heading to the #acsfall2024 conference in Colorado this week?
Don't miss the chance to join colleagues from our GSK Chemistry team Linda Suen Lai, Mark Nilson and John Woodard tomorrow, as they share their expertise in world-class science.
Find out more @AmerChemSociety -
GSK US
@GSKUS
Meet Westbrook, a Duke University intern in our North Carolina manufacturing, science, and technology department.
Our Programs: gsk.to/3SQvHx2
#careersstarthere #internseason -
GSK US
@GSKUS
It’s #throwbackthursday! Meet Kevin!
He began his journey at GSK in the commercial development programme from @elonuniversity, ultimately paving his way for exciting opportunities in the US digital communications team. -
GSK US
@GSKUS
Meet Lexi from @TAMU, majoring in Management Information Systems w/Minor in Cybersecurity. She’s interning with our Supply Chain department and has a passion for technology.
Our Early Talent Programs: gsk.to/4dH8kxR
#careersstarthere #internseason -
GSK US
@GSKUS
In collaboration with @TheFranklin we’re inspiring students to explore the captivating world of #stem.
Find resources to “Be an Astrobiologist” and join the adventure at home 👉 gsk.to/3WCXGkW
#gsksis #stemkids -
GSK US reposted
GSK
@GSK
Not only does the use of AI and robots promise greater efficiency, but it reduces our reliance on essential resources, making us greener.
Read our article to learn more: gsk.to/4ccUan6 -
GSK US
@GSKUS
Thank you to @UWMadisonChem for joining our 3rd annual @UWMadison + GSK Symposium!
We’re grateful for the scientists, graduate students and postdocs who gave talks on their research. Thank you to Prof. Richmond Sarpong @UCBerkeley for joining us.
#drugdiscovery #chemistry -
GSK US
@GSKUS
It’s #tbt! Meet Brittany.
As a Business Administration major from @NCState, she started her career as a Future Leader #intern at GSK. That experience helped carve her path into product management.
Our Early Talent Programs: gsk.to/3ywnx5W -
GSK US
@GSKUS
This February, we teamed up with Sideline RSV spokesperson @MagicJohnson and @philaymca, to spread the word in our home city of Philadelphia about the potential risks of severe #rsv infection among older adults.
Go #behindthescience to learn more: gsk.me/4dagfE3 -
GSK US
@GSKUS
Ready to be a space scientist?
#gsksis, in collaboration with @TheFranklin is back!
"Be a Robotics Engineer" and learn the mechanics of a rover’s arm like this student. Find this activity and more to try at home 👉 gsk.to/4dstyzu
#gsksis #stem -
GSK US
@GSKUS
Our #processchemistry #scientists were honored to receive the 2024 Peter J. Dunn Award 🏆 from @AmerChemSociety Green Chemistry Institute Pharmaceutical Roundtable for their groundbreaking work in developing a more #sustainablemanufacturing approach.
#sustainability
#chemistry -
GSK US
@GSKUS
We are thrilled for the opportunity to bring a new treatment option to appropriate patients with #endometrialcancer who have historically had limited options. Learn more: gsk.to/3YDyVI5
-
GSK US
@GSKUS
#niam is an opportunity to highlight the importance of #diseaseprevention through routine #vaccination for all communities.
We created the EasyVax scheduler as a resource to simplify and streamline #adultimmunization for patients: www.easyvax.com
#aheadtogether -
GSK US
@GSKUS
We are proud to be part of the 3rd GSK + @Penn Symposium!
Thank you @PennChemistry and Prof. Matt Sigman from @UUtah.
GSK Scientists discussed #processchemistry, #medicinalchemistry and where a career in #chemistry can take you.
#gskchemistry #innovation #futurescientists -
GSK US
@GSKUS
GSK Science in the Summer™ in collaboration with @TheFranklin is back this summer. Our enthusiastic young scientists are learning to “Be a Planetary Geologist” 🌏. Find this activity and more to try at home below:
👉gsk.to/3ymZruj #gsksis -
GSK US
@GSKUS
#tbt 📅 As an #intern, Brad majored in #biology at @TCNJ and worked with our Sales, and Charitable Investments teams, leading him to opportunities in #dei.
Now, he is our HR business partner in Regulatory and Epidemiology.
#careersstarthere ✅ gsk.to/46x01Cp -
GSK US
@GSKUS
#news for #investors and #media: The U.S. FDA has approved an expanded indication of our #endometrialcancer therapy plus chemotherapy.
Learn more: gsk.to/4fwRtQfThis media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Prevention can change the course of disease.
We believe in investing in health before treatment is needed. Read more from @NYT’s conversation with GSK scientists Kate and Len as they talk about our focus on #diseaseprevention to improve #publichealth here gsk.to/3WCxuYL -
GSK US reposted
GSK
@GSK
News for #investors and #media
Take a look at key highlights from our Q2 2024 performance. For more insights, visit us at gsk.to/3ylCLe0. $GSK -
GSK US reposted
GSK
@GSK
News for #investors and #media
Watch our CEO Emma Walmsley as she shares our Q2 results, with continued strong performance and upgraded full-year guidance for 2024.
For more, visit gsk.to/46wvZim
$GSK #news #q2results -
GSK US
@GSKUS
Check out our future innovators learning to “Be a Rocket Engineer” through our #scienceinthesummer program with @TheFranklin and @NCCU 🚀✨
Join the #stemkids fun with experiments and other free #stem resources here 👉 gsk.to/4c7XZKi
#gsksis -
GSK US reposted
GSK
@GSK
#news for #investors and #media: Today we announced that we have entered into an agreement with Flagship Pioneering to discover future medicines and vaccines for patients.
Find out more: gsk.to/3WmmZHH -
GSK US
@GSKUS
Meet Rachel from @sheffielduni.
Based in London, she's interning with our US Digital Comms team. She's leveraging her #stem skills & scientific mind on strategic digital plans & impactful analysis to share our GSK US story.
Our programs 👉gsk.to/3YDGpLd
#internship -
GSK US
@GSKUS
It’s #nationalinternday!
Our #interns are collaborating with scientists, networking with accomplished colleagues, and gaining insightful industry knowledge, all while getting practical, hands-on experience.
Our program👉gsk.to/46jkMBk
#careersstarthere #internship -
GSK US reposted
GSK
@GSK
HIV remains one of the world’s biggest health epidemics, with 1.3 million new diagnoses annually. Our goal is to minimise the impact of HIV on people’s lives by treating and preventing the disease, and tackling HIV-related stigma.
🔗Find out more: gsk.to/3Yk84Ra
#aids2024 -
GSK US
@GSKUS
We’re developing one of the broadest #vaccine portfolios in the world to help protect people at all stages of life – because preventing disease is always better than treating it.
Read more from @nytimes’s conversation with Dr. Len about GSK’s focus on #prevention.✔️ -
GSK US reposted
ViiV Healthcare
@ViiVHC
#news for #investors and #media: New data presented at #aids2024 reinforces our leadership in #hiv innovation and supporting the community. This includes data from our pipeline, data evaluating long-acting prevention and oral 2-drug regimens.
More at:www.viivhealthcare.com -
GSK US reposted
GSK
@GSK
“There are three things necessary to ending the HIV/AIDS epidemic…and prevention is key”.
Find out what it means to change the course of disease through prevention and earlier intervention 👇
#aids2024 gsk.me/4f9W7mX -
GSK US
@GSKUS
Vaccines only work when people have access to them. Discover why ensuring access to #vaccines is key to our plan to improve #publichealth in this article from @nytimes featuring GSK’s Kate Hashey and Len Friedland.
👉 Visit: gsk.to/3LsGb1k -
GSK US
@GSKUS
July is National Minority Mental Health Awareness Month and we’re shining light on ways lupus impacts communities of color. Taking early action to manage mental stress can help lessen disease flares and reduced flares can lower risk for organ damage: gsk.me/3WqwS8D
-
GSK US reposted
ViiV Healthcare
@ViiVHC
Our data at #aids2024 will reinforce the need to create new #hiv treatment and prevention options that may allow for less frequent dosing intervals.
Find out more about our presence in Munich here: viivhealthcare.com/hiv-news-and-media/medical-conferences…
@iasociety #putpeoplefirst #wewontstop -
GSK US reposted
-
GSK US
@GSKUS
✅ Our commitment to protecting people from influenza remains unwavering as we plan ahead to ensure a steady supply of vaccines to help prevent this illness.
💪 We’re working to help families everywhere stay ahead of the flu!
#fluvaccine #stayahead #fluisafamilyaffair -
GSK US reposted
GSK
@GSK
As for many people living with #myelofibrosis (MF), Andrew’s journey was not straightforward. MF can present unique symptoms for each patient, making diagnosis and treatment challenging. Read more about how he lives life to the fullest @WebMD: gsk.me/4cl5xtq
-
GSK US reposted
GSK careers
@GSK_careers
R&D is essential to our purpose of getting ahead of disease together.
By combining the science with leading edge technology, we aim to discover and develop new vaccines and medicines that could transform people's lives.
#aheadtogether #gskcareers -
GSK US
@GSKUS
#news for #media and #investors: Today, at the Advisory Committee on Immunization Practices (ACIP) to the US @CDCgov, ACIP voted on RSV vaccination recommendations.
Find out more here: gsk.to/3VJze0E -
GSK US reposted
GSK
@GSK
Meet Zack, GSK chemist, early riser and planet protector working on #greenchemistry solutions to help make more sustainable medicines and vaccines that benefit patients and the planet. Watch his inspiring story and find out more about life at GSK #wearegsk #lcaw2024 #gskcareers
This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
In honor of Spartanburg, SC high school football player Keegan, who passed away from #meningitis B, we worked with @SpartanburgYMCA, his mother Allison, @gregolsen88, and local pediatrician Dr. Barnes to raise awareness around meningitis.
➡️Visit ask2bsure.comThis media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Our #gskchemistry team is looking forward to the @EWOC8 2024 Empowering Women in #organicchemistry Conference.
The conference emphasizes the importance of supporting and elevating #womeninscience.
#ewoc2024
#womeninchemistry
#womeninstem -
GSK US
@GSKUS
#gskscienceinthesummer celebrates our 38th year with Boston-area #gskvolunteers building kits for "Be a Space Scientist" student programs at the @EcoTarium.
Rocket Engineer, Robotics, and Astrobiologist activities are all set to inspire young minds 🚀🤖💫 #stem -
GSK US
@GSKUS
Over 60 educators gathered at the @TheFranklin to participate in activities that they will teach students this summer, focused on space-related careers.
Learn more about this year’s #gskscienceinthesummer program 👉 gsk.to/3XuAXJQ and how you can also #beaspacescientist -
GSK US reposted
GSK
@GSK
Thanks for having us #londontechweek! We’ve had a blast connecting with the tech community here in London and beyond.
We’re at a transformational moment in health. With science and tech, we can prevent and change the course of disease better and faster than ever before. #ltw24This media couldn't be displayed. See it on the original post. -
GSK US reposted
GSK
@GSK
The key to leading an organisation through a period of change? Resilience and empathy 🙏
London Tech Week
@LDNTechWeek
“You can’t change what you don’t care about.”
@GSK Chief Digital and Technology Officer Shobie Ramakrishnan drops gem after gem 💎 in this insightful conversation with @OliBarrett about healthcare, impact, and resilience. 👇🏥✨ #londontechweek #ltw24This media couldn't be displayed. See it on the original post. -
GSK US reposted
GSK
@GSK
At GSK, we’re revolutionising our supply chain. Using data tech, robotics and automation to increase the speed, quality and scale of product supply, we are driving performance to reach patients and people, better and faster. This is smart manufacturing.
#londontechweek #ltw24This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
This Pride Month, we’re highlighting people who work at GSK and ViiV from the LGBTQ+ community and allies in STEM roles who are committed to making a positive impact on patients’ lives.
Find out more from Kaylia, Ana and Ethan. -
GSK US
@GSKUS
Consider our 2024 Science @ Scale Symposium!
This two-day on-site experience is an opportunity to explore career development pathways in #pharmard, network with GSK scientists, and connect with mentors.
For details and application, please visit: gsk.to/4emtnqy -
GSK US reposted
GSK
@GSK
By combining deep expertise in artificial intelligence (#ai) and machine learning with access to rich troves of genetic, genomic and health data, scientists are unlocking new discoveries about disease that could change the face of healthcare 👇
#ltw24 www.gsk.com/en-gb/behind-the-science-magazine/ai-ml-data-… -
GSK US
@GSKUS
June is #uterinecancerawarenessmonth. #dyk that #uterinecancer is the most frequently diagnosed form of #gynecologiccancer in the United States?
Let’s stand together to spread awareness, encourage #earlydetection, and support those affected. Learn more: gsk.to/3xal8NC -
GSK US
@GSKUS
News for #investors and #media: Today, we announced that the @US_FDA expanded the indication of our RSV vaccine.
Find out more here:
gsk.to/3VmD7Zw -
GSK US reposted
GSK
@GSK
Heading to #londontechweek? We are! Join our colleagues at featured panel sessions, check out our Learning Lab and visit booth 501 to have your say on the future of tech at our award-winning #gskdata visualisation wall.
🔗 Learn more about GSK at #ltw24: gsk.to/4bP3Epg -
GSK US
@GSKUS
At GSK, we’re committed to advancing cancer care through innovation. Discover more about the cancers we're urgently working to address: gsk.to/4c0LikY
#asco24 -
GSK US
@GSKUS
#news for #investors and #media: We’re pleased to share the latest research from a GSK supported trial evaluating our immuno-oncology therapy for #rectalcancer at #asco24.
Learn more: gsk.to/3VrrBNm -
GSK US
@GSKUS
#news for #investors and #media: At #asco24, we shared late-breaking research from a phase III clinical trial evaluating our #multiplemyeloma therapy.
Learn more: gsk.to/3V55ZFi -
GSK US reposted
Lupus Foundation of America
@LupusOrg
Living with lupus can be incredibly challenging, but stories like Shawnelle's inspire us all. Diagnosed at 20, Shawnelle has faced lupus and other conditions with incredible strength. Through her love of music and her passion for helping others, she finds ways to cope and thrive.
-
GSK US reposted
Lupus Foundation of America
@LupusOrg
Living well with lupus involves making some changes within your family, your profession and your social circle. Even though this disease may affect many different areas of your life, it's important to take time to do activities that you enjoy to help you reconnect with yourself.
-
GSK US
@GSKUS
Tomorrow is #nationalcancersurvivorsday, a day to recognize the #cancer survivors in your community, raise awareness of the challenges of cancer survivorship, and #celebratelife.
Learn about our commitment to the cancer community: us.gsk.com/en-us/company/oncology/. #ncsd2024 -
GSK US reposted
Lupus Foundation of America
@LupusOrg
Vivir bien con lupus a menudo implica hacer algunos cambios dentro de tu familia, tu profesión y tu círculo social. Toma tiempo para hacer actividades que disfrutes, desde hornear o hacer arte. Lee cómo mantener una vida plena con lupus:
www.lupus.org/resources/coping-with-lupus-guide -
GSK US reposted
GSK
@GSK
The impact of climate change on health alongside AMR are two huge challenges hindering global health progress. Our chief global health officer @ThomasBreuer_MD reflects what we can do in the face of these challenges in our latest Behind the gsk.to/3ViFgXi
#wha77 -
GSK US
@GSKUS
#news for #investors and #media: We’re pleased to share new data related to our oncology portfolio at #asco24, including two late-breaking presentations in #multiplemyeloma and #rectalcancer. Read more: gsk.to/3WZvZVn
-
GSK US
@GSKUS
Today at #ats24, we’re sharing our latest in severe asthma research, reinforcing our commitment to advancing care for the respiratory community.
Learn more: gsk.to/3wsHFVP -
GSK US
@GSKUS
Elevated eosinophil levels play a critical role across diseases, including #severeasthma and #egpa, and are a key source of inflammation. Stay tuned at #ats2024 for late breaking safety data across eosinophil-driven diseases.
Learn more: gsk.to/44N128r -
GSK US
@GSKUS
This World Day for Cultural Diversity, we’re highlighting the importance of ensuring people most impacted by a particular disease are included in clinical research.
Watch @Maimah’s story to learn how we’re working with @tigerlilycares to help achieve equitable health outcomes.This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
We are sharing our industry-leading respiratory portfolio by talking to leaders, advocates and partners about respiratory and prevention to change the course of disease #ats2024
gsk.to/4bKP2XC -
GSK US
@GSKUS
We are excited to be at #ats2024, where we will be showcasing our work to redefine the future of respiratory care and improve the lives of millions.
Follow us for more. gsk.to/4dNUlHC -
GSK US
@GSKUS
We are proud to be an Education Partner for APFED’s 2024 celebration of National Eosinophil Awareness Week.
Learn about eosinophils and eosinophil-associated diseases and explore suggested activities to spread awareness at apfed.org/neaw.
#neaw #eosaware -
GSK US
@GSKUS
We’re excited to be at #ats2024 sharing the different ways we’re committed to disease prevention and solutions for respiratory conditions like #asthma and #copd.
Learn more: gsk.to/44Lf62f -
GSK US
@GSKUS
While patients may have different goals when it comes to managing their #asthma, controlling one’s asthma is critical for disease management. We’re looking forward to discussing our latest research around asthma control at #ats2024.
Learn more: gsk.to/3K6spkC -
GSK US
@GSKUS
Getting ahead of #antimicrobialresistance is critical to protecting modern medicine as we know it. But we can’t do it alone.
Our CEO, Emma Walmsley, spoke with @Ara_Darzi on how we will be the founding partner of the global @FlemingCentre - tackling #amr, together: -
GSK US
@GSKUS
Our CEO, Emma Walmsley, is at an event with @RoyalSociety today celebrating global efforts and initiatives to tackle #antimicrobialresistance, including our new partnership with #fleminginitiative shared earlier today
-
GSK US
@GSKUS
We’re proud that we will be the first founding partner of the global #fleminginitiative – an innovative and collaborative approach to tackle #antimicrobialresistance around the world.
Together we can get ahead of #amr @FlemingCentre
Read more: gsk.to/3WDQgj1 -
GSK US
@GSKUS
There are several symptoms people living with lupus may be managing. While patients’ experiences can vary, everyone can benefit from preventive action.
Find ways to talk about this condition: www.usinlupus.com/talking-about-lupus/
#lupusawarenessmonth #makelupusvisible -
GSK US
@GSKUS
Our #apprentices receive a combination of paid on-the-job training while studying towards a degree or trade qualification.
Kay is working in our #qualitycontrol Lab and studying at @waketechcc.
Visit: gsk.to/3USqTIV
#yaw2024 #apprenticeshipusa #youthapprenticeshipweek -
GSK US
@GSKUS
Our #apprentice Program provides recent and soon-to-be high school graduates the opportunity to build technical skills through a tailored entry-level development program. Felix is working in our #engineering group and studying at @mccc.
Visit gsk.to/3ybEyBU
#yaw2024 -
GSK US
@GSKUS
We offer #apprenticeships across many of our sites in the US. The program offers a chance to study, train in a role, and it is fully funded towards nationally recognized qualifications.
For details: gsk.to/3ybBsxM
#yaw2024
#youthapprenticeshipweek
@USDOL -
GSK US reposted
GSK
@GSK
This World Ovarian Cancer Day, we are raising awareness for the tens of thousands of women diagnosed with #ovariancancer each year. Hear from Carmen about navigating her diagnosis. #wocd2024 #nowomanleftbehind
-
GSK US
@GSKUS
When it comes to ovarian cancer, early diagnosis is key. By sharing the below 5 facts, you can help spread the word. For more helpful information, click here: us.gsk.com/en-us/company/oncology/ovarian-cancer/.
#wocd2024 #nowomanleftbehind -
GSK US reposted
GSK
@GSK
Our CEO Emma Walmsley has been at #miglobal sharing how we’re using science and tech to prevent and change the course of disease – and why we’re partnering with @MilkenInsitute to help health systems invest in prevention and earlier intervention: gsk.to/4bnNeDA
-
GSK US
@GSKUS
It’s #youthapprenticeshipweek!
This week, we’ll highlight #apprentices and their paths at GSK.
Meet Brynn. She’s a student at @mccc working in our #qualitycontrol #biochemistry Lab.
#yaw2024
#apprenticeshipusa #apprenticeship
@USDOL -
GSK US
@GSKUS
We’re pleased to be the founding partner of Project Prevent, a new initiative from MilkenInstitute bringing together cross-sector experts to accelerate investment in, and access and uptake of, preventative healthcare. #miglobal
Find out more:
gsk.to/44xuWO2 -
GSK US
@GSKUS
During #asthmaawarenessmonth, we’re recognizing the importance of talking to a doctor about proper treatment plans, which may include a triple therapy.
Find out how to take control of your #asthma with the #ownyourasthma quiz: gsk.to/3UOlLWn -
GSK US reposted
GSK
@GSK
Looking forward to our CEO Emma being part of the conversation on shaping our shared future at #miglobal this weekend.
Milken Institute
@MilkenInstitute
Join us LIVE from May 5-8 for Global Conference 2024 to hear how @KGeorgieva , David Beckham, @ValerieJarrett, @fedex CEO Raj Subramaniam, @GSK CEO Emma Walmsley, @IvanDuque, and many more will be shaping a shared future!
Explore our full lineup here: milkeninstitute.org/events/global-conference-2024
#miglobal #future #innovation #leadership -
GSK US
@GSKUS
This #lupusawarenessmonth we honor the 1.5 million people living with this chronic, autoimmune condition in the U.S. Early intervention is key to slowing disease progression and helping people living with lupus manage symptoms. Read more: www.usinlupus.com/symptoms-in-depth/
#makelupusvisible -
GSK US reposted
GSK
@GSK
News for #investors and #media
Explore our Q1 2024 figures at a glance. gsk.to/4aUgYZ5. $GSK -
GSK US reposted
GSK
@GSK
News for #investors and #media
Hear our CEO Emma Walmsley talk about our strong Q1 performance and learn more about our upgraded outlooks for the year.
For more, see gsk.to/3wgznQu
$GSK #news #q1results -
GSK US reposted
GSK
@GSK
Did you know there are an estimated 82 million new gonorrhoea cases globally each year?
Go Behind the Science to learn more about disease prevention 👇 gsk.me/3JDJOkr -
GSK US reposted
GSK
@GSK
Discover how we are leading the fight against #infectiousdiseases. Our ground-breaking research and development efforts are aimed at protecting communities worldwide. Learn more 👇
-
GSK US
@GSKUS
April 2024 marks the first National Cancer Prevention and Early Detection Month, urging investment in #cancer prevention and early detection efforts for all. Let’s get ahead of disease together. gsk.to/3Wh2MET
#aheadtogether #cancermoonshot -
GSK US
@GSKUS
As people’s immune systems weaken with age, the burden of vaccine-preventable diseases rises. That’s what motivates us to work towards making adult immunization the standard of care across the globe.
#wiw2024 #vaccination
#worldimmunisationweek -
GSK US
@GSKUS
#news for #investors and #media: Our application for a potential expanded indication for our immuno-oncology therapy has been accepted by the @US_FDA with Priority Review status.
Learn more here: gsk.to/3JA2b9C -
GSK US
@GSKUS
For the past two years, 100% of our Phase III clinical trials have had diversity plans to reflect the people most impacted by a particular disease. Find out more: gsk.to/3Uv0osG
-
GSK US
@GSKUS
Calling all HCPs!
On Apr. 24 at 8:30 p.m. ET, as part of GSK’s Vaccine Virtual Days #medicaleducation event, we will host Vaccination for Grown-Ups: A journey into confidence, equity, and the power of collaboration.
✔️ Live + on demand
✔️ Register here gsk.to/3W6m7sl -
GSK US
@GSKUS
News for #media and #investors: Today, we announced new positive long-term follow-up trial data for shingles.
Find out more: gsk.to/3U9U9cK -
GSK US
@GSKUS
#news for #media and #investors
Today, we announced that the Biologics License Application for our meningococcal vaccine candidate has been accepted by the @US_FDA.
Learn more at: gsk.to/3VZowou -
GSK US reposted
GSK careers
@GSK_careers
James has always been interested in understanding how things work. Now he uses that passion to get ahead of disease as a Biomedical Engineer at GSK.
Want to know more about our engineering roles? #aheadtogether #gskcareers -
GSK US reposted
GSK
@GSK
All patients deserve access to high quality healthcare, yet the needs of many go unmet due to preventable factors.
This is why closing the health equity gap not only benefits those facing barriers to access, but society as a whole: gsk.to/43ZlvGP -
GSK US
@GSKUS
#endometrialcancer is the most common type of cancer that affects the female reproductive organs. We’ve partnered with @NathalieMckenz3, MD, MSPH, to help spread awareness about how you can advocate for yourself & your health.
Read the article on @EBONY: gsk.to/3U5H0lY. -
GSK US reposted
ViiV Healthcare US
@ViiVUS
#media We are proud of our focused efforts to improve and expand #hiv care for children and adolescents. Lynn Baxter, Head of North America, shares what our latest FDA approval means for young people living with HIV. viivhealthcare.com/en-us/media-center/news/press-releases…
-
GSK US
@GSKUS
We’re honored to be recognized at the 17th Annual Vaccine Industry Excellence #vie Awards at the annual World Vaccine Congress @vaccinenation, celebrating the industry’s most outstanding achievements.
GSK was selected as the WINNER of the Best Pharma Company!
#wvcusa #wvc2024 -
GSK US
@GSKUS
This @UnityConsortium Adolescent Immunization Action Week #aiaw24, we're stressing the importance of asking good questions!
Sierra created our #ask2bsure campaign to encourage parents to get the facts and ask the right questions to protect their children against meningitis. -
GSK US
@GSKUS
Sorting through vast amounts of #vaccine information and navigating your family’s busy schedules can make it feel overwhelming to help your teen stay up to date on recommended vaccines.
Explore #aiaw24 to get started ✔️️www.unity4teenvax.org/aiaw24/
#vaccination #healtheducation -
GSK US
@GSKUS
As part of our commitment to #publichealth, we’re gearing up for @UnityConsortium's Adolescent Immunization Action Week (April 1-5)!
Explore #aiaw24 resources & help us spread the word: ✔️gsk.me/3PE3ZSw -
GSK US
@GSKUS
Maya Martinez-Davis, President US Commercial, shared at the @RE_Pharma conference how fostering highly collaborative teams can lead to #innovation for patients.
Thanks for a compelling discussion Kana Hutton and Reuters!
#repharmausa -
GSK US
@GSKUS
During #myelomaawarenessmonth and every month, we are grateful for all the organizations who support the #multiplemyeloma community by providing resources, support, and awareness for patients and caregivers. Thank you to @IMFmyeloma, @theMMRF, @HealthTreeMM & @LLSusa.
-
GSK US
@GSKUS
We believe prevention is the best medicine – for patients, societies, and our economy.
Here’s why: gsk.to/4a4YDYL
#aheadtogether #repharmausa -
GSK US
@GSKUS
Our U.S. Vaccines team joined forces with health advocate and Sideline RSV spokesperson @MagicJohnson to help spark important conversations about #rsv at YMCAs across the U.S.
@ymca @ymcanyc @YMCAChicago @philaymca @YMCADallas @YMCALA @VOSYMCA 🏀 -
GSK US
@GSKUS
We’re looking forward to meeting industry colleagues next week at the @RE_Pharma conference. We'll talk about how collaboration can advance innovation for patients, the next frontier in analytics, patient engagement & more. Meet our team who’ll be presenting at #repharmausa
-
GSK US
@GSKUS
News for #media and #investors: We’ve just announced a cap on out-of-pocket costs at $35 per month for eligible US patients for our entire portfolio of asthma and COPD inhalers. Learn more: gsk.to/4a1Fp6k
-
GSK US
@GSKUS
Lupus is a disease in which the immune system attacks the organs. Symptoms can include fatigue, joint pain and fever.
Talk with a doctor early about lupus and take the first step in creating a plan to reduce the risk of permanent organ damage. Learn more: gsk.to/49xODa9 -
GSK US reposted
-
GSK US
@GSKUS
Congratulations to Leila Bazzi and Nivi Thyagarajan on being named as 2024 @HBAnet Rising Star and Luminary Awardees for their outstanding performance, leadership, and commitment to advancing gender parity.
Learn more: gsk.to/3TIYUuM
#hbawoty24 #hbaimpact -
GSK US
@GSKUS
We look forward to seeing you at the @AmerChemSociety Conference!
Join Jeffrey and Marcus as they each host an #acsspring2024 talk on Wednesday afternoon.
#gskchemistry #medchem #drugdiscovery -
GSK US
@GSKUS
Hello from the @AmerChemSociety Conference!
Join Damian at “Process Chemistry as a Central Science in The Pharmaceutical Industry” session for his talk this Sunday.
#acsspring2024 #gskchemistry #gskmedchem #gskprocesschemistry #drugdiscovery -
GSK US
@GSKUS
#news for #investors and #media: today at the 2024 #sgomtg, we shared our latest findings in gynecologic cancer research. Learn more:
gsk.to/43kLsAe -
GSK US
@GSKUS
Our #gskchemistry team is looking forward to #acsspring2024 @AmerChemSociety conference in New Orleans, Louisiana from March 17-21.
🧪 For meeting details, visit: gsk.to/3Tjsgyf
#drugdiscovery -
GSK US
@GSKUS
We are committed to continuing to advance gynecologic cancer research to improve outcomes for those living with #ovariancancer and #endometrialcancer. We are looking forward to connecting with industry leaders and sharing some of our recent findings at the 2024 #sgomtg this week.
-
GSK US
@GSKUS
#lupus can cause permanent organ damage to the kidneys. Lupus nephritis, when the kidneys are inflamed and possibly work improperly, can occur within 5 years after symptoms appear.
Learn why it's key to talk to a doctor early about lupus: gsk.to/4cgmmGH
#worldkidneyday -
GSK US
@GSKUS
Delayed #lupus diagnosis can damage organs like the kidneys. Social factors like workplace and lifestyle can be barriers to early diagnosis for diseases.
Learn why social drivers of health must be considered when making healthcare decisions #worldkidneyday gsk.to/3VB6c5d -
GSK US
@GSKUS
According to Q1-Q3 2023 data from #vaccinetrack, average monthly non-flu vaccination rates for adults aged 19 and older rose above 2019 levels (1% higher) for the first time since the pandemic began.
Learn more: vaccinetrack.com -
GSK US
@GSKUS
We are incredibly proud to acknowledge the brilliant #womeninstem across our company. We embolden and learn from each other, and always encourage the next generation of women to follow in our footsteps.
Read Nicole's story: gsk.to/3Vdzdn5
#internationalwomensday #iwd2024 -
GSK US
@GSKUS
When it comes to a contagious respiratory virus like respiratory syncytial virus, or #rsv, older adults should know the risks and take preventative actions.
Learn the risks to help #sidelinersv: sidelinersv.com -
GSK US
@GSKUS
This International Women’s Day, we’re celebrating GSK people who #inspireinclusion by making a positive impact on women’s health and helping to forge a more inclusive world for women. Find out more 👇
#iwd2024 -
GSK US
@GSKUS
As part of our goal to achieve higher adult vaccination rates and #healthequity in the US, we are announcing the second year of our COiMMUNITY Initiative, with new patient resources and additional funding to support #nonprofits and community-based groups: gsk.to/3T7l8F5
-
GSK US reposted
GSK
@GSK
News for #investors and #media: Today @ViiVHC, our specialist HIV company, have announced an update on the LATITUDE study evaluating adherence challenges faced by people living with #hiv.
Find out more: gsk.to/49X29E3 -
GSK US
@GSKUS
Organ damage in #lupus occurs when the immune system attacks and inflames organs. This could be prevented for some patients if timely action is taken. Talk with a doctor early to determine what next steps in a treatment plan may be. Listen to Isha’s story: gsk.to/48CDVOo
-
GSK US
@GSKUS
To positively impact the health of 2.5 billion people, we need exceptional talent. Cynthia's story highlights how diverse teams offer unique insights, helping us to better understand the needs of diverse patients: gsk.to/3ThUGtM
-
GSK US
@GSKUS
Check out our public health initiative, THRIVE@ 50+, that aims to raise awareness and educate those over the age of 50 about their risk for #shingles and the impact the disease can have on everyday life.
Join us here ✔️ facebook.com/thriveat50
#shinglesawarenessweek, -
GSK US
@GSKUS
March is #myelomaawarenessmonth! #multiplemyeloma is the second most common blood cancer in the United States, with an estimated 35,780 new cases to be diagnosed in 2024. Find out who is more likely to be impacted by this disease in this quick video 👇
-
GSK US
@GSKUS
It’s important for older adults to know their risk for severe #rsv infection. If you’re 60+, our #sidelinersv Doctor Conversation Guide can help you create a game plan to talk to your doctor about RSV.
Download the guide at sidelinersv.com -
GSK US reposted
GSK
@GSK
#investors and #media
In our 2023 #gskannualreport, CEO Emma Walmsley, reflects on our progress. With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide. -
GSK US reposted
GSK
@GSK
#investors and #media
We’ve published our 2023 #gskannualreport and
#esg Performance Report. Learn how we are uniting science, technology and talent to get ahead of disease together for health impact, shareholder returns and thriving people
More: gsk.to/3IlY40g -
GSK US
@GSKUS
It’s #shinglesawarenessweek, and if you are 50 years or older, you are at an increased risk for #shingles.
With help from @KatieCouric Media, we are sharing a story from GSK patient advocate, Laarni, who was caught off guard by shingles and its pain. Read her story. 👇 -
GSK US reposted
GSK
@GSK
#investors and #media
We’re publishing our Annual Report tomorrow. At GSK we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade. #gskannualreport. -
GSK US
@GSKUS
🌟 It's #shinglesawarenessweek!
Even if you live a healthy and active lifestyle, adults aged 50+ are at an increased risk for developing #shingles.
If you know someone who is 50 years and older, encourage them to learn more about their risk and about vaccination. Details 👇 -
GSK US
@GSKUS
News for #investors and #media: @ViiVHC, our specialist HIV company, are presenting 64 abstracts from our innovative pipeline and portfolio of medicines at #croi2024
Find out more: gsk.to/48AOOAj -
GSK US
@GSKUS
#dyk that #rsv is a common, contagious respiratory virus that usually results in mild symptoms?
It can cause serious infections in older adults and those with chronic heart or lung disease, such as COPD, heart failure and asthma.
Visit sidelinersv.com
#sidelinersv -
GSK US
@GSKUS
Thanks to @HuPharm_college for recognizing our own Wanda Hill! We're proud of her leadership and mentorship here at GSK.
Howard University College of Pharmacy
@HuPharm_college
#blackhistorymonth #blackpharmacist #pharmacyexcellence #diversityinpharmacy
-
GSK US
@GSKUS
#blackhistorymonth holds different meanings for different people. For one GSK leader, it is a time to honor a part of his heritage that may surprise people.
Read Rob's story and find other articles about our outstanding team! gsk.to/49OiLxQ -
GSK US
@GSKUS
We’re proud to have @ViiVHC, our specialist HIV company, presenting at #croi2024.
ViiV Healthcare
@ViiVHC
At #croi2024, we will be showcasing our commitment to producing the next generation of treatment and prevention options for people living with #hiv
More here: viivhealthcare.com/hiv-news-and-media/medical-conferences…
#wewontstop -
GSK US
@GSKUS
This #shinglesawarenessweek, we are educating those 50 years and older about their risk for #shingles and how it can impact their life.
Join @GarcelleB and ask your doctor or pharmacist about your risk for shingles and about #vaccination. -
GSK US
@GSKUS
This #shinglesawarenessweek, it is important for those 50 years and older to understand their risk for #shingles.
Visit gsk.me/3TcWLag to learn more. 👇 -
GSK US
@GSKUS
Over the last few months, we’ve seen the power of meeting people where they are, through our Sideline RSV community events. We’re grateful to our spokesperson @MagicJohnson for sharing #rsv facts at our final event at @YMCADallas.
🏀 Visit sidelinersv.com. -
GSK US
@GSKUS
Diana is using her #engineering skills and personal experiences to pave the way for a brighter and more diverse future in engineering for the next generation. #nationalengineersweek
Learn what life is like at GSK 🧪 gsk.to/3I9gCAO
#eweek2024 #womeninstem -
GSK US
@GSKUS
Empathy, curiosity, and a desire to invent new options in healthcare inspired Nikita to become a #chemicalengineer.
She’s part of the process in making transformational medicines and why we celebrate #nationalengineersweek.
Life at GSK 🧪 gsk.to/49hWeJM
#eweek2024 -
GSK US
@GSKUS
Many #engineers were inquisitive children with a fascination for problem-solving, building, breaking, and re-thinking ideas. James, a #biomedicalengineer, shares his inspiration on #nationalengineersweek.
Learn what life is like at GSK 🧪 gsk.to/3uHK6CQ
#eweek2024 -
GSK US
@GSKUS
On #eweek2024, we’re recognizing the passions & paths of colleagues like Helen.
As a #chemicalengineer, she translates equations & scientific phenomena into user-friendly modeling tools for deeper insights into pharmaceutical processes.
Life at GSK👉 gsk.to/3USyAz0 -
GSK US
@GSKUS
It’s #nationalengineersweek and our engineers impact what we do every day. Learn what inspired Kacey, a #chemicalengineer on our Drug Substance Development team.
Learn what life is like at GSK 🧪 gsk.to/4bKkHca
#eweek2024 #womeninstem -
GSK US
@GSKUS
We’re continuing our #sidelinersv community events with spokesperson @MagicJohnson – this time on our home turf in #philadelphia @philaymca – bringing this important conversation about #rsv and the risks for older adults to center court.
🏀 Visit: sidelinersv.com -
GSK US reposted
GSK
@GSK
#news for #investors and #media: We have completed the acquisition of Aiolos Bio. We look forward to building on our expertise in respiratory medicines.
gsk.to/3uK91pc -
GSK US
@GSKUS
Black history is American history. During #blackhistorymonth, we recognize those who, imbued with courage and determination, stood strong in the face of adversity.
We wanted to share more insight from colleagues who describe what Black History Month means to them. -
GSK US
@GSKUS
"We’re not a world of men – it's as simple as that."
Learn how gender diversity in clinical trials improves health outcomes for women and how we are addressing Barriers to representation. Go #behindthescience here: gsk.to/3OGws9I
#womeninstem #idwgis -
GSK US
@GSKUS
Katie is thankful for a high school mentor who taught her to solve unanswered questions and dive into meaningful research.
Science fairs and research presentations were just the first steps on her journey to an exciting #stem career, leading her to GSK.
#womeninstem #idwgis -
GSK US
@GSKUS
For health advocate and #sidelinersv spokesperson @MagicJohnson, staying healthy is a priority. Yet, like many older adults, he wasn’t aware of his risk for #rsv, a common, contagious respiratory virus.
Learn more at sidelinersv.com. -
GSK US
@GSKUS
You can’t be what you can’t see. Learn why diversity in #stem is key to greater medical innovation and how we're funding initiatives to ensure the brightest individuals can pursue careers in #stem.
Visit: gsk.to/4bAHFCu
#womeninstem #idwgis #behindthescience -
GSK US
@GSKUS
Tessa’s fascination with science was encouraged by her father, intrigued by experiments on TV, and solidified by a teacher who taught her to believe in herself. She is a scientist and continues to foster opportunities to make #stem approachable to everyone.
#womeninstem #idwgis -
GSK US
@GSKUS
Recognizing the important role we all play in reducing the gender gap in #stem disciplines, let’s celebrate the progress, organizations, and individuals inspiring and supporting women and girls to pursue sciences. #idwgis
#womeninstem #womeninengineering -
GSK US
@GSKUS
#inspiration can come from anywhere. On #internationaldayofwomenandgirlsinscience, learn how our scientists were inspired to follow a path in #stem.
🧪Adding a special shout-out to the amazing, truly inspiring #chemistry & #biology teachers!
#womeninstem #idwgis #girlsinstem -
GSK US
@GSKUS
It's International Day of Women and Girls in Science! Listen in with Diana, Esther, and Mia talking about #inspiration, career paths, advice, acknowledging the gender gap, and inspiring girls to consider a path in #stem.
🧪🏗️📐Visit: gsk.to/3whbvw0
#womeninstem #idwgis -
GSK US
@GSKUS
🏀 Ever play a game of H-O-R-S-E?
Watch Sideline RSV spokesperson @MagicJohnson play a fun round of R-S-V with GSK’s own Dr. Len while learning about this common, contagious respiratory virus.
🏀 Learn more about #rsv and vaccination for older adults at sidelinersv.com -
GSK US
@GSKUS
At GSK, we continue building an #inclusive company where everyone can feel a sense of belonging and better serve those who need our clinical trials, medicines, and vaccines.
Some of our outstanding colleagues shared their thoughts on #blackhistorymonth. -
GSK US
@GSKUS
#news for #investors and #media: Today, we announced that the @US_FDA accepted our application to expand the indication of our #rsv vaccine.
Find out more here: gsk.to/42tdw40 -
GSK US
@GSKUS
At our #sidelinersv events, we teamed up with spokesperson @MagicJohnson and local #ymcas, like @ymcanyc, to help older adults better understand the risks of respiratory syncytial virus (#rsv) and what they can do to help prevent it.
🏀Learn more: sidelinersv.comThis media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Today is #worldcancerday! We stand with the @uicc in their mission to #closethecaregap and reduce the burden of cancer by taking action to help solve inequities in diagnosis and treatment.
Learn more and discover ways to get involved: www.worldcancerday.org/take-action -
GSK US reposted
GSK
@GSK
Cancer is the second leading cause of death worldwide. As #worldcancerday approaches, our focus remains on driving research and innovation to bring novel treatment options to people living with cancer so we can #closethecaregap.
-
GSK US
@GSKUS
Every day is precious, so help sideline #rsv.
Through our partnership with @KatieCouric Media we’re sharing Irene’s story about her experience with RSV and what she missed out on while she was sidelined by RSV.
To learn more visit: www.sidelinersv.com
#sidelinersvThis media couldn't be displayed. See it on the original post. -
GSK US reposted
GSK
@GSK
News for #investors and #media
We’ve announced our strong full year 2023 results. Swipe through our key highlights. For more insights, visit us at www.gsk.com. $GSK -
GSK US reposted
GSK
@GSK
News for #investors and #media
Explore our full year 2023 figures at a glance. Dive into the data: www.gsk.com. $GSK -
GSK US reposted
GSK
@GSK
News for #investors and #media
Watch our CEO, Emma Walmsley, share strong full year and Q4 2023 results and upgrades to our growth outlooks.
For more, see gsk.com
$GSK #news -
GSK US
@GSKUS
#rsv is particularly smart at evading our immune system, but thanks to recent advances, we now have fresh insight into a protein that helps us develop immunity against RSV.
Hear more from GSK’s Dr. Temi Folaranmi on this sponsored @sciam #podcast here: gsk.me/3UgrZyg -
GSK US reposted
GSK careers
@GSK_careers
At GSK we make a positive impact on our patients and each other every day. Karen's story is testament to how early influences can inspire us to help others find their own path to success.
Join our team and thrive with us. #aheadtogether #togetherwegrow #inspiringleaders -
GSK US
@GSKUS
The health of communities depends on building a more #equitable adult #vaccination approach. Our COiMMUNITY Initiative combines funding, data transparency, and resource sharing to help close the adult immunization gap.
👉 gsk.to/3RVju90
#behindthescience #healthequity -
GSK US
@GSKUS
While #mlkday is a GSK company holiday for the US, our Mosaic #erg encourages everyone to view it as a ‘day on’ not a ‘day off’.
As the group celebrates its 30th birthday this year, they’re also organizing events for #mlkday and #blackhistorymonth. -
GSK US
@GSKUS
We believe prevention is the best medicine – for patients, societies, and our economy.
Here’s why: gsk.to/3H5JwRN
#aheadtogether #jpm24 #jpm2024 -
GSK US
@GSKUS
We believe prevention is the best medicine. It’s why we’ve built one of the broadest vaccine portfolios in the world to help protect all stages of life. #aheadtogether #jpm24 #jpm2024
-
GSK US
@GSKUS
#investors and #media: Hear Emma Walmsley, our CEO, talk live today at #jpm2024 about our exciting year ahead, at 1030 EST / 0730 PT / 1530 GMT. Her presentation will be followed by a Q&A.
Tune in here: gsk.to/3Sgfodb -
GSK US
@GSKUS
We believe the bigger the challenge, the bigger the need for collaboration. We have long been committed to partnering with the world's best minds - like Wave Life Sciences - at the intersection of science & tech. #aheadtogether #jpm24 #jpm2024
More: gsk.to/4b1Dhwr
1/2
GSK US
@GSKUS
Our acquisition of Affinivax.
Find out more about our collaborations: gsk.to/4aKTt4T
2/2 -
GSK US
@GSKUS
#investors and #media can listen to Emma Walmsley, our CEO, speaking live at #jpm2024 at 1030 EST / 0730 PT / 1530 GMT tomorrow, followed by a Q&A.
Tune in here: gsk.to/3tIbQXr -
GSK US
@GSKUS
#investors and #media: On Tuesday 9 January our CEO, Emma Walmsley and Chief Scientific Officer and President, R&D, Tony Wood will be joining the annual JP Morgan Healthcare Conference as we kick off another exciting year for GSK. #jpm2024 #jpm24
gsk.to/3S6OmUj -
GSK US
@GSKUS
We’re looking forward to meeting investors & industry colleagues at next week’s JP Morgan Healthcare Conference in San Francisco and sharing more about our focus on prevention to get ahead of disease. #jpm2024 #aheadtogether #jpm24
gsk.to/4aBwt8i -
GSK US
@GSKUS
Wishing you a happy and healthy 2024!
#happynewyear -
GSK US
@GSKUS
Investing in adult vaccine programs is not only beneficial for individuals but also for society as a whole. CEO of the Global Coalition on Aging, @MWHodin, calls for collective action to make adult immunisation the new standard of care 👇 #gcoa
gsk.to/3NzuJCL -
GSK US
@GSKUS
By responsibly harnessing #ai, we can transform healthcare and deliver better outcomes for patients. Below, our AI experts discuss how we can embrace this powerful technology to accelerate delivery of new medicines and vaccines 👇 gsk.to/3tAJTkd
-
GSK US
@GSKUS
Wishing you a holiday season filled with joy and peace!
-
GSK US reposted
GSK
@GSK
Do you know what percentage of total health spending is dedicated to #prevention across wealthy countries?
-
GSK US
@GSKUS
We are excited and proud to shine a light on @families2gether, a 2023 GSK IMPACT Award US winner, being featured during the @NYSE Global Giving Campaign 🎄
👉 Learn more about our 2023 #gskimpactus award winners on our US Charitable Investments page: gsk.to/4anvHMh -
GSK US
@GSKUS
This week we announced 10 projects that will receive funding through the COiMMUNITY Initiative #grants! The funding supports programs demonstrating innovative, ambitious & actionable ideas for boosting adult #vaccination. Visit: gsk.to/3v4SWu0
#nonprofit #healthequity
GSK US
@GSKUS
Recipients are implementing tangible solutions to help educate US communities on vaccination best practices and boost vaccine confidence: @CAChronicCare @VaccinateIN @LungAssociation @pharmacists @APhAFoundation @CAHE_AHC @GHLForg @ImmKSCoalition @PQAAlliance @WhyImmunize
-
GSK US
@GSKUS
We’re excited to announce the #grant recipients of the COiMMUNITY Initiative, a multipronged effort to support the design of a more systematic and equitable approach to adult #vaccination.
Visit: gsk.to/47PwFzd
#nonprofit #healthequity -
GSK US
@GSKUS
We all have a role to play to #changethetrajectory of the impact of climate change on human health. At #cop28uae, we hosted an insightful discussion with climate and health experts, reflecting on Health Day and the importance of turning conversation into action.
This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Thanks to @Forbes for including our CEO Emma Walmsley on the 2023 World's Most Powerful Women list, representing the most dynamic female business leaders making an impact on the world today. #aheadtogether
Forbes
@Forbes
The World’s Most Powerful Women
This year’s list represents the most dynamic female business leaders, entrepreneurs, investors, philanthropists, and politicians making an impact on the world today.
SEE LIST: www.forbes.com/lists/power-women/
#powerwomen -
GSK US
@GSKUS
Together with our partners, we work in lower income countries where children’s health is affected by climate change. Routine immunisations can offer a first line in defence against disease outbreaks and is at the heart of our partnerships with @gavi and @savechildrenuk #cop28uae
-
GSK US
@GSKUS
As part of this year’s National Influenza Vaccination Week, we joined @flucoalition for a #fluchat discussion to help #fightflu.
Spread the word, not the #flu!
Click #fluchat to read the full Q&A.
Coalition to Stop Flu
@flucoalition
Q2: Flu vaccination rates are lagging behind last year, and far behind pre-pandemic levels for vulnerable populations like children and pregnant people. What accounts for this decline, and what can we do about it? #fluchat
-
GSK US
@GSKUS
How can we help #fightflu?
Join us for the #fluchat discussion with @flucoalition today, 12/7 at 12pm ET! -
GSK US
@GSKUS
Climate change is creating new health threats. In this article, created in partnership with the @FT, we explain why, with our partners, we’re in the race to eradicate infectious diseases in the face of climate change. gsk.to/46JX2Fo #cop28uae
-
GSK US
@GSKUS
Today, in partnership with @IQVIA_global and #gcoa, we shared new data funded by GSK uncovering local inequities in #vaccine uptake in 5 global cities, including New York and Chicago.
Read more here: gsk.to/46HcuBT -
GSK US
@GSKUS
“This is an investment, not an expense.” Climate change is impacting the spread and burden of disease and accelerating anti-microbial resistance. Vaccines can help protect people’s health but are under-recognised and under-resourced. Read more: gsk.to/4a7DUDR #cop28uae
-
GSK US
@GSKUS
Lupus is a chronic disease that can cause organ damage and hospitalization, resulting in high costs. We aim to improve care by considering social determinants of health.
Read our latest #behindthescience article to learn more: gsk.to/3R8x6gU gsk.to/486bJ6u -
GSK US
@GSKUS
This #idpwd, we're sharing how we embrace diversity to positively impact the health of people with disabilities. Chiko describes how we include the voices of diverse patients, helping us to design and develop more inclusive medicines and devices. gsk.to/3GjTxui
-
GSK US
@GSKUS
It’s #healthday at #cop28uae, and we’re sharing more about the tangible action we are taking to get ahead of climate change and nature loss.
Follow us to find out more.
#healthyplanethealthypeople -
GSK US reposted
PhRMA
@PhRMA
"The holy grail, ultimately, is to be able to cure [HIV]," says Dr. Kimberly Smith of @ViiVUS, @GSKUS’ HIV company. Watch our full conversation with Dr. Smith and other industry leaders about the current state of HIV research: onphr.ma/4a3ocJU
-
GSK US reposted
ViiV Healthcare
@ViiVHC
On #worldaidsday, we continue to partner with the HIV community to in the fight to #endhivstigma 💪
Our #hivinview partners @BexDeHavilland, @AxelRBautista, @VictoriaRoscow, @Inad_Rie, and @D_Moraa share why it's important to #letcommunitieslead. -
GSK US
@GSKUS
#news for #investors and #media:
Today, we announced data from our new global survey that suggests significant gaps in the understanding of #shingles amongst adults aged 50 and over, a group at higher risk of the disease.
Find out more here: gsk.to/3N8cKmv -
GSK US
@GSKUS
Huge congratulations to the #gskimpactus winners 🎉
Each of these winners help to improve health outcomes in their local communities.
Follow below to learn more 👇Post not available here, view on X
GSK US
@GSKUS
Thank you to the #gskimpactus winners that provide wrap-around services, improving the health of their local communities.
The winners are Refugee Community Partnership and Ann’s Heart.
Learn more about our winners: gsk.to/3GmjN7j
#tcf40years
GSK US
@GSKUS
We hope you have been inspired by these 20 outstanding #gskimpactus award winners and their contributions to the health of communities where we live and work. These nonprofits offer a wide variety of resources and volunteering opportunities.
👉 Learn more: gsk.to/410pBx0 -
GSK US reposted
GSK
@GSK
Excited to be ranked #2 among large organisations in @Computerworld’s annual list of Best Places to Work in IT. Find out more 👇
#aheadtogether #gskproud #bestplacesit gsk.to/46xCboE -
GSK US
@GSKUS
We’re getting ready for #cop28uae 🌍 which will include the first ever #healthday. Together, we have a chance to get ahead of this threat and stop disease in its tracks.
-
GSK US
@GSKUS
As part of #theclimateandus series, we embark on a journey to Nepal to explore the impact of climate change on typhoid and learn why partnership is vital in helping protect children from the disease #cop28uae
-
GSK US
@GSKUS
Medicare #immunization claims experienced a 14% increase in H1’23 compared to H1’19. Contributing to that increase, Medicare Part D claims were up 36% in H1’23.
Learn more at: www.vaccinetrack.com
#vaccinetrack -
GSK US
@GSKUS
We’re part of #theclimateandus series that draws links between climate and health. Join us at our manufacturing site in Nashik, India where we’re reducing our water impact and working with local partners to increase water security. For more: gsk.to/3sHjSzt
#cop28uaeThis media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
News for #media and #investors: We’re announcing a major step towards our sustainability ambitions with advancement to phase III trials for our metered dose inhaler. Find out more: gsk.to/46p9ycU
-
GSK US
@GSKUS
According to data from #vaccinetrack, national #vaccination rates have increased in H1 2023, marking the first time there has been an increase in H1 national #immunization claims in comparison to pre-pandemic levels (2019). #vaccinetrack
Learn more: www.vaccinetrack.com -
GSK US
@GSKUS
We’re investing in making STEM education more equitable to inspire and empower the next generation of diverse innovators who can help us discover and develop future medicines and vaccines. Find out more 👇
#gskstemuk -
GSK US
@GSKUS
Ahead of #cop28uae, we’re excited to announce our #netzero targets have been approved by @sciencetargets. Delivery towards this target is part of how we’re working to get ahead of the health impacts of climate change.
Read more: gsk.to/40CG4r0
#sciencebasedtargets -
GSK US
@GSKUS
For many living with #lupus, managing flares goes beyond physical symptoms. Talking with a loved one, prioritizing movement, or getting quality sleep may help the emotional impact of the disease.
Learn more: gsk.to/40IcHUi -
GSK US
@GSKUS
Today we are proud to celebrate local nonprofits in the Greater Philadelphia and the Triangle (North Carolina) regions for their outstanding contributions to improving community health.
👉 Join us today at 11am ET on YouTube as we honor our winners: gsk.to/46de91N! -
GSK US
@GSKUS
We’re thrilled to announce this year’s #gskimpactus Awards on November 14th at 11AM EST on gsk.to/3FV2CK7!
Join us to learn more about the 20 nonprofits making #philly and #trianglenc healthier and how you can get involved! -
GSK US
@GSKUS
Thank you to our 2023 GSK IMPACT Awards Community Safety Winners: Orange County Rape Crisis Center and @PrisonSociety.
Be sure to tune into our awards ceremony on November 14th and learn more about our winners here: gsk.to/3SyAJyU -
GSK US
@GSKUS
This National STEM Day let’s #throwback to #gskscienceinthesummer!
We want children to discover the wonders of science and consider a career in STEM one day.
Follow the link to find resources for your future innovators on this National STEM Day: gsk.to/49vZEcj -
GSK US
@GSKUS
Community activism drives health innovation. Let's harness the lessons learned from #hiv and amplify our voices for #tuberculosis. Together, we can help address the needs of those living with both. Watch our #scienceonthesofa episode for more. #hivstigma
-
GSK US
@GSKUS
We're proud to support @tigerlilycares in honoring @Tania_Small with the 2023 Maverick Award. Tania’s dedication to patient-driven science, and passion to improve diversity, equity and inclusion in GSK’s clinical research are nothing short of inspiring. #aheadtogether
-
GSK US
@GSKUS
Our Drug Substance Dev team hosted the inaugural Science @ Scale Symposium, a program showcasing careers that drive our pipeline from #drugdiscovery to development to commercial #manufacturing. We’re grateful to the undergraduate, graduate, & post-doctoral students who joined us.
GSK US
@GSKUS
Thank you to the students who joined us from:
@EmoryUniversity, @TempleUniv, @Cornell, @LifeAtPurdue. @OhioState, @UMich, @UofSC, @penn_state, @AuburnU, @NJIT, @PittTweet, @UDelaware, @penn_state -
GSK US
@GSKUS
We’re excited to share Robert Truckenmiller's first article as Head of US Vaccines!
He outlines 3 ways public & private partners can collectively help close the adult immunization gap in the US in light of new policy provisions.
#vaccines #healthequity gsk.to/49wDeb8 -
GSK US reposted
GSK
@GSK
Science has a diversity problem. Black people, women, and those from lower socio-economic backgrounds are under-represented in the scientific workforce.
Find out why diversity in STEM is key to greater medical innovation: gsk.to/49kABsH -
GSK US reposted
GSK
@GSK
News for #investors and #media
Watch our CEO, Emma Walmsley, as she announces our results for Q3 2023.
For more, see gsk.to/3SjfEbH
$GSK #news #financialresults -
GSK US reposted
GSK
@GSK
News for #investors and #media
See our Q3 Results highlights gsk.to/3SnpoBt. $GSK -
GSK US reposted
GSK
@GSK
News for #investors and #media
Explore our Q3 2023 figures at a glance. gsk.to/3tWJcSc. $GSK -
GSK US
@GSKUS
Thanks for joining us at the @SWEtalk Conference!
By bringing outstanding people together in an inclusive environment to do work that matters, we can impact the world’s health.
Explore career opportunities here: gsk.to/3s6nQRV
#womeninstem #womeninengineering -
GSK US
@GSKUS
Hello from booth 2629 at the Society of #womenengineers Conference @SWEtalk! 👋
Join us at the #we23careerfair or explore U.S. career opportunities here: gsk.to/3FyanVR
🔬📐⚙️🧮
#womeninstem #womeninengineering
#careerfair #stemcareers -
GSK US
@GSKUS
This #rsvawarenessmonth, health advocate and Sideline RSV spokesperson @MagicJohnson took an important conversation about #rsv and the risks for older adults to center court!
Learn more about our recent #sidelinersv Community Conversation events: gsk.to/3FrJZwY -
GSK US reposted
GSK
@GSK
Honoured to be ranked as a Top Employer on @ScienceMagazine's annual list for the 5th consecutive year
#aheadtogether #gskproud #sctopemployers
Science Careers
@ScienceCareers
The verdict is out! The 2023 Top Employers survey has captured insights from 6,800 professionals in #biotech, #pharma & #biopharma, revealing their priorities when choosing an employer. Click to explore the results! #sctopemployers
www.science.org/content/article/making-happy-workplace-em… -
GSK US
@GSKUS
We're at the Society of #womenengineers Conference @SWEtalk in #losangeles!
Visit our team at the #we23careerfair at booth 2629 this week -- and learn how we "Live without Limits" at #we23.
Check out: gsk.to/3tPqkEL
#womeninstem #womeninengineering
#careerfair -
GSK US
@GSKUS
When it comes to advocating for your health, education is key! That’s why we’re sharing information about RSV this #rsvawarenessmonth.
Learn more about #rsv and vaccination for adults 60 years and older at sidelinersv.com. -
GSK US
@GSKUS
#news for #investors and #media: Today, at the Advisory Committee on Immunization Practices (ACIP) to the US @CDCgov, we shared new data on our #rsv vaccine.
Find out more here: gsk.to/3Qx2xlC -
GSK US
@GSKUS
News for #media and #investors: We’ve been included in @Time’s 2023 Best Inventions list!
Their selection reflects our tireless R&D efforts to lead the way in being ambitious for patients by developing an innovative vaccine pipeline.
#timebestinventions -
GSK US
@GSKUS
This #rsvawarenessmonth, it’s important for older adults to know that they may be at an increased risk for severe #rsv infection.
Understand your risks to help #sidelinersv and learn more about RSV and vaccination for adults 60 years and older at sidelinersv.com. -
GSK US
@GSKUS
It's essential we address the stigma faced by people living with #hivandtb. Joining forces with @ViiVHC on their latest #scienceonthesofa episode, we talk about the need for holistic care in changing the trajectory for people living with HIV and TB.
-
GSK US
@GSKUS
Thanks @STATnews @pharmalot @EdSilverman for hosting an engaging #statsummit discussion with CEO Emma Walmsley about “GSK’s New Groove”, our story of transformation and our strong focus on vaccination and prevention.
GSK US
@GSKUS
Learn more about our prevention focus here:
-
GSK US reposted
Matthew Herper
@matthewherper
“We used the catalyst of the separation of the world’s largest consumer group to start a whole new chapter for $GSK.” CEO Emma Walmsley #statsummit
-
GSK US
@GSKUS
Thanks to @YaleChem for joining the inaugural @Yale + GSK #organicchemistry Symposium!
Prof @Nagiblab @OhioState spoke about radical + carbene #chemistry. Our scientists discussed #drugdiscovery + careers in #gskchemistry.
@ellman_lab @HerzonLab @NewhouseGroup @MillerGroupYale -
GSK US
@GSKUS
We’re in Chicago for #tropmed23 to discuss the important topics and issues in #globalhealth - come and see us at booth 221 to find out how, with our partners, we’re aiming to change the trajectory of infectious diseases in lower income countries. Thanks, @ASTMH for having us!
-
GSK US
@GSKUS
Dr. Kimberly Smith will join @STATnews tomorrow in a compelling session called “We Can End the HIV Epidemic – Why Haven’t We?” at this week’s #statsummit.
-
GSK US
@GSKUS
Our CEO Emma Walmsley will join @EdSilverman @STATnews at the #statsummit tomorrow to talk about “GSK’s New Groove” – the transformation story of how we got here and where we’re going. gsk.to/45xgbty
-
GSK US reposted
ViiV Healthcare US
@ViiVUS
“Jules…don’t tell anyone about this.”
#loveingravity season two continues as we dive deeper into these stories of passion in the gay and queer Latinx community. Check out this week’s episode “One Night”: linktr.ee/loveingravity -
GSK US reposted
ViiV Healthcare US
@ViiVUS
Meet some of the faces you’ll see in As Much As I Can, our award-winning theater experience following a day in the life of four men facing the realities of HIV stigma.
Chicago, book your tickets through October 21 now: www.eventbrite.com/e/as-much-as-i-can-chicago-tickets-588… -
GSK US
@GSKUS
We asked the #hlth2023 community what they thought about the future of digital health innovation and here’s what they said. 📹
Discover more insights from #gskdata: gsk.to/3FgJiGEThis media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
This post is intended for US healthcare professionals.
Thank you for joining #shinglesawarenesschat. It has been great to discuss the impact of #shingles with #hcps involved!
Want to lean more? gsk.to/3rIIszx
#meded #medchat #sponsoredbygskusma -
GSK US
@GSKUS
This post is intended for US healthcare professionals.
🩺Join us in one hour for a compelling #shingles discussion featuring experts
@Boghuma
@dr_fcalderaibd
@DrMoIbrahim
@drjrutland
Be part of the #shinglesawarenesschat
#meded #medchat #sponsoredbygskusma -
GSK US
@GSKUS
In the face of great challenges, we can and must learn from the past.
Together with @ViiVHC we're exploring ways that our deep experience in HIV can inform new approaches to treating TB.
Watch the latest #scienceonthesofa now. -
GSK US
@GSKUS
This post is intended for US healthcare professionals.
Are you an #hcp? Want to learn more about #shingles or share your expertise? Join the #shinglesawarenesschat on October 13 at 12:00-13:00 EDT with
🩺@Boghuma
@dr_fcalderaibd
@DrMoIbrahim
@drjrutland
#sponsoredbygskusma -
GSK US
@GSKUS
By bringing together the power of data and platform technology, we expand what's possible for patients.
Learn more about our partnerships, including our innovative work with @WaveLifeSci: gsk.to/3RQXUUD 🔬
#hlth2023 -
GSK US
@GSKUS
Infectious diseases affect everyone, everywhere, and this is a major concern for society. That’s why we’re in #boston for @IDWeekmtg.
Our #infectiousdisease portfolio is the broadest in the industry and represents two-thirds of our pipeline. #idweek2023
gsk.to/3ZOd4fv -
GSK US reposted
ViiV Healthcare US
@ViiVUS
We’re onsite in Boston at #idweek2023 to present our latest research! Follow along as we share our commitment to meeting the needs of #hiv community through scientific innovation. #wewontstop @IDWeekmtg viivhealthcare.com/en-us/media-center/
-
GSK US
@GSKUS
“The folks who need the most are getting access to the least.”
That’s why @ViiVHC’s head of R&D, Dr Kimberly Smith, spoke about #healthequity at yesterday's “Healthcare, Policy & Advocacy Walk into a Bar” panel.
Find out more: gsk.to/3ZUG9FZ
#hlth2023 -
GSK US
@GSKUS
It’s the final day of #hlth2023 and we’ve had a blast connecting with the innovation community here in Las Vegas and beyond. Thanks for joining us! 🙏
Discover what we’ve learned: gsk.to/3rLhqY6 -
GSK US
@GSKUS
DYK that 34% of #hlth2023 delegates told us that if they could modify one aspect of healthcare collaborations to drive innovation, they would be more open to working with unexpected relationships.
Discover more insights from #gskdata: gsk.to/46JzMHN 🔍 -
GSK US
@GSKUS
This post is intended for US healthcare professionals.
👩⚕️A must for #hcp who want to learn more about #shingles or are keen to weigh in on the conversation, you won’t want to miss the #shinglesawarenesschat #meded #medchat #sponsoredbygskusma -
GSK US
@GSKUS
We’re at #hlth2023 connecting, engaging, and exchanging ideas with the brightest in health-tech innovation!
Read more about GSK at HLTH 2023 here: gsk.to/3LUBwWGThis media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Lisa Banks joined pharma #innovation leaders from @Pfizer, @AstraZeneca, @JNJInnovation & @GeneralCatalyst on stage at @HLTHEVENT to discuss what technologies are exciting them, and how they are envisioning the future of #lifescience and #digitalhealth collaborations.
#hlth2023 -
GSK US
@GSKUS
#hiv medicines are getting better all the time, but stigma is still a major issue that many people experience.
Learn how @ViiVHC 's “Chapters of Stigma” #virtualreality experience teaches empathy and better understanding of patients’ needs: gsk.to/3RSi7JZ 👈 -
GSK US
@GSKUS
Live from the #hlth2023 floor, Mike Montello joined @ChitraNawbatt on the @HLTHEVENT Daily Show to talk everything from how digital and tech powers all that we do at GSK, to his own personal leadership journey. #healthtech
-
GSK US
@GSKUS
Yesterday we discussed “How digital health can advance #healthequity: From research to patient healthcare access” with @DrIvorHorn, Director of Health Equity and Product Inclusion @GoogleHealth.
See what else we have planned at #hlth2023: gsk.to/3LW7F0e 📆
@ViiVHC -
GSK US
@GSKUS
The results are in! 24% of #hlth2023 conference go-ers have told us that the use of cutting-edge tech best demonstrates a #biopharma company is at the forefront of #innovation.
More daily insights: gsk.to/45txRpI -
GSK US
@GSKUS
Today at #chest2023, pulmonary experts will be discussing the positive impacts of switching from dual therapy to single-inhaler triple therapy for #copd patients.
Learn more about triple therapy: gsk.to/3rBrDXf -
GSK US
@GSKUS
This post is intended for US healthcare professionals.
Join the #shinglesawarenesschat with leading healthcare professionals and share your expertise on infectious diseases like #shingles
📅 Friday, October 13, 2023
⏰ 12:00 – 13:00 PM EDT
#meded #medchat #sponsoredbygskusma -
GSK US reposted
-
GSK US
@GSKUS
Our team, including Lisa Banks and Maggie Czarnogorski, spoke about digital health innovations at the @HLTHEVENT Global Health Connector Village yesterday.
View our #hlth2023 speaker schedule: gsk.to/3F74RJK 📣 -
GSK US
@GSKUS
Lisa Banks [VP, Global Head Digital Health & Innovation] draws on her experience of leading a biotech start-up to advise how best to land a collaboration with a global biopharma
#hlth2023 👇 gsk.to/3LUFw9D -
GSK US
@GSKUS
Yesterday at #hlth2023 we joined Mike Montello, SVP, R&D Digital & Tech, at the Pharma & Life Sciences Forum talking about the groundbreaking technologies reshaping #biopharma.
Find out what else we’re up to: gsk.to/3F7bRWS -
GSK US
@GSKUS
We’re live at #hlth2023 connecting, engaging, and exchanging ideas with the brightest in #healthtech #innovation!
Watch our highlights video from day one and see what else we have planned: gsk.to/3LPtQoE 🎬This media couldn't be displayed. See it on the original post. -
GSK US reposted
-
GSK US reposted
GSK careers
@GSK_careers
Joining us at #hlth2023? Over the next few days you’ll hear us share our expertise and discover new ways to get ahead of disease together.
Can't make it? Explore our opportunities here: gsk.to/3PNBLUM
#aheadtogether -
GSK US
@GSKUS
We believe innovation starts when we stop to listen.
Visit us at Booth 4424 at #hlth2023 to add your perspective to our #gskdata visualisation wall and help shape the future of healthcare #innovation.
Find out more: gsk.to/3Q6RJL5 -
GSK US
@GSKUS
We believe the bigger the challenge, the bigger the need for #collaboration.
We have long been committed to partnering with the world's best minds at the intersection of science & tech, while continuing to invest in our own capabilities: gsk.to/3ZLzxK7 🤝
#hlth2023 -
GSK US
@GSKUS
Heading to #hlth2023? We are!
Be sure to join our colleagues featured on panel sessions and visit booth 4424 to let us know what you think about the impact of technology across the healthcare ecosystem at our #gskdata visualisation wall.
Learn more: gsk.to/3tfJ6oi -
GSK US
@GSKUS
Later this week we’ll be at @HLTHEVENT 2023. We’re looking forward to spending some time meeting, collaborating, and listening!
We’ve got a number of speakers lined up – see them all here and what they’ll be talking about: gsk.to/3S4u8Mz 📣
#hlth2023 -
GSK US
@GSKUS
Congratulations to our CEO Emma Walmsley and all of the other accomplished women named to
@FortuneMagazine's list of the 100 most powerful women.
Check out the full list here: gsk.to/46junY6 (Paywall) -
GSK US
@GSKUS
We’re proud that our Chief Scientific Officer, Tony Wood, has been named a Fierce 50 Breakthrough honoree by @FiercePharma, celebrating healthcare and biopharma trailblazers and visionaries fighting for patient care. 👏 🔬
-
GSK US
@GSKUS
During #bloodcancerawarenessmonth and every month, we are committed to making a difference in the lives of those living with #multiplemyeloma and #myelofibrosis.
-
GSK US
@GSKUS
We want to thank all the advocacy groups who are making an impact on patients' lives every day. Thank you to @LLSusa, @mpnadvocacy, @MPN_RF, and @theMMRF from GSK and the blood cancer community. #bloodcancerawarenessmonth
-
GSK US reposted
GSK
@GSK
"It’s like a life sentence of just being uncomfortable.” Kristen Butcher explains the reality of living with cholestatic pruritus of primary biliary cholangitis.
This #pbcawarenessmonth we’re highlighting how #pbc is relentless in affecting people’s quality of life. -
GSK US
@GSKUS
#myelofibrosis symptoms can present and advance differently for everyone. It’s important to speak to your healthcare provider about any signs and symptoms you may be experiencing. #bloodcancerawarenessmonth
-
GSK US
@GSKUS
September is #gynecologiccancerawarenessmonth and #ovariancancerawarenessmonth! This month and every month, we thank all the advocacy groups, including @FacingOurRisk, @GYNCancer, @NOCC_National, and @ocrahope who are working tirelessly to make a difference for these communities.
-
GSK US
@GSKUS
Our 2023 GSK #chemistry Scholars Program is designed to give graduate students the opportunity to learn more about #gskchemistry and the #drugdiscovery process while networking, and sharing student research with our scientists.
Early talent opportunities: us.gsk.com/en-us/careers/early-talent/ -
GSK US
@GSKUS
It’s #gynecologiccancerawareness Month! #dyk that pap smears do not detect #endometrialcancer?
-
GSK US
@GSKUS
Even when faced with health concerns, men are less likely to seek medical attention than women. Coming out of #asthmapeakweek, #asthma triggers may still be at elevated levels, so for those with symptoms it’s important to prioritize talking with a doctor to help improve control.
-
GSK US
@GSKUS
This #ovariancancerawarenessmonth, check out Samantha’s story aimed to encourage those facing #ovariancancer to advocate for themselves.
-
GSK US
@GSKUS
#dyk that #myelofibrosis is a complex bone marrow cancer that impacts ~25,000 people in the U.S.? During #bloodcancerawarenessmonth and every month, we’re committed to helping those impacted by MF and their loved ones navigate this disease.
-
GSK US
@GSKUS
Let's give #tb the attention it deserves! Vincent's story is a powerful reminder of the harsh reality of this disease - the stigma, treatment challenges, and impact on families.
If we truly want to change the trajectory and #endtb, collaboration is key: gsk.to/48tkqJb -
GSK US
@GSKUS
In honor of #gynecologiccancerawarenessmonth, we urge you to familiarize yourself with the signs & symptoms of #endometrialcancer.
-
GSK US
@GSKUS
"I have become grateful for what I have, rather than what I’ve lost.”
September is #ovariancancerawarenessmonth! Watch as Alisa shares how her outlook on life changed following her #ovariancancer diagnosis. -
GSK US
@GSKUS
TB accounts for a third of all deaths of people living with HIV. Recognising this intersection of HIV and TB is crucial for targeted healthcare solutions as care is often siloed.
Together, we're trying to change the trajectory of #hivandtb #scienceonthesofa -
GSK US
@GSKUS
This #worldgoday, we’re shining a light on the importance of advancing care for people living with gynaecologic cancers. Through precision medicine technologies like biomarker testing, innovative research can help us get ahead of gynaecologic cancers. #gofortesting
-
GSK US
@GSKUS
At 11am EDT today, @ThomasBreuer_MD and head of impact partnerships Sabena Solomon will be joining @devex for a panel with @gavi, @sabinvaccine and @savechildrenuk. There’s still time to register! gsk.to/3PxBpCC
-
GSK US
@GSKUS
#lupus mortality rates among Hispanic women are almost six times higher than non-Hispanic women.
This #hispanicheritagemonth, Juana discusses the importance of finding resources to help support a loved one living with lupus like her sister, Estela. -
GSK US
@GSKUS
Converging global challenges of health, climate and #nature need collaborative and urgent action!
We’ll be at the #gcleaderssummit today to help inspire and challenge organisations to accelerate progress. Register now: gsk.to/3t0VJDT -
GSK US
@GSKUS
To protect human health and get ahead of disease, we need to take action on #nature. That’s why we worked with leading experts to develop practical guidance to help ensure human health is a central outcome of global efforts to protect and restore nature: gsk.to/3RnxdqB
-
GSK US
@GSKUS
We celebrated the 50th Anniversary of the @NOBCChE annual meeting in #neworleans recognizing professional advancement of black excellence in #chemistry and #chemicalengineering.
We networked, and showcased mentorships between students of all levels.
#nobcche50 #nobcche2023 -
GSK US
@GSKUS
#myelofibrosis is a blood cancer that historically has had limited treatment options due to the diverse manifestations of the disease. We are honored to bring a much-needed therapeutic option to those living with this condition.
-
GSK US
@GSKUS
It's #unga78 and we’ve got a date for your diary!
This Wednesday, @ThomasBreuer_MD and head of impact partnerships, Sabena Solomon, talk with @devex on the importance of partnerships and our new #zerodose commitment with @savechildrenuk: gsk.to/3PxBpCC #devexevent -
GSK US
@GSKUS
#news for #investors and #media: The @US_FDA has approved our new treatment for intermediate or high-risk #myelofibrosis that may address key manifestations of the disease, namely anemia, constitutional symptoms and splenomegaly.
-
GSK US
@GSKUS
Partnerships lie at the heart of our mission to improve #healthforall. @ThomasBreuer_MD talks with @devex at #unga78 about how partnerships are changing the trajectory of infectious diseases in lower income countries: gsk.to/3PxBpCC
🗓️ 20 September
🕚11am EDT -
GSK US
@GSKUS
The third week of September is recognized as #asthmapeakweek – the time that sees the most #asthma flareups and hospitalizations of the year due to environmental and viral factors.
Understand the triggers and get prepared with an #asthmaactionplan. -
GSK US
@GSKUS
We’re thrilled to be at @WomensHealth_US, where Nicole St Jean, our Head of Precision Medicine, External Business Strategy, will be discussing how we are leveraging AI-powered precision medicine to advance oncology research, including in gynaecologic cancers. #whisusa
-
GSK US
@GSKUS
Action on nature matters for climate, health and business success. That’s why we’re working to reduce our impact on nature across our full value chain, investing in the protection and restoration of #nature, and helping to drive collective action.
More: gsk.to/3Zen2X2 -
GSK US
@GSKUS
There are over 75,000 reasons why getting ahead of disease together matters so much to us.
Watch the full-length film: gsk.to/3P5tx9Z
#aheadtogether -
GSK US
@GSKUS
We’re excited to announce Sideline RSV Community Conversations, a health education event series at @YMCA locations across the US, featuring @MagicJohnson, a #sidelinersv spokesperson, who will help us raise awareness about the risk of RSV infection for older adults.
-
GSK US
@GSKUS
#gskscienceinthesummer may be coming to an end, but learning doesn’t have to stop!
Together with our partners @TheFranklin and @moreheadplanet, we want to continue to inspire future scientists all year round.
👉 Check our free education resources: gsk.to/3suV5Oq -
GSK US
@GSKUS
Decades of innovation in #hiv treatment has transformed the way patients live their lives. Now, a new digital assessment tool could assist further by helping uncover hidden burdens adversely impacting health-related quality of life.
Learn more: gsk.to/44xcD9W -
GSK US
@GSKUS
Head of Vaccines Retail, Adam Friedman, shares how we meet people within their own communities to support older adults in prioritizing their health, especially through vaccination.
Watch below! #niam #niam23This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
As a child, Shreya took part in our #gskscienceinthesummer program, igniting her passion for science 🔬
Now a GSK employee, Shreya shares with us her inspiration to pursue a career in #stem -
GSK US
@GSKUS
Temi Folaranmi, Vice President and Head, US Medical and Clinical Affairs, Vaccines, discusses the importance of community-based public health organizations in creating solutions that help increase adult #vaccination rates.
Watch to learn more.
#niam #aheadtogether -
GSK US
@GSKUS
Our #gskchemistry team was proud to join the fall @AmerChemSociety Conference.
We enjoyed meeting everyone, sharing our science, learning new science and hearing about achievements from all the presenters.
See you at the next one!
#acsfall2023 #proudtobeachemist #chemistry -
GSK US
@GSKUS
Paul was inspired to be a physicist as a child and pursue a career in #stem 🌌
Learn how future innovators can "Be a Physicist" at home through #gskscienceinthesummer!
gsk.to/3sleWQ2 -
GSK US
@GSKUS
See how much fun our future innovators had building and testing homemade parachutes! 🪂
With our partners @TheFranklin and @moreheadplanet e’re bringing the wonder of #physics and #stem to students participating in #gskscienceinthesummer.
Learn more 👉 gsk.to/44o3Qav -
GSK US
@GSKUS
Data shows #vaccination rates against non-seasonal diseases peak at the same time of year as vaccinations against seasonal diseases, like the flu.
Learn more about recommended year-round #vaccines to help protect against vaccine-preventable diseases.
#adultvaccination -
GSK US
@GSKUS
Our recent #whitepaper, developed in collaboration with Capview Strategies, discusses why adult #immunization rates remain low and outlines three immediate and actionable steps to increase rates.
-
GSK US
@GSKUS
With mosquitoes becoming ever more resistant to insecticides and the malaria parasite developing resistance to treatments, novel interventions are urgently needed.
This #worldmosquitoday go Behind the Science to learn about our commitment to #endmalaria gsk.to/3JMGjZ9 -
GSK US
@GSKUS
Share the joy #physics is bringing to our future innovators at #gskscienceinthesummer. Our physicists share what inspired them as children to pursue a career in #stem
Learn more about the program
👉 gsk.to/3shbJRI
#stem #stemkids #beaphysicist -
GSK US
@GSKUS
Ramsey joins us from @PittTweet @PittEngineering @ChemePitt. It's his second summer with us!
He was a #neuroinflammation #intern in the Novel #humangenetics Research Unit, and now, he's on our #digitaltransformation team, observing ways of working in #analyticaldevelopment. -
GSK US
@GSKUS
#news for #investors and #media:
Today, we are proud to share our #rsv vaccine is now available in major retail pharmacies. Find out more here: gsk.to/45cYErc -
GSK US
@GSKUS
Marc, Associate Scientist in our Biopharma area, believes that Science is like art, requiring creativity minds and input of multiple people for innovation to flourish.
Hear his story 👇
#aheadtogether -
GSK US
@GSKUS
Rachel is a #biomedicalengineering student from @Cornell University working with our Tumor Cell Targeting Research Unit.
As an #oncology research #intern, she sees how the team’s work impacts the ability to generate therapies to transform healthcare.
👩🔬 gsk.to/3KFSlEc -
GSK US
@GSKUS
Check out our future innovators at #gskscienceinthesummer having so much fun being power plant engineers with @TheFranklin and @girls_inc.
Follow the links to learn more
👉 scienceinthesummer.fi.edu
👉 girlsincpa-nj.org
#womeninstem #stem #stemkids #beaphysicist #physics -
GSK US
@GSKUS
The health of communities depends on building a more #equitable adult #vaccination approach.
Our COiMMUNITY Initiative combines funding, data transparency, and resource sharing to help close the adult immunization gap.
#ivax2protect #behindthescience -
GSK US
@GSKUS
Callie is a #chemistry major at @DrexelUniv working with our #biopharm Drug Substance Development team.
She’s encouraged to contribute ideas, build a network, and learn about the endless opportunities in pharma sciences.
Programs: gsk.to/3QnggvV
#intern #internship -
GSK US
@GSKUS
🤩 We are celebrating Angel’s @AmerChemSociety Industrial Mid-Career Investigator Award and both Heng's and Chris’s Technical Achievement in #organicchemistry awards.
Click for details about their award talks at #acsfall2023 👇 -
GSK US
@GSKUS
Welcome to #gskscienceinthesummer, where fun and education go hand in hand! Look at how eager our future innovators were to discover the invisible force of #magnetism 🧲
Inspire your future innovators here
👉 gsk.to/3OST2fY
#stem #stemkids #physics @moreheadplanet -
GSK US
@GSKUS
According to 2023 trends from #vaccinetrack national trends in Q1 2023 indicate that vaccination rates are slowly increasing toward pre-pandemic levels. While it is too early to consider this trend a complete win for public health, the uptick in rates is a positive sign!
-
GSK US
@GSKUS
What better way to spend your summer than as a #biopharmaceuticalmanufacturing #intern with our #processtechnology team?
Meet Tristan, a #molecularbiology #biotechnology major joining us from @millersvilleu.
Visit 👉gsk.to/44Wr9Jo
#internship #oncology -
GSK US
@GSKUS
🏅 Congratulations to Gregg, Melissa, and Valer for receiving the @AmerChemSociety Industrial Early Career #investigator Awards.
— And, Matt for receiving an Industrial Mid-Career Investigator Award.
👇 Click for details about their #acsfall2023 award talks. -
GSK US
@GSKUS
As we continue to highlight our GSK Physicists this summer, see what inspired Sabrina to become a #physicist.
Try some of the activities that our future innovators are learning about this summer at home.
👉 Get involved gsk.to/44VLYop
#stem #stemkids #beaphysicist -
GSK US
@GSKUS
Working with our Sterile Operations team, Kacey is learning how aseptic techniques make a product sterile and safe. A #biotechnology student from @MSMEDU, she’s focused on #engineering + #biology + #chemistry to advance technologies. #internship
Visit: gsk.to/3OjS6jf -
GSK US
@GSKUS
We believe #innovaton starts when you stop and listen #hivscience #hiv
Find out how we’re turning talk into treatment: gsk.to/450K7yu -
GSK US
@GSKUS
Our GSK Chemistry team is looking forward to @AmerChemSociety #acsfall2023 conference in San Francisco Aug 13 - 17.
We’ll join #chemistry professionals to share our world-class science and learn about Harnessing the Power of Data.
For meeting details: gsk.to/3OKFS4z -
GSK US
@GSKUS
Thank you to @UWMadisonChem students for joining our second annual @UWMadison + GSK Symposium!
Prof. Levin from @UChicago discussed single atom skeletal editing. Scientists, Nikki Goodwin and Heather Hintz discussed #drugdiscovery, #collaborations, and #chemistry careers. -
GSK US
@GSKUS
Last week Andrea shared why she chose to be a physicist. Now let's see what inspired her husband Jorge as a child to pursue #physics. Perhaps the same thing will inspire our future innovators at #gskscienceinthesummer.
Get involved 👉 gsk.to/3KzZrdv
#stem #stemkids -
GSK US
@GSKUS
Ash is a #chemicalengineering (MS) major at @TuftsUniversity taking his childhood inspiration and working with our Facilities and #engineering team streamlining the response processes during his #internship this summer.
Program details: gsk.to/3OGaeoT
#intern -
GSK US reposted
BBC Newsnight
@BBCNewsnight
Good Newsnight: the first in a series looking at some of the better news stories around
@katelamble examines the breakthroughs in malaria research that could save millions of livesThis media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Thank you @PennChemistry for joining the 2nd @Penn + GSK Symposium! And, Prof. Sarpong who spoke about complex molecule total synthesis.
GSK Scientists, Doug Fuerst & Janelle Steves discussed #drugdiscovery, #predictivechemistry & where a career in #chemistry can take you. -
GSK US
@GSKUS
Happy #niam!
#vaccines are powerful tools in helping protect against serious diseases. Yet gaps in adult #immunization rates remain. We remain committed to closing these gaps.
Learn more: gsk.to/43Y2WBl
#ivax2protect #behindthescience #immunizationawarenessmonth -
GSK US reposted
GSK
@GSK
The scientific community didn't believe an agent could be found which would have activity against HIV. But Marty St Clair, a virologist working at a GSK legacy company in the 1980s, proved them wrong with a life-saving discovery: gsk.to/3Q4vQMI
-
GSK US
@GSKUS
Meet Caitlyn. She’s an Integrated BS-MS in #biotechnology student from @penn_state @PSUScience, working on her #internship with our #immunooncology Research team.
Learn more about the benefits of our early talent program 👉gsk.to/3q99FKY
#interns #oncology -
GSK US
@GSKUS
We believe #innovaton starts when you stop and listen #hivscience #hiv #aheadtogether
Learn more: gsk.to/3QoiuLq -
GSK US
@GSKUS
At GSK, we’ve been uniting our science, technology and talent to get ahead of #malaria for over 70 years, and we’re not stopping. Find out more 👇 gsk.to/458Yl0F
-
GSK US
@GSKUS
#breakingnews: A step closer to eradicating #malaria for good. Learn how the bacterium Delftia tsuruhatensis TC1 could be a game-changer in the fight to save lives from malaria. 🦟
gsk.to/45cnTcD -
GSK US
@GSKUS
Our future innovators are having an amazing time learning how to #beaphysicist at #gskscienceinthesummer. Get in on the action by discovering what excited our GSK physicists as children.
Learn why we do what we do
👉 gsk.to/47cR9BZ
#stem #stemkids #physics -
GSK US reposted
GSK careers
@GSK_careers
Transforming medical discovery, improving R&D success rates, shaping how diseases are prevented and treated – at GSK our people can have a real impact on the future of healthcare.
With great tech and your knowledge, where could you take us?
#aheadtogether -
GSK US
@GSKUS
#news for #investors and #media: Today, the @US_FDA has granted approval for a new indication for our #endometrialcancer therapy. Learn more: gsk.to/44ZkldM
-
GSK US
@GSKUS
We believe #innovaton starts when you stop and listen #hivscience #hiv #aheadtogether
Learn more: gsk.to/3rHND29 -
GSK US
@GSKUS
It’s #nationalinternday!
Our #interns work with #scientists, learn about #manufacturing, build presentations, analyze data, network with experienced #engineers, & get a taste of what it is like to work across our businesses.
More about our program
👉gsk.to/43EQ2I9 -
GSK US reposted
GSK
@GSK
News for #investors and #media
Explore our Q2 2023 figures at a glance. gsk.com
$GSK -
GSK US
@GSKUS
As future innovators learn how to #beaphysicist this summer during our #gskscienceinthesummer program, take a minute to learn about our very own GSK Physicists who share what inspired them as kids to pursue a career in #physics. #stem #stemkids
-
GSK US reposted
ViiV Healthcare
@ViiVHC
Here at #ias2023, we are talking about the positive impact that Patient Reported Outcomes can have on individualised care. Keep your eyes peeled for these conversations in our new series of Science on the Sofa coming soon! 👀
#wewontstop -
GSK US reposted
ViiV Healthcare
@ViiVHC
Today is #zerohivstigmaday, marking the birthday of Prudence Nobantu Mabele- a courageous activist who fought to end #hivstigma
-
GSK US
@GSKUS
We believe #innovation drives disease prevention. #vaccinescience #rsv #aheadtogether
Learn more: gsk.to/425Caa7 -
GSK US
@GSKUS
Getting older is a gift, and it’s important that you take care of your health. Through our partnership with @katiecouric we’re sharing three lifestyle habits that you can start today to help you stay healthy well into your golden years.
-
GSK US
@GSKUS
School is out and #gskscienceinthesummer is in with @moreheadplanet and @TheFranklin. See how our future innovators will learn to #beaphysicist this summer. Check out other activities here that you too can try at home:
gsk.to/44Ev3WI
#stem #stemkids #physics -
GSK US
@GSKUS
We believe #innovation drives disease prevention #vaccinescience #malaria #aheadtogether
Learn more: gsk.to/40LD9dS -
GSK US
@GSKUS
🌞 We hope you're not thinking about #flu this summer, but we are!
Today, we're proud to be the first to start shipping flu #vaccine to the US ahead of the '23-'24 flu season.
🏖️ For details: gsk.to/3XPlNgh
#fightflu -
GSK US
@GSKUS
#icymi, our Chief Global Health Officer @ThomasBreuer_MD spoke with @devex about our £1bn R&D commitment to help change the trajectory of infectious diseases such as malaria, TB and HIV that disproportionately affect lower income countries 👇
-
GSK US
@GSKUS
For Katie, Director of Patient Advocacy, Oncology, working with patient groups to bring their voices back into GSK is what makes her role so special.
Hear her story 👇
#aheadtogether -
GSK US reposted
GSK
@GSK
We're so proud of the GSK people who are part of SPECTRUM, our employee network group for LGBTQ+ employees and allies, who marched at #prideinlondon.🌈
We want GSK to be a workplace where everyone can feel a sense of belonging and thrive. Find out more: gsk.to/43h2MVk -
GSK US
@GSKUS
RSV has evaded scientists for over 60 years. Now, innovations in structural biology and immunology may bring us closer to finding new ways to help protect people.
Find out how fresh insights could finally help us tackle RSV: gsk.to/3XIIfIa
#vaccinescience -
GSK US
@GSKUS
“We’re not dealing with a static enemy… we have to stay on top of this.”
At GSK, we’ve been uniting our science, technology and talent to get ahead of #malaria for over 70 years, and we’re not stopping. Find out more 👇 gsk.to/3JMGjZ9 -
GSK US reposted
GSK
@GSK
Unconscious biases are the attitudes or stereotypes that people hold in the unconscious part of their brain.
Go #behindthescince to find out how that can affect the outcome of clinical trials - and what our scientists are doing to overcome it 👇 #dei
www.gsk.com/en-gb/behind-the-science-magazine/men-women-g… -
GSK US
@GSKUS
June has officially been declared #uterinecancerawarenessmonth by the @IGCSociety. #dyk that uterine cancer is the most common gynecologic cancer in high-income countries? Early detection is key – learn more: gsk.to/439EUCV
-
GSK US
@GSKUS
At GSK, we’re working with others to understand and overcome disparities in health. By uniting science, technology and talent, we can help drive health impact at scale. 👇 gsk.to/3Xu5Wng
-
GSK US reposted
GSK
@GSK
.@wellcometrust and @gatesfoundation announce funding to advance M72/AS01E, a candidate vaccine against #tb. We’re proud to have led on its early development. If successful in Phase 3, it'll be the first new vaccine against active TB in over a century in lower income countries.
-
GSK US
@GSKUS
#machinelearning and #ai are changing the way we think about #drugdevelopment. Read what Kim Branson, our SVP & Global Head of AI & ML, said about the potential of Large Language Models #llms - such as #chatgpt - in the search for new medicines.
Bloomberg Law
@BLaw
ChatGPT is already helping in the search for new medicines, cutting the time it takes to identify molecules for potential new drugs from a month down to a week, says Gaurav Sharma of biotech firm Atom Bioworks. blawgo.com/x6cRUr0
-
GSK US reposted
The Franklin Institute
@TheFranklin
Supported by @GSK and in partnership with TFI, #scienceinthesummer, a free STEM program for elementary-aged students, will inspire over 27,000 youth across the country to take on the role of physicists! fi.edu/sites/default/files/2023-06/Rls_2023 GSKGSK Scienc…
-
GSK US reposted
ViiV Healthcare US
@ViiVUS
National HIV Testing Day is June 27th, and it’s a great time to go get tested. HIV prevention is for us, and the first step is knowing your status. Get more information about where you can find local HIV prevention resources here: viivhealthcare.com/en-us/ending-hiv/resources/
-
GSK US
@GSKUS
Thanks for joing us at #ewoc2023!
Our #gskchemistry team was empowered and inspired by hearing the success stories from resilient female scientists that have overcome many obstacles and challenges at @EWOC8.
#womeninchemistry
#womeninscience
#womeninstem -
GSK US
@GSKUS
Technology used to create vaccines during the pandemic marks the start of a new age in the field of vaccine development.
Learn about the array of novel approaches scientists are turning to, to protect people against infectious disease: gsk.to/3XAl2b7
#vaccinescience -
GSK US reposted
Biotechnology Innovation Organization
@IAmBiotech
#biogivesback with @LS_Cares was back for #bio2023! Thanks to sponsorship by @Amgen and @GSK, attendees got the chance to make 900 care kits to support underserved communities in the Boston area.
-
GSK US
@GSKUS
#news for #investors and #media: Today the US @CDCgov Advisory Committee on Immunization Practices (ACIP) made recommendations on use of our RSV vaccine.
Find out more: gsk.to/3CHgxBG -
GSK US
@GSKUS
Meet our #gskchemistry team at #ewoc2023:
✔️ 6/22 at 12:30 PST: Meet the Sponsors session
✔️ 6/22 at 4:30 PST: Professionals Networking #medicinalchemistry session
✔️ 6/23 at 4:30 PST: View our science posters
Details👉 gsk.to/43ZV8zo
#womeninscience @EWOC8 -
GSK US
@GSKUS
Join Nicole Goodwin, Director, Medicinal Chemistry and our #gskchemistry team at the Empowering Women in Organic Chemistry Conference @EWOC8 June 22-23.
The conference emphasizes the importance of supporting and elevating #womeninscience.
#ewoc2023 #womeninchemistry -
GSK US
@GSKUS
As part of our #ask2bsure campaign, we worked with @lifetimeTV and GSK spokesperson Soleil @Moonfrye to create a short film to increase awareness around the risks of meningitis B for teens and young adults.
Watch the short film: gsk.to/3XgmwXA
BEXVID230026 June 2023 -
GSK US reposted
ViiV Healthcare US
@ViiVUS
During Juneteenth, we’re working towards a deeper awareness of the historical and present-day struggles that the Black community faces. We acknowledge the disproportionate impact of HIV on this community and work tirelessly towards treatment and prevention of this epidemic.
-
GSK US
@GSKUS
Thanks to the outstanding @CornellChem students for attending the first GSK + @Cornell Symposium.
#gskchemistry scientists Nikki Goodwin and Doug Fuerst joined students to talk about #drugdiscovery, chemical manufacturing, and where a career in #chemistry can take you. -
GSK US
@GSKUS
Justin, Senior Director, Oncology Marketing, feels great responsibility to do the right thing for patients after witnessing first-hand a close family member battle with cancer.
Hear his story 👇 -
GSK US
@GSKUS
Our new program, Pharma Research Immersion and Medical Experience (PRIME), is designed to continue enhancing our talent pool. This summer, we’ve invited medical students, specifically targeting #hbcu, to venture into a deep dive into our world.
@MSMEDU @templemedschool -
GSK US
@GSKUS
This #pridemonth 🏳️🌈 ⚧️, we’re proud to support GSK people of all sexual
orientations and identities to thrive. Bryn’s story reminds us how
embracing diversity helps us better understand and positively impact the
health of LGBTQ+ people.
Learn more: gsk.to/43BiSKe -
GSK US
@GSKUS
#icymi What a week at #bio2023! We’re thrilled to be part of the innovation community, immersed by the brightest in biotech who share our belief that by uniting science, technology and talent and by working together, we can get ahead of disease.
This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Thank you to the #bio2023 participants, panelists, policymakers, organisers, our current & future #biotech & academic partners & all the members of the @IAmBiotech community for creating such an exciting experience right at the heart of a growing, global hub of health innovation.
This media couldn't be displayed. See it on the original post. -
GSK US reposted
ViiV Healthcare US
@ViiVUS
What will it take to end the HIV epidemic? We think partnerships with leading science and tech companies are critical. Today @IAmBiotech, Kimberly Smith, Head of Research and Development, spoke about collaborating to bring new innovation to prevent and treat HIV. #bio2023
-
GSK US
@GSKUS
Last day of #bio2023! We’re thrilled to be part of the #innovation community, immersed by the brightest in #biotech who share our belief that by uniting science, technology and talent and by working together, we can get ahead of disease.
Thank you for a great week @IAmBiotech!This media couldn't be displayed. See it on the original post. -
GSK US reposted
GSK
@GSK
#vaccines are global health’s biggest success, helping people of all ages live longer, healthier lives. Judy Stewart, SVP US Vaccines, shared at today’s #bio2023 session how we’re turning up the dial on adult #immunization.
-
GSK US
@GSKUS
Day three at #bio2023! We’ve been talking about the importance of collaboration in a ‘Partnering to get ahead of disease together’ session. Plus we shared how we’re fighting antimicrobial resistance with #vaccine #innovation.
Watch the highlights + visit: gsk.to/42u0qSkThis media couldn't be displayed. See it on the original post. -
GSK US reposted
-
GSK US
@GSKUS
Our Head of Market Access Robert Truckenmiller, Amanda Mott from @ViiVHC and J Lance Grady from
@AvalereHealth came together with Nick Shipley
of @IAmBiotech to discuss the Inflation Reduction Act and how it impacts patient care and innovation. #bio2023 -
GSK US
@GSKUS
We believe the bigger the challenge, the bigger the need for collaboration.
That’s why we collaborate with a number of different organizations to get ahead of disease together, including @Halozymeinc and @WaveLifeSci.
Thanks for a great discussion today at #bio2023! -
GSK US
@GSKUS
#antibiotics extended lives by an estimated 20 years, but natural resistance over decades means we need more types in order to keep treating infections.
Find out how we’ll contribute to this challenge when you go #behindthescience #bio2023 www.gsk.com/en-gb/behind-the-science-magazine/amr-antibio… -
GSK US
@GSKUS
At #bio2023, we're addressing one of the most pressing healthcare topics, antimicrobial resistance #amr, with our own Leonard Friedland, VP Public Health Vaccines; Jim Wassil - Vaxcyte; Joseph Sevilla @HarvardChanSPH; @Victornizet @CHARM_UCSD & moderator Jomana Musmar @HHSGov.
-
GSK US reposted
Biotechnology Innovation Organization
@IAmBiotech
“Last five years signaled a new era in science” says @GSK CEO Emma Walmsley at #bio2023. GSK focuses on prevention of disease at scale as “prevention is the best outcome for patients and for all of us.”
-
GSK US
@GSKUS
We believe innovation drives disease prevention – that's why we’re at #bio2023 talking about RSV. #aheadtogether
-
GSK US reposted
Pauline Yang
@paulinebhyang
On today's Cross Validated podcast, we have Kim Branson, Senior Vice President and Global Head of AI and ML at GSK. GSK is one of the 10 largest pharmaceutical companies globally. @altcap
In this episode, we discuss:
- Applying ML to genetic data, clinical trials and more + gen AI to processes
- Building on open source technologies and reusable components in models
- Data and data generation as a critical asset
- Regulatory framework on AI
Subscribe for the next episode: t.ly/6imFA -
GSK US
@GSKUS
Today at #bio2023 our CEO Emma, CSO Tony, & CTO Shobie spoke with @KrofahEsther of @MilkenInstitute on how uniting science, technology & talent can prevent and change the course of disease.
See our highlights + visit: gsk.to/3NfGo9ZThis media couldn't be displayed. See it on the original post. -
GSK US reposted
-
GSK US
@GSKUS
#news for #investors and #media: The @US_FDA has accepted the supplemental Biologics License Application and granted Priority Review for a potential new indication for our immuno-oncology treatment for #cancer patients.
Learn more: gsk.to/3qyj527 -
GSK US
@GSKUS
We’re live at #bio2023, connecting, engaging & exchanging ideas with the brightest in #biotech #innovation!
Watch our highlights video & tune in tomorrow for a session with Emma, CEO, Tony Wood, CSO & Shobie, CTO, on ‘A new era for science and tech to get ahead of disease’. -
GSK US reposted
-
GSK US
@GSKUS
Lynn Baxter, SVP of our HIV company @ViiVHC, spoke on a panel at #bio2023 today with @genentech @flagshipPioneer @SyneosHealth @pharmaessentia talking about leadership advantages women bring to the biopharma c-suite. #bio2023 👏 👏
-
GSK US reposted
ViiV Healthcare US
@ViiVUS
Putting the unmet needs of patients first led us to our partnership with @halozymeinc and to make a significant impact for people living with HIV. We’re bringing our spirit of collaboration to #bio2023 in Boston, come connect with us!
-
GSK US reposted
GSK careers
@GSK_careers
Are you looking for your next career opportunity? Chat with us at #bio2023 in Boston and discover how we’re advancing science and getting ahead of disease together.
Can’t wait? Explore our open roles today: gsk.to/3IYdPeK
#aheadtogether #standupforscience #gskboston -
GSK US reposted
ViiV Healthcare US
@ViiVUS
Ever wondered how we create new medicines for #hiv?
Our scientists at Branford (USA) test millions of compounds to identify new potential medicines for people living with HIV. We’re taking our hard work to @IAmBiotech to show the strides we’re making in ending HIV. #bio2023 -
GSK US
@GSKUS
What’s on your #bio2023 agenda? We’ve got a number of speakers lined up – see them all here and what they’ll be talking about gsk.to/3C75Yrf
-
GSK US
@GSKUS
Today, GSK announced the launch of the COiMMUNITY Initiative, a multipronged effort to reduce health inequities and help set a new precedent for adult #immunization rates in the US through funding, data transparency and collaborations, and resource-sharing opportunities.
-
GSK US reposted
GSK
@GSK
At GSK our fight against HIV started over 40 years ago. Today we continue to innovate and unite science, technology and talent so patients like Jorge can live long, healthy and full lives. 👇
Watch the full conversation: gsk.to/3qeQpLv -
GSK US reposted
ViiV Healthcare US
@ViiVUS
Did you know that the HIV virus can hide in the body, even if a person is on effective antiviral medicine? At @IAmBiotech, we’ll talk about healthcare innovation and our approach to ending #hiv. #bio2023
This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
GSK is committed to helping patients breathe easier. We’re wrapping up #asthmaawarenessmonth with some tips to help patients breathe better, especially through the change in seasons.
Thanks for joining and #springintoaction with us once again next May! -
GSK US
@GSKUS
Michael Petroutsas, Senior Vice President, Head of US Specialty Business Unit, recognizes #asthmaawarenessmonth and shares ways that doctors and specialists can help patients prioritize their respiratory and overall health.
#springintoaction and learn more. -
GSK US
@GSKUS
During #aapimonth, we continue to celebrate the many contributions and achievements by this diverse population. We’re inspired by the compelling journey of one of our colleagues. Read more about Marcia here: gsk.to/3IMzUwP
-
GSK US
@GSKUS
We believe #innovation drives disease prevention. #aheadtogether #bio2023
-
GSK US
@GSKUS
Next week we’ll be at #bio2023 with @IAmBiotech. We’re looking forward to spending some time meeting, collaborating and listening to you! See more about what we’ll be getting up to here: gsk.to/42gbKRY
-
GSK US
@GSKUS
#rsv infections can be dangerous for older adults and those with chronic medical conditions like #asthma and #copd. With the warm weather returning, it’s important to #springintoaction by learning RSV prevention tips for those who may be at high risk of severe infection.
-
GSK US
@GSKUS
As the over 60s outnumber children under five for the first time, vaccine-preventable disease among adults is increasing.
Could routine adult immunisation be the answer? gsk.to/3Wxmquy
#vaccinescience -
GSK US
@GSKUS
Our #respiratory leaders led a panel discussion on the future of respiratory health, the importance of focusing on patients’ unmet needs, the latest on #vaccines and the future of anti-infectives.
Learn how we are working to address diseases such as #asthma, #copd and #rsv.This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
We’re stepping up our work with suppliers on #nature impact. We’ve developed a set of ambitious new standards that apply specifically to the materials we source that are most highly dependent on nature.
Learn more: gsk.to/3otphrE -
GSK US
@GSKUS
Great to see GSK people recognised in @INvolvePeople’s 2023 Empower Role Model Lists for making an impact by driving change, supporting people of colour and inspiring inclusion within GSK and beyond.
See the full lists here: gsk.to/3WspyYB
#emrolemodels23 -
GSK US
@GSKUS
We’ve been selected by the @SBT_Network to be part of the first group of companies preparing to set #sciencebasedtargets #fornature, building on our existing nature targets.
We’ll use new methodologies to increase positive outcomes for nature and people: gsk.to/436fyqu -
GSK US
@GSKUS
As weather changes, flowers are blooming and #asthmaawarenessmonth continues, #springintoaction with some tips to best manage severe eosinophilic #asthma to adjust to season changes, so you can enjoy your time outdoors without worry.
-
GSK US
@GSKUS
Some #lupus symptoms aren’t visible to others, so it's sometimes deemed an “invisible illness.” That doesn’t mean lupus isn't serious. This #lupusawarenessmonth, we’re spreading awareness to make lupus visible. Learn more.
GSK is not affiliated with LFA. gsk.to/3MoNS93 -
GSK US
@GSKUS
Today, #pulmonary & #allergy experts are discussing the future of #severeasthma care at #ats2023.
Our program, “Aiming for Clinical Remission: The Next Frontier,” will delve into the endpoints that may define clinical remission and the unmet needs that underlie this ambition. -
GSK US
@GSKUS
This #wdcddd, we celebrate our diverse people and their contributions to positively impacting the health of 2.5 billion people. Diversity fuels innovation, helping us perform better for patients.
Learn more about diversity at GSK: gsk.to/45dEwpf
#culturaldiversityday -
GSK US
@GSKUS
We’re headed to #ats2023 to share info on #biologics, #eosinophils and real-world outcomes of treatment.
-
GSK US
@GSKUS
Developing vaccines has historically been a time-consuming process, often taking more than a decade.
Learn how we’re using a digital twin to speed up the entire vaccine development process: gsk.to/45czj0W
#vaccinescience -
GSK US
@GSKUS
In preparation for the #ats2023 congress, leaders from our #respiratory business met to discuss the latest in #rsv, #asthma and #copd. Tune in to their discussion to learn more. @atscommunity
-
GSK US
@GSKUS
We are proud to be an Education Partner for @APFEDorg’s 2023 celebration of National
#eosinophilawarenessweek.
Learn about eosinophil-associated diseases & explore suggested
awareness activities at apfed.org/neaw.
#neaw #eosaware -
GSK US
@GSKUS
We’re honoring #eosinophilawarenessweek with education on eosinophil-driven conditions like severe eosinophilic #asthma.
#springintoaction by learning more about #eosinophils and ways your doctor can check for these diseases. #asthmaawarenessmonth -
GSK US
@GSKUS
On #mothersday (and every day) we celebrate our mothers, grandmothers, aunts, care-givers, and the role models who have raised and inspired us.
Read Amruta's story on finding balance and purpose as a mother and GSK scientist. #womeninscience
gsk.to/3MmP2TN -
GSK US
@GSKUS
The predictive power of genetics, genomics, and AI holds the key to transforming medical discovery for the better.
Find out how we're getting ahead of infectious diseases with advanced technology: gsk.to/3HSzfJN
#vaccinescience -
GSK US
@GSKUS
#dyk that persistent asthma exacerbations can be a sign of #uncontrolledasthma?
#springintoaction with GSK leader Court Horncastle to learn about what patients can do if asthma is keeping them indoors this season. #asthmaawarenessmonth -
GSK US
@GSKUS
This #lupusawarenessmonth, learn from experts about the importance of open communication between people living with #lupus and their doctor.
Register now for a webinar session this May 👇
gsk.to/42XsWNd -
GSK US
@GSKUS
Today is #worldovariancancerday, a day where we globally raise our voices in solidarity in the fight against #ovariancancer.
In honor of this important day, we encourage you to learn more about this disease: us.gsk.com/en-us/company/purpose-strategy-and-culture/onc…. #wocd2023 #nowomanleftbehind -
GSK US
@GSKUS
We celebrate the many contributions and achievements across the US during #aapiheritagemonth. Our colleagues in our Asian employee resource group, Fusion, have been incredibly busy planning activities. We managed to ask them to share one thing about their culture 👇
-
GSK US
@GSKUS
It’s Vasculitis Awareness Month. We’re highlighting less common conditions like #egpa, a rare form of #vasculitis.
#springintoaction and talk to your doctor if you may be experiencing any signs and symptoms. #vam2023 -
GSK US
@GSKUS
#myelofibrosis patients may experience a range of manifestations of disease, including enlarged spleen, fatigue, bone and joint pain, easy bruising/bleeding, and anemia. Here at GSK, we are committed to helping patients get the information they need about their disease.
-
GSK US
@GSKUS
Lorenzo, VP, Head of Global Recruitment, is responsible for attracting the right talent to GSK, valuing those that bring a diverse set of skills and thoughts to the table.
Hear his story 👇
#aheadtogether -
GSK US
@GSKUS
#news for #investors and #media: Today we are proud to share that the @US_FDA has approved our vaccine as the first for respiratory syncytial virus (#rsv) for older adults: gsk.to/44oIb36
-
GSK US
@GSKUS
Let’s celebrate Spring and #worldasthmaday. Today, and throughout May, we’ll #springintoaction and learn more about different types of #asthma.
#asthmaawarenessmonth -
GSK US
@GSKUS
May is #lupusawarenessmonth, and we’re hosting webinars to educate about managing #lupus – a chronic disease affecting nearly 5 million people worldwide. Register now for an upcoming session. 👇
-
GSK US
@GSKUS
We believe #innovation drives disease prevention. #vaccinescience #malaria #aheadtogether
Learn more: gsk.to/41J6PcU -
GSK US
@GSKUS
We believe #innovation drives prevention of infectious diseases. Learn how breakthroughs in vaccine innovation are helping to protect more lives.
#wiw2023 #thebigcatchup -
GSK US reposted
GSK
@GSK
News for #investors and #media
We’ve announced a strong start to 2023. Swipe through for the highlights and see more on our website. $GSK -
GSK US reposted
GSK
@GSK
News for #investors and #media
Watch our CEO, Emma Walmsley, as she outlines a strong start to 2023.
For more, see www.gsk.com
$GSK #news -
GSK US
@GSKUS
We’ve been uniting our science, talent and technology to get ahead of #malaria for over 70 years. And we’re not stopping. We’re #investing in #innovation to find new medicines and working with partners to #implement the first #malariavaccine in malaria endemic regions. #wmd2023
-
GSK US
@GSKUS
As we age, the #immunesystem weakens making us more vulnerable to #infectiousdiseases.
#wiw2023 #thebigcatchup
Want to find out more? 👇 -
GSK US
@GSKUS
Have you heard of #myelofibrosis, a rare form of blood cancer? Dr. John Mascarenhas, a hematologist oncologist, explains what this condition is, how it presents and how it is diagnosed. Watch the video here: gsk.to/3KQpI7P
-
GSK US reposted
GSK
@GSK
An estimated 3.5 to 5 million lives are saved every year thanks to #immunisation. Help protect future generations from vaccine-preventable diseases. #wiw2023 #thebigcatchup
-
GSK US
@GSKUS
💊 Today is the day! Bring your unwanted, unused, and expired medicines to the 24th @DEAHQ's National Prescription Drug #takebackday between 10AM - 2PM.
💊 Find a participating location near you at takebackday.dea.gov
#ppswg #myoldmeds #safedisposal -
GSK US
@GSKUS
During the 2022 #takebackday, the @DEAHQ collected over 324 tons of household medicines! Can we break that record on Sat 4/22?
Find a participating location at:
💊 takebackday.dea.gov
#ppswg #myoldmeds #safedisposal -
GSK US
@GSKUS
Real conversations generate impactful change. At this year’s @NMQF Summit on Health Disparities, VP of Commercial Communications, Sri Ramaswami, joined a panel discussion on Addressing Barriers to Patient Accessibility to Necessary Therapies. #nmqfleadershipsummit
-
GSK US
@GSKUS
The next @DEAHQ's National Prescription Drug #takebackday will be held on Saturday, April 22!
Learn how to prepare, what will be collected, and how to safely store your medicine until the event at:
💊💊myoldmeds.com/blog.
#ppswg #myoldmeds #safestorage #safedisposal -
GSK US
@GSKUS
Congrats to the @startupfiu students in the GSK #innovation Challenge addressing low vaccination rates in the Hispanic community. The winners found large companies with a big Hispanic workforce and created solutions including an employer caregiver toolkit and caretaker programs.
-
GSK US reposted
GSK
@GSK
Did you know that #antimicrobialresistance could result in 10 million deaths every year by 2050?
Go Behind the Science to learn more about #amr 👇 gsk.to/41b2SNS -
GSK US
@GSKUS
#news for #investors and #media: Today we announced the proposed acquisition of @BELLUSHealth, a clinical stage biopharmaceutical company that further strengthens our specialty medicines and respiratory pipeline.
Find out more: gsk.to/41zwzb7 -
GSK US
@GSKUS
While everyone can be impacted by #myelofibrosis, certain risk factors can increase the likelihood that a person will develop it.
Click here to learn more: gsk.to/3zRZBXY -
GSK US reposted
GSK careers
@GSK_careers
Get ready to take your career in an exciting new direction. At GSK, we can help you use your skills in a different way.
Discover your potential and find out how you can help us get ahead of disease here: gsk.to/3MALcHc #aheadtogether -
GSK US
@GSKUS
Are you familiar with the signs and symptoms of #myelofibrosis?
In early stages, ~1/3 of people with the disease may not have any, but as it progresses, patients may experience a variety of symptoms that differ from person-to-person. Learn more: gsk.to/3KRNW1B -
GSK US
@GSKUS
We look forward to the discussion and research coming out of @NKF. GSK is committed to helping people impacted by #anemia of chronic kidney disease and getting ahead of disease together. #nkfclinicals
-
GSK US reposted
GSK careers
@GSK_careers
Our advances in digital and data have put GSK at the forefront of innovation in healthcare. We're looking for ambitious Data and Platform Engineers to live up to this status and design better medicines faster.
Apply today gsk.to/3ZL4ZXo
#gskonyx #gskcareers -
GSK US
@GSKUS
#myelofibrosis is a rare and potentially fatal blood cancer that is characterized by the buildup of excessive scar tissue in the bone marrow, which interferes with the production of healthy blood cells.
-
GSK US reposted
-
GSK US
@GSKUS
During #myelomaawarenessmonth and every month, we are grateful for all the organizations supporting the #multiplemyeloma community year-round and their commitment to treating this disease. Thank you @imfmyeloma, @theMMRF, @HealthTreeMM & @LLSusa!
-
GSK US reposted
ViiV Healthcare
@ViiVHC
#news for #investors and #media on progress in our commitment to voluntary licensing for populations with unmet needs. More at: viivhealthcare.com
-
GSK US
@GSKUS
Our colleague Allison Doherty, participated in the 23rd Moving Mountains for Multiple Myeloma trek to raise awareness & support for #multiplemyeloma research. #mm4mm #myelomaawarenessmonth
-
GSK US
@GSKUS
Thanks to @CNBCevents and @jimcramer for a great discussion about innovation at GSK during today’s #healthyreturns Summit.
-
GSK US
@GSKUS
#dyk that #multiplemyeloma arises in a person’s bone marrow when plasma cells mutate into problematic myeloma cells? These cells accumulate, crowding out healthy blood cells. Learn more: gsk.to/3Zo4zpD. #myelomaawarenessmonth
-
GSK US
@GSKUS
We are proud to sponsor @imfmyeloma’s #myelomastory campaign to raise awareness of #multiplemyeloma and inspire community members to share their stories. Share your story & visit gsk.to/3Zi19ok to learn more.
-
GSK US reposted
-
GSK US
@GSKUS
#multiplemyeloma survivor Thomas shares his story from diagnosis at a young age, to continued treatment, his role in clinical trials, and life as an advocate: gsk.to/3LMhvCG #multiplemyelomaawarenessmonth
-
GSK US
@GSKUS
Last summer the Moving Mountains for Multiple Myeloma #mm4mm team climbed Mount Washington to advocate for those with #multiplemyeloma.
This #myelomaawarenessmonth, we recognize all those who work tirelessly to positively impact the lives of people living with Multiple Myeloma.This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
We partner with the #hiv community to develop medicines that fit into people’s lives. Find out how we’re getting ahead of HIV together in the @FT gsk.to/FTHIVORG
-
GSK US
@GSKUS
We know that when people are truly themselves, we’re more innovative and deliver better outcomes for patients. Hear the stories of four of our amazing people.
Learn more: gsk.to/3Z7C2Vb -
GSK US
@GSKUS
March is #myelomaawarenessmonth! #multiplemyeloma is the second most common form of blood cancer in the U.S. It’s more common in people aged >65 years old, men and African Americans. Learn more: gsk.to/3JUT1pt
-
GSK US reposted
GSK
@GSK
Until recently, medicines and vaccines were mainly tested on men. This has had a detrimental effect on the health outcomes of women around the world. However, attitudes are shifting: gsk.to/3LvMQcD
-
GSK US
@GSKUS
We believe innovation starts when we stop to listen.
Find out more about how we’re getting ahead of HIV together @FT gsk.to/FTHIVORG -
GSK US
@GSKUS
Dana, Senior Specialty Account Specialist, Sales, and global lead for GSK’s Indigenous Peoples Association believes that having a diverse and multicultural workforce is vital to business success.
Hear her story 👇 -
GSK US
@GSKUS
#lupus nephritis occurs when the immune system attacks and inflames the #kidneys, which can lead to permanent kidney damage. This National #kidneymonth, develop a long-term disease management plan with your physician to help reduce risk.
-
GSK US
@GSKUS
We’re teaming up w/@MagicJohnson to help bring important conversations around the risks of #rsv among older adults center court. As a health advocate for more than 30 yrs, he will join #sidelinersv to help raise awareness about the potential seriousness of #rsv for older adults.
-
GSK US
@GSKUS
We’re excited to announce #sidelinersv! Together w/ @MagicJohnson, a Sideline RSV spokesperson, we’re committed to raising awareness about #rsv & the potential risk for severe infection in older adults & adults w/ underlying conditions like COPD, asthma or chronic heart failure.
-
GSK US
@GSKUS
#news for #investors and #media: Today we have announced positive top-line Phase III data in #meningitis. To find out more gsk.to/3JDgzPc
-
GSK US reposted
-
GSK US reposted
GSK
@GSK
For #investors and #media
Our CEO, Emma Walmsley, reflects on our progress in 2022 and looks ahead to 2023 in the #gskannualreport
Read more in our Annual Report: www.gsk.com/en-gb/investors/financial-reports/annual-repo… -
GSK US reposted
GSK
@GSK
For #investors and #media
We’ve published our 2022 #gskannualreport and ESG Performance Report detailing our progress in getting ahead of disease together: www.gsk.com/en-gb/investors/financial-reports/annual-repo… -
GSK US
@GSKUS
In support of @WorldKidneyDay, learn how we’re getting ahead of disease together to help people with #anemia of chronic kidney disease (CKD). #worldkidneyday #kidneyhealthforall
-
GSK US
@GSKUS
Mindful of how under-represented women were when she entered the #chemistry field, Beth talks about how important #rolemodels are and how she does her best to be an example for others.
Go #behindthescience for her #womeninscience story.
#embraceequity #iwd2023 #womeninstem -
GSK US
@GSKUS
As we #embraceequity on #iwd2023, we’re focused on healthcare and education. Hear from our colleagues helping women get the treatment they need 👇 Plus read about one of our leaders delivering much needed resources to underserved communities here: gsk.to/3SVheih
-
GSK US
@GSKUS
This #iwd2023, we’re celebrating the amazing GSK people who are contributing to women’s health equity.
Hear from members of our Women’s Leadership Initiative which turns 25 this year, sharing their commitment to creating a more equitable future for women.
#embraceequity -
GSK US
@GSKUS
A new global survey emphasizes the importance of early communication between #lupus patients and health care providers to help minimize the risk of potential damage, including the #kidneys.
This National #kidneymonth, learn more about the impact of delayed lupus care: -
GSK US reposted
GSK careers
@GSK_careers
We’re working with @UCSF and @UCBerkeley to unlock the power of genomics. It’s how we’re discovering new drugs and delivering for patients.
Learn more about how we’re using innovative technologies to advance genomic research: gsk.to/3EZYnww #aheadtogether -
GSK US reposted
ViiV Healthcare
@ViiVHC
“This is an activist community. They deserve our attention, and we absolutely need to hear what they have to say.”
Read more in the Financial Times about how we are turning #hiv community conversations into innovative medicines: gsk.ft.com/article/hiv-community-tells-industry-struggle-…
#wewontstop
@GSK @FT -
GSK US
@GSKUS
A diverse and inclusive culture helps us understand our diverse patients and perform better. That’s why we want to increase gender and ethnic diversity representation in senior leadership by 2025.
-
GSK US reposted
NFID
@NFIDVaccines
#rsv Update: Majority of @US_FDA advisory panel agreed that @GSK RSV #vaccine safety data was adequate, and unanimously agreed that efficacy was good www.cnbc.com/2023/03/01/fda-advisors-recommend-gsks-rsv-v… via @CNBC #preventrsv
-
GSK US
@GSKUS
For #shinglesawarenessweek, we’re committed to spreading the word about this illness. Did you know that 1 in 3 people will develop #shingles in their lifetime?
Learn more about shingles and talk to your doctor or pharmacist about your risk and #vaccination. -
GSK US reposted
GSK careers
@GSK_careers
What makes a good leader? For Maya it means listening to every voice, creating an inclusive environment and inspiring great work. All things she does every day in our leadership team.
Join a company where you can thrive. Discover GSK: gsk.to/3kwxxFh #aheadtogether -
GSK US
@GSKUS
We think about HIV every day so people like Warren don't have to. @ViiVHC gsk.to/FTHIVORG
-
GSK US
@GSKUS
For adults 50+, there may be a lack of awareness about the aging immune system and the likelihood of experiencing certain conditions, like #shingles.
If you had #chickenpox as a child, you already carry the same virus that causes shingles.
#shinglesawarenessweek -
GSK US
@GSKUS
DYK #multiplemyeloma disproportionately impacts African Americans? To get ahead of this disease, we're working with patient advocates to increase the number of African American participants in clinical trials.
This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
At #aaaai23 and throughout the year, we are committed to understanding #egpa and supporting the community impacted by this #raredisease disease, which affects 5,000 people nationwide.
Join us as we discuss the top patient profiles of those people living with this condition. -
GSK US
@GSKUS
Conditions like #severeasthma impact individuals differently based on other underlying factors. Follow along at #aaaai23 as we share our latest research on severe #asthma and patient experiences with eosinophil-driven diseases.
-
GSK US
@GSKUS
There are many activities designed to raise awareness and support the community during #blackhistorymonth. We asked some of our colleagues…what do you hope people learn or realize during this month?
-
GSK US reposted
ViiV Healthcare
@ViiVHC
#news for #investors and #media on our SOLAR study presented at #croi2023.
More here: viivhealthcare.com -
GSK US
@GSKUS
#scientists have been searching for ways to get ahead of respiratory syncytial virus since 1955. But what is #rsv?
Find out more: gsk.to/3kj9fyw -
GSK US
@GSKUS
The combination of #flu, #covid19 and #rsv has become known as the #tripledemic. What are the things we can all do to reduce the impact?
Find out more: gsk.to/3XB62rw -
GSK US reposted
ViiV Healthcare
@ViiVHC
Prevention is key to ending #hiv.
Jamanii is a Prevention Consultant and member of the Black Women’s Working Group, who have co-created the Risk to Reasons initiative with @ViiVUS.
Hear her story and learn more here: viivhealthcare.com/content/dam/cf-viiv/viivhealthcare/en_…
#risktoreasons #croi2023 -
GSK US
@GSKUS
“It makes me really happy that I can connect with patients and get them access to clinical trials.” – Nisha Patel (GSK)
We're working with organisations like MiOra to ensure that women from underserved communities are represented in clinical trials for #ovariancancer.This media couldn't be displayed. See it on the original post. -
GSK US reposted
-
GSK US
@GSKUS
Congrats to our own Jennifer Tolley on making the @MMMnews 40 Under 40 list! #mmm40under40 👏👏👏
MM+M
@MMMnews
Congratulations to Jennifer Tolley of @GSK for earning a place on this year’s MM+M 40 Under 40 list! #mmm40under40 www.mmm-online.com/40-under-40/40-under-40-jennifer-tolle…
Get tickets here: www.mmm40under40.com?promo=SC&tr=true -
GSK US
@GSKUS
As #covid19 restrictions ease, there has been a resurgence of #rsv infections. Thanks to advances in science, technology and #structuralbiology, we could be on the cusp of finding new solutions for this pervasive disease. Find out more: gsk.to/3KcStf0
This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
#news for #investors and #media: @NEJM has just published pivotal data for our #rsv older adult vaccine candidate. Read more: gsk.to/3YQQy3H
-
GSK US reposted
ViiV Healthcare US
@ViiVUS
Our #risktoreasons community grants are the largest philanthropic investment dedicated to HIV prevention and care for Black women in the US. We’re fueling new messages, new messengers and new methods to increase awareness and action.
-
GSK US
@GSKUS
During Black History Month, we want to recognize outstanding colleagues like DeWayne Lanier.
Read more about how his move from the football field to the pharmaceutical field means tackling barriers to health equity: gsk.to/3lEVwlK -
GSK US reposted
ViiV Healthcare
@ViiVHC
#news for #investors and #media - We're excited to present new data at this year's CROI conference.
More here: viivhealthcare.com
#croi2023 -
GSK US
@GSKUS
“I’m optimistic that HIV clinical trials will have a lot more diversity both in front of the lab coat and behind the lab coat.” – Tori Cooper
We’re committed to ensuring the communities most impacted by #hiv are included in clinical trials.This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Go #behindthescience and learn how the support and guidance of remarkable teachers led Karen to love small molecule research, and find exactly where she belongs: in the labs of #medicinalchemistry with a thriving team. 🧪🔬
#womeninscience #womeninstem #idwgis23 -
GSK US
@GSKUS
The latest #vaccinetrack #data from Jan-Sept 2022 shows that 39 states had claim reductions for CDC recommended adult #vaccinations (excl. flu) compared to 2019 pre-pandemic levels. This amounts to 5 more states than in the beginning of 2022. Learn more at vaccinetrack.com
-
GSK US
@GSKUS
Updated #vaccinetrack #data: Average monthly claims from Q1-Q3 2022 for CDC-recommended adult vaccines show improvements compared to ‘21 but remain below ‘19 levels.
More focus is needed to ensure adults receive recommended vaccines. Learn more at vaccinetrack.com. -
GSK US reposted
GSK
@GSK
The combination of three prominent respiratory viruses this winter – Covid, flu, and RSV – continues to raise the risk for older and at-risk adults. But what can we all do to reduce the impact? #behindthescience gsk.to/3DMnsdZ
-
GSK US
@GSKUS
Clinical trials commonly enrol participants based on census data. Our experience shows us there’s a better way to improve diversity in clinical trials, given that some diseases disproportionately impact specific patient groups.
Learn more: gsk.to/3HXQs4T -
GSK US
@GSKUS
Today is #worldcancerday!
We stand with the @uicc in their mission to create a future without #cancer and to #closethecaregap.
Learn more about our commitment to the #oncology community: gsk.to/3RuD0Zc -
GSK US
@GSKUS
We released our 2022 full year results today. Our CEO, Emma Walmsley, joined @MegTirrell on @SquawkCNBC earlier to share some highlights.
-
GSK US reposted
GSK
@GSK
News for #investors and #media
We’ve announced a strong set of full year results for 2022. Swipe through for the highlights and see more on our website. $GSK -
GSK US reposted
GSK
@GSK
News for #investors and #media
Watch our CEO, Emma Walmsley, as she discusses our strong performance in 2022.
For more, see gsk.com
$GSK #news -
GSK US
@GSKUS
The 12-week GSK Innovation Challenge at Florida International University is on! We’ve asked @StartUPFIU students to address the low rate of immunizations in the Black and Hispanic community.
This effort is part of our #hbcu #hsi commitment to get ahead of disease together.
StartUP FIU
@startupfiu
ICYMI: @GSK and @startupfiu kick off the GSK Innovation Challenge! This 12-week program brings together @FIU undergrads from a variety of majors to better understand vaccine #health disparities in #underserved communities and develop #creative ways to address these challenges.
-
GSK US
@GSKUS
MAPS is a new vaccine technology with the potential to deliver breakthrough innovation – and the beauty of it is its simplicity.
#behindthescience
www.gsk.com/en-gb/behind-the-science-magazine/maps-techno… -
GSK US reposted
GSK careers
@GSK_careers
Our Onyx team is rethinking and reshaping the role data plays in research and are laying the foundation for scientific breakthroughs that help people all over the world. It’s data with a point.
Are you ready to make a difference? gsk.to/3GPEkB8 #aheadtogether #gskonyx -
GSK US reposted
ViiV Healthcare
@ViiVHC
To see her interview with @SciAm on ending the HIV epidemic, watch the full #18minuteswith now: www.youtube.com/watch?v=7QhX7TeHv_M
-
GSK US reposted
GSK
@GSK
Researchers are testing innovative new ways to protect people against infectious disease – and pursuing effective vaccines to fight bacteria and viruses that have eluded them for decades. #behindthescience
gsk.to/3WobUDY -
GSK US
@GSKUS
Carving out careers in STEM provide challenges for young women trying to enter the field. To mark National #mentoringmonth, we salute all the GSK mentors working to make a difference! Our thanks to all who are driving change. gsk.to/3keNX4D
-
GSK US
@GSKUS
In 2019, a scientific breakthrough about the connection between kidneys and blood oxygen levels won the @NobelPrize in Physiology or Medicine. Scientists then considered how this science could be harnessed in #anemia of chronic kidney disease. Learn more gsk.to/3QOh2QE
-
GSK US
@GSKUS
For some, #flu can be more than just a temporary inconvenience, it can be serious, even for healthy people & spreads easily. #vaccination is the best way to keep your family safe this flu season. It’s not too late! Talk to your doctor or pharmacist & visit fluisafamilyaffair.com
-
GSK US
@GSKUS
Shout out to our colleagues who spent #mlk Day giving back to the community. From @Habitat_org to @bookharvestnc, they are honoring Dr. King’s legacy and dream of an equitable community.
-
GSK US
@GSKUS
If you’re a mom, parent, or consider yourself the “Chief Health Officer” of your family – you care about their health, and the flu may bring challenges to an already busy schedule. Talk to your doctor or pharmacist about getting vaccinated and learn more: fluisafamilyaffair.com
-
GSK US
@GSKUS
We believe #innovation starts when we stop to listen. #aheadtogether #jpm2023 #jpm23
-
GSK US
@GSKUS
We believe #innovation drives disease prevention #aheadtogether #jpm2023 #jpm23
Learn how breakthroughs in vaccine innovation are helping to protect more lives: gsk.to/3CyUttm -
GSK US
@GSKUS
We unite science, technology and talent to get ahead of disease together. #aheadtogether #innovation #jpm2023
Go Behind the Science with us: gsk.to/3vUSLPn -
GSK US
@GSKUS
We believe #innovation drives disease prevention #aheadtogether #jpm2023 #jpm23
Learn how breakthroughs in vaccine innovation are helping to protect more lives: gsk.to/3ZrHcMU -
GSK US
@GSKUS
Excited to see our leaders together in action talking innovation at the @JPMorgan conference. Learn more about our innovation: gsk.to/3VZFdMY
#jpm2023 #aheadtogether #gskproud #jpmhc23 -
GSK US
@GSKUS
We believe #innovation drives disease prevention #aheadtogether #jpm2023 #jpm23
Learn how breakthroughs in vaccine innovation are helping to protect more lives: gsk.to/3Xmef34 -
GSK US
@GSKUS
#investors and #media: Hear Emma Walmsley, our CEO, talk live today at #jpm2023 about our exciting year ahead, at 1030 EST / 0730 PT / 1530 GMT. Her presentation will be followed by a Q&A.
Tune in here: gsk.to/3jXSBEb -
GSK US
@GSKUS
That’s a wrap at the @STATnews panel at #jpm2023! Thanks to @rickberke, @UrnovFyodor for joining John Lepore onstage for a great discussion about genomic research and drug discovery. #jpmhc23 #aheadtogether
-
GSK US
@GSKUS
We unite science, technology and talent to get ahead of disease together.
#innovation #aheadtogether #jpm2023 #jpm23 -
GSK US
@GSKUS
We’re combining the power of genetic and genomic insights with the speed and scale of AI and ML to help us predict more about human health, and develop better medicines for the future.
Go Behind the Science with us: gsk.to/3GvLxGr
#jpm2023 #jpm23 -
GSK US
@GSKUS
We believe the bigger the challenge, the bigger the need for collaboration. #innovation #jpm2023 #jpm23 #aheadtogether
View full video here: gsk.to/3Gq0Ujv -
GSK US
@GSKUS
We’re sponsoring tonight’s #jpm2023 @STATnews panel with our own John Lepore and Fyodor Urnov from @UCBerkeley and Laboratory for Genomics Research. #statatjpm marketing.statnews.com/stat-at-jpm-2023?linkId=1000001763…
-
GSK US
@GSKUS
#investors and #media can listen to Emma Walmsley, our CEO, speaking live at #jpm2023 at 1030 EST / 0730 PT / 1530 GMT tomorrow, followed by a Q&A. Tune in here: gsk.to/3Zfd5Ix
-
GSK US
@GSKUS
Join us at the ‘STAT@JPM: What’s Next For Biotech?’ event to hear Dr. John Lepore, Head of Research, GSK, and Fyodor Urnov, Professor of Molecular and Cell Biology @UCBerkeley, discuss the power of partnerships for science innovation. #jpm2023 #statatjpm
gsk.to/3GHaqAf -
GSK US reposted
GSK
@GSK
The combination of #flu, #covid19 and #rsv has become known as the #tripledemic. What are the things we can all do to reduce the impact? Find out: gsk.to/3Zb0tlW
-
GSK US reposted
GSK careers
@GSK_careers
Innovation is key to us getting ahead of disease together. That’s why we’re building a team of outstanding people who want to take ownership of their work and achieve ambitious goals.
Sound like you? See our available opportunities: gsk.to/3YITBM3
#aheadtogether -
GSK US reposted
GSK
@GSK
It’s been a long fight against #hiv – but we, and @ViiVHC, will not stop now.
Go #behindthescience with us #aheadtogether www.gsk.com/en-gb/behind-the-science-magazine/the-40-year… -
GSK US reposted
GSK
@GSK
How can we help avoid #amr becoming the next pandemic? Find out when you go #behindthescience www.gsk.com/en-gb/behind-the-science-magazine/antibiotic-…
-
GSK US
@GSKUS
GSK is proud of the US Charitable investments we made in 2022 to support communities where we live and work.
-
GSK US reposted
Stephen J. Ubl
@steveubl
It is a pleasure to announce Kate Hashey of @GSKUS as this week’s #workingforcures Champion. Her experience as an R&D scientist helped launch “Vaccine Track,” a searchable database where the public and policymakers can explore vaccination rate disparities. www.youtube.com/watch?v=AW0j0oAppr0&list=PLJMiwuC-KnulaV1…
-
GSK US
@GSKUS
Dominic, Bioprocess Development Engineer, uses his know how to find ways to make the manufacturing process of new medicines cost-effective for customers.
Hear his story 👇
#aheadtogether -
GSK US
@GSKUS
Our CSO, Tony Wood, joined @BioCentury Editor in Chief @FishburnSimone for a discussion on our approach to R&D, including our focus on areas like #infectiousddiseases.
Register for free access: gsk.to/3FVGlg0
#pharma #oncology #researchanddevelopment #thebiocenturyshow -
GSK US
@GSKUS
Nature has always been a passion for Fiona, as a research scientist at GSK, she believes that by helping nature, we can improve the development of our medicines and vaccines and have a positive impact on human health.
Hear her story 👇 #aheadtogether #cop15 -
GSK US reposted
GSK
@GSK
#news for #investors and #media: Today we announced a new collaboration with @WaveLifeSci to drive discovery and development of oligonucleotide therapeutics leveraging our expertise in genetics and genomics
-
GSK US
@GSKUS
Frameworks to understand business impacts on nature are still forming and evolving, but action to protect and conserve nature can’t wait.
We’re sharing these 5 tips to help others get started.
#cop15 #fornature 🌱🌍 -
GSK US
@GSKUS
Protecting human health and getting ahead of disease takes action on nature and biodiversity, as well as climate. We have set clear and measurable targets to help meet our aim to have a net positive impact on nature by 2030 across our entire value chain.
#cop15 #fornature 🌱🌍 -
GSK US
@GSKUS
#news for #investors and #media: Today at #ash22, we shared notable data from our #myelofibrosis research programme. Learn more.
-
GSK US reposted
GSK
@GSK
Exciting things are happening at #ash22! 🤳
Learn how we’re getting #aheadtogether to improve the lives of blood cancer patients at our selfie station and hear from Rebecca Russell, Global Congress Director, Oncology, for more on the sponsored #ashrunwalk. -
GSK US reposted
GSK
@GSK
P.J. has been raising awareness around HIV issues within the Black Queer Community since he was in college. Following his own HIV diagnosis, he’s continued to inspire his community in his role as Senior External Affairs Manager at @ViiVHC.
Hear his story 👇 #worldaidsdayThis media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
#gonorrhea is the second most common sexually transmitted bacterial infection and a high priority pathogen for @WHO due to growing resistance to antibiotics. That’s why we are researching new solutions.
-
GSK US reposted
GSK
@GSK
In 2011, GSK launched Trust in Science in Latin America. The public-private partnership model focuses on peer-to-peer scientific collaboration. Earlier this week, the first licensing agreement was signed out of this public-private partnership model. @CONICETDialoga @FilmusDaniel
-
GSK US
@GSKUS
Find out what #mentoring, #chemistry, and discovering medicines mean when you collaborate with "Team Ann."
Go #behindthescience for our #womeninscience series: gsk.to/3F5Jbx4
#womeninstem #medicinalchemistry -
GSK US
@GSKUS
For Andy, a life-changing diagnosis led to a complete shift in career. Now, as Workplace Adjustments Service Director at GSK, he helps support employees needing workplace adaptions to carry out their day-to-day work reach their full potential.
Hear his story 👇
#idpwd 💜This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
To celebrate the #internationaldayofpersonswithdisabilities, we’re proud to be talking about our partnership with @Valuable500 to drive action for disability inclusion.
Learn more from Caroline Casey, CEO of Valuable 500 and GSK's Sally Jackson 👇
#idpwd 💜 -
GSK US
@GSKUS
#news for #investors and #media: Today we announced positive topline results evaluating our medicine plus standard of care chemotherapy in patients with primary advanced or recurrent #endometrialcancer.
Click to learn more -
GSK US reposted
ViiV Healthcare US
@ViiVUS
We’ve spearheaded the launch of a new business coalition to accelerate progress to #endhiv with @adahealth, @AvitaPharmacy, @meetBLK, @ChispaApp, @CVSHealth, @GileadSciences, @healthvana, @NGLCC, @orasure, The Powell Companies Real, @Tinder, @Uber, @Walgreens and @Walmart. #wad
-
GSK US reposted
ViiV Healthcare
@ViiVHC
This #worldaidsday, we're spotlighting the beautiful and strong individuals living with HIV who shared their inspiring story with us 👇
Through each photo, we were able to challenge stigma and public perceptions of #hiv.
We are ViiV Healthcare, and we are here until HIV isn't.This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Today is #worldaidsday2022
This day is an opportunity for people across the globe to challenge #hiv stigma and discrimination, to show support for people living with HIV and remember those who have died from AIDS-related illnesses worldwide.
#rocktheribbon -
GSK US
@GSKUS
With a 50+ year legacy in #respiratorycare,we are committed to helping patients #breathebetter by redefining the #copd treatment paradigm and shaking the #copdstigma.
-
GSK US
@GSKUS
New global survey highlights the need for people living with lupus and their healthcare providers to prioritise discussions around organ damage prevention.
Learn more: gsk.to/3ONLQQw -
GSK US
@GSKUS
Congratulations to our #gskimpactus winners @CORAFoodPantry @rowPCR @GOTRPhilly. Thank you for feeding neighbors & building healthier communities in #philly & #trianglenc. Learn more: gsk.to/3GUWDq6
-
GSK US
@GSKUS
Organ damage impacts many people living with #lupus within 5 years of diagnosis.
A new global survey of healthcare professionals suggests conversations with patients about #sle organ damage risk may not be happening early enough in course of disease.
gsk.to/3gGTIH8 -
GSK US
@GSKUS
We are proud to support the #gskimpactus winners in #philly who are providing services that provide a foundation for good health and wellbeing for families @Rock2Future @MitzvahCircle @seniorlawcenter #seniorlawcenter. Learn more: gsk.to/3APwy7Y
-
GSK US
@GSKUS
Congratulations to the #gskimpactus winners in the #trianglenc who are providing services that provide a foundation for good health and wellbeing for families @VolCaregiving @lgbtqdurham, @SwingPals, White Oak Foundation. Learn more: gsk.to/3ijQn0Q
-
GSK US
@GSKUS
Thank you to the #gskmpactus winners that provide housing and essentials for individuals and families in #philly & #trianglenc @DCLTNC, @rtofthetriangle @Philly_VIP #wearerebuilders. Learn more here: gsk.to/3Ouzixd
-
GSK US
@GSKUS
We are proud to support our #gskimpactus winners for empowering people in #philly & #trianglenc through employment and life skills support.
@welcomingcenter @hand2paw_philly #hand2paw @StepUpMinistry @communityef -
GSK US
@GSKUS
Congratulations to our #gskimpactus winners Student U and Beyond Literacy, for supporting high-quality, equitable education in #trianglenc & #philly. Meet the other winners and learn more about the GSK IMPACT Awards here: gsk.to/3AlkT0M #belit
-
GSK US
@GSKUS
Thank you to our #gskimpactus winner @AVPPhila from #philly, who provide support and counselling for victims and their families. Meet the other winners and learn more about the GSK IMPACT Awards here: gsk.to/3EF0E0l
-
GSK US
@GSKUS
#vaccinetrack #data from Jan-June 2022 shows that 34 states had claims reductions for CDC recommended #vaccination (excluding flu) for adults 19+ vs. 2019 pre-pandemic levels; however, nationally, average claims are still below 2019 levels - 3% lower than 1st half of 2019.
-
GSK US
@GSKUS
Huge congratulations to today’s #gskimpactus winners 👏
Learn more about our winners and how you can support them: gsk.to/3X7i5hq -
GSK US
@GSKUS
Today we are proud to be honoring local nonprofits in #philly and #trianglenc with $50k IMPACT Awards. Join us on YouTube at 11am ET today as we announce our 20 winners! Watch the event here: 👇
gsk.to/3TEWb1V -
GSK US reposted
GSK
@GSK
Access is core to our ambition to positively impact more than 2.5 billion lives. That’s why we’re delighted to be top of the @ATMIndex again in 2022.
📺CEO Emma Walmsley and President of Global Health and CEO of @ViiVHC Deborah Waterhouse discuss the news: youtu.be/FvP0RfK4zCU -
GSK US
@GSKUS
New insights from #vaccinetrack, the first publicly available database for adult #vaccination #data across the US, showed average monthly claims through June 2022 for CDC recommended vaccines (excl. flu) improved vs. 2020 and 2021.
Visit vaccinetrack.com for more. -
GSK US
@GSKUS
Court Horncastle, VP and Business Unit Head, recently participated at the @RE_Pharma Reuters Pharma & Patient USA 2022 event where he discussed GSK’s commitment to helping patients with #copd and #asthma breathe better. Click to learn more about his panel experience.
-
GSK US
@GSKUS
In honor of #nationalfamilycaregiversmonth, read as care partner Jim offers advice on different ways care partners can support their loved ones throughout their experience with ovarian cancer. gsk.to/3tyf38s
-
GSK US
@GSKUS
Jess has spent most of her career talking to respiratory healthcare workers, describing herself as a patient advocate. She’s joined GSK’s Electric Vehicle programme believing it will benefit both the environment and the respiratory patients she advocates for.
Hear her story 👇This media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
Our congratulations to Dr. Tania Small for receiving this year’s Women of Color in Pharma Trailblazer Award! As a tireless advocate and ally, Tania provides a voice and opens doors for those who are underrepresented at work, in clinical trials and in the community.
-
GSK US
@GSKUS
Today at #hlth2022, Mike Montello, SVP of R&D Digital and Tech, explores new tech’s mapping of “inner space” to understand #biology and the patient — and fuel #drugdiscovery like never before.
If you’re at @HLTHEVENT, head to Seaport Stage at 3:50 PM.
#aheadtogether -
GSK US
@GSKUS
We’re thrilled to announce this year’s #gskimpactus Awards will be online at 11am ET next Wednesday, November 16th! 🎉 Join us to learn about the 20 nonprofits making #philly and #trianglenc healthier as well as how you can get involved! RSVP here: gsk.to/3UvRau0
-
GSK US
@GSKUS
Ann knew she was interested in #chemistry, but what could it be as a career, and what path could she take to get there?
Learn how an early #mentoring experience led her to become a "drug hunter" and how a unicorn keeps her inspired.
#womeninstem #behindthescience -
GSK US
@GSKUS
More than 27 million people in the US are living with #copd. However, due to the #copdstigma, many COPD patients feel hesitant to seek the medical care they need. Click to learn more about how COPD impacts patients.
#shakethecopdstigma -
GSK US
@GSKUS
We salute our servicemen and women like Lenore Vollmar, who made history in Iraq as a member of the US Army.
Our thanks to all of you on this Veterans Day.
Read more about Lenore’s story here: gsk.to/3AuSiWX -
GSK US
@GSKUS
What an action-packed week at @COP27P. We announced updates on how we are collaborating with our peers and supply chain to drive action on emission reductions and our work to help vulnerable communities get ahead of the health impacts of #climatechange. gsk.to/3DZgKAy
-
GSK US
@GSKUS
#lupus can cause devastating complications. Earlier treatment — and closer collaboration between specialists — may hold the key to optimising lupus or lupus nephritis patient outcomes. Read more in our sponsored article with @NatureCustom gsk.to/3NSOR1z
-
GSK US
@GSKUS
Air pollution is causing and exacerbating respiratory diseases.
Today we’ve joined the @wef #allianceforcleanair, a coalition of global companies putting clean air at the heart of #climateaction. #cop27
Learn more: gsk.to/3huQeHH -
GSK US
@GSKUS
We’re working to help vulnerable communities get ahead of the health impacts of climate change and joining the @UN's #racetoresilience campaign. Together with partners we’re aiming to support the health resilience of 15 million people by 2030. gsk.to/3NTk84l #cop27
-
GSK US reposted
GSK careers
@GSK_careers
At GSK, we bring outstanding people together to do work that matters in an inclusive environment.
Could that be you? If you want to make a difference then check out our opportunities gsk.to/3EfwBMK.
#aheadtogether -
GSK US
@GSKUS
Catch GSK Vice President & Business Unit Head, Court Horncastle, speaking at the @Reuters Pharma & Patient USA 2022 event.
Click to learn more about the event. #patientusa -
GSK US
@GSKUS
We’re at #cop27 🌎 sharing how we’re collaborating with our peers and supply chain to drive action on carbon and helping vulnerable communities get ahead of the health impacts of a changing environment.
Hear more from Emma.
#togetherforimplementation #justandambitious -
GSK US
@GSKUS
#news for #media and #investors: The @US_FDA has now approved a new presentation of GSK’s rotavirus vaccine. Learn more: gsk.to/3zSaeuf
-
GSK US
@GSKUS
We’ll be at @ASNKidney to share our latest research in #anemia of chronic kidney disease (CKD). We’re committed to new discoveries for the millions of patients impacted by anemia of CKD. Learn more: gsk.to/3hcpwUc #kidneywk
-
GSK US reposted
GSK
@GSK
At GSK, we know #antimicrobialresistance is not a future problem, it’s a problem now. That’s why we are committed to uniting science, technology and talent to get ahead of #amr together.
-
GSK US
@GSKUS
Climate change and nature loss are creating new health threats and changing the spread and burden of disease. This is putting already stretched health systems under pressure and reinforcing health inequalities.
That’s why we’ll be at #cop27 next week.
#justandambitious -
GSK US reposted
GSK
@GSK
News for #investors and #media
We’ve announced a strong set of Q3 results. Swipe through for the highlights and see more on our website. -
GSK US
@GSKUS
#news for #media and #investors: The @US_FDA has accepted the new drug application for our #rsv vaccine candidate.
Learn more: gsk.to/3Uf57fh -
GSK US reposted
GSK
@GSK
News for #investors and #media
Watch our CEO, Emma Walmsley, as she discusses our strong performance in Q3.
For more, see gsk.com
$GSK #news -
GSK US
@GSKUS
We are kicking off #copdawarenessmonth by asking what aspects of a #copd diagnosis everyone wants to know more about.
-
GSK US
@GSKUS
Today is the first day of #nationalfamilycaregiversmonth! Join us in honoring and recognizing #oncology care partners for all they do for their loved ones throughout the cancer experience, and access tips for family care partners here: gsk.to/3DqSjeY
-
GSK US
@GSKUS
We’re excited to be joining the #miamiwsf today to discuss why tackling gender inequality is so important for economic development.
International Economic Forum of the Americas
@AmericasForum
Why is tackling #genderinequality critical for economic growth? Join us on Oct. 31 at the #miamiwsf as we discuss economic development & #women in #business with @SiemensUS_CEO @SiemensUSA, @GSKUS, @mdcpresident @MDCollege & @RetaJoLewis @EximBankUS! 📝👉 events.forum-americas.org/WORLDSTRATEGICFORUM2022-MIAMI.
-
GSK US reposted
GSK
@GSK
Honoured to be ranked as a Top Employer on @ScienceMagazine annual list.
#aheadtogether #gskproud #sciencetopemployer
Science Careers
@ScienceCareers
The results are in: the 2022 #sctopemployer survey gathered the voices of over 6,000 scientists in #biotech & #pharma to uncover what they value in #industry employers. Click to find out! www.science.org/content/article/2022-s-top-employers-prov…
-
GSK US
@GSKUS
It’s not flu or COVID - Respiratory Syncytial Virus, or #rsv, is a contagious virus that can easily be spread on contaminated surfaces, by cough or sneeze. If you’re over 65, you are at higher risk of severe disease from RSV. Talk to your doctor to learn more. #rsvawarenessmonth
-
GSK US reposted
ViiV Healthcare US
@ViiVUS
That’s a wrap for #idweek2022! After an outstanding meeting, we’re excited to translate our learnings into action as we drive progress to address the evolving needs of people living with #hiv. #wewontstop
-
GSK US reposted
CSIS
@CSIS
NEW: The CSIS AI Council, co-chaired by @JulieSweet and @BradSmi, aims to chart a path forward for corporate responsibility, international collaboration, and effective governance on AI.
Learn more: www.csis.org/news/csis-launches-ai-council -
GSK US
@GSKUS
We stand together with over 330 companies calling for mandatory assessment and disclosure on nature to be included in the #cop15 biodiversity framework. Learn more: gsk.to/3N7mE6I
#makeitmandatory -
GSK US
@GSKUS
#icymi: Watch Judy Stewart, Head of #vaccines @GSKUS & Dr. Kelly Moore, Head of @ImmunizeOrg on @PostLive as they discuss learnings from #covid19 and using #data & insights to address declining adult #vaccination rates.
#postlive #publichealthThis media couldn't be displayed. See it on the original post. -
GSK US
@GSKUS
#gskchemistry #medicinalchemistry is proud to join @SACNAS, National Diversity in #stem Conference on Oct. 27-29 in San Juan, Puerto Rico.
#sacnas2022 is the largest multidisciplinary & multicultural #stemdiversity event in the US.
Details: gsk.to/3srPG7M #2022ndistem -
GSK US
@GSKUS
Our Chief Digital and Technology Officer will be live on stage tomorrow at @EconomistEvents Innovation@Work 2022 sharing how agile working can help keep the lights on in times of crisis. Find out more and register here: events.economistenterprise.com/business-innovation-summit/ #econinnov
-
GSK US
@GSKUS
How do animals interact with the environment? If flowers bloom early, what does this mean for hummingbirds? Be a Biologist and find out! 🌿
Kids can learn at home using downloadable resources. Find out more 👉gsk.to/3coOFZB
#scienceinthesummer @TheFranklin -
GSK US
@GSKUS
#vaccine Track uncovered adult #vaccination data trends that can help identify opportunities to work together to improve adult #immunization and prevent disease and death in adult and older adult populations.
Learn about the platform built in partnership with @IQVIA_global -
GSK US
@GSKUS
Catch-up adult #immunizations are more important than ever for preserving #publichealth. Vaccine Track is GSK’s new platform, in partnership with @IQVIA_global, aimed at enhancing public health efforts around improving adult immunization across the US.
-
GSK US
@GSKUS
#news: Announcing Vaccine Track, the first-of-its-kind, public data trend platform for understanding adult vaccination trends in the US.
Learn more about how, in partnership with @IQVIA_global, we're empowering #publichealth communities with actionable information. -
GSK US
@GSKUS
When GSK advocate Soleil @moonfrye recently learned her daughter, 16, may not have received #meningitisb vaccination, she started a conversation with her pediatrician. Now, she helps empower other parents to do the same. Read Soleil's story at ask2bsure.com. #ask2bsure
-
GSK US
@GSKUS
We’re proud of SOWN Supportive Older Women’s Network! 👩🏼🤝👩🏽 They provide innovative solutions so adults 50+ lead independent, healthy lives & age in their homes & communities. Congrats on your 2020 #gskimpact Award!
Meet our winners:
🏆 gsk.to/3fpFfKA
@PhilaFound -
GSK US
@GSKUS
Today, we are celebrating our 2020 #philly #gskimpact Award winners! Each of these 🔟 #nonprofit organizations received $40,000 for working hand-in-hand with our community to improve health.
Meet our winners:
🏆gsk.to/2IRNsek
@NavyYardPhila @PhilaFound -
GSK US
@GSKUS
We’ll be back for more! On Thursday, we’ll announce our #philly area #gskimpact Award winners!
Learn about the awards and the transformational programs that make our communities healthier:
🏆 gsk.to/36Mx9rk
@NavyYardPhila @philafound -
GSK US
@GSKUS
2020 marks the 90th anniversary of our iconic brand: @TUMSOfficial. Production began in #stlouis, MO in 1930 & has continued at the same factory. 🎉Cheers to the community & our team that supports America’s beloved heartburn solution! 🔵
#tbt -
GSK US
@GSKUS
Missed our CSO and President, R&D, Hal Barron @BIOConvention last week with @JohnCendpts and @endpts? Click to hear him and other top R&D exces talk about R&D leadership during the #covid19 pandemic 👇 💊 #innovation #biodigital
-
GSK US
@GSKUS
Our free #scienceinthesummer program invites children to play the role of biologist, zoologist, geneticist, chemist and discover the importance of all kinds of science. Stay tuned for announcements about our 34th season & learn about the program 👇 #gsksis
-
GSK US
@GSKUS
We celebrated the hard work, passion, compassion & ❤️ these 10 #nonprofit organizations put into our #philadelphia communities! Congrats to our #philly #gskimpact winners!
More about our program: gsk.to/2KvT3Vs
@philanthropyPHL @PhilaFound -
GSK US
@GSKUS
We’re celebrating with @girlsinc_panj at our #gskimpact Awards! 💪They make an impact on thousands of girls by inspiring them to be strong, smart, & bold in order to lead healthy lives & succeed academically.
Meet our winners gsk.to/2KvT3Vs
#wednesdaywisdom @PhilaFound -
GSK US
@GSKUS
Congratulations @codedbykids on your 2019 #gskimpact Award! 💻They teach young people to succeed as tech & innovation leaders through projects & mentorship creating career opportunities.
Meet our winners gsk.to/2KvT3Vs
#wednesdaywisdom @PhilaFound #stem -
GSK US
@GSKUS
We’re celebrating @bartramsgarden & their 2019 #gskimpact Award! They work closely w/ Southwest #philadelphia neighbors, offer a range of free programs about nature, healthy living, & science.
The winners 🌼gsk.to/2KvT3Vs
#wednesdaywisdom @PhilaFound -
GSK US
@GSKUS
Congratulations to our 2019 #philly-area #gskimpact Award winners! Today, we’re honoring these 10 amazing #nonprofit organizations that work every day to make our communities healthier.
Meet the winners 🏆 gsk.to/2KvT3Vs
#wednesdaywisdom @PhilaFound -
GSK US
@GSKUS
Meet our #lupus ambassadors! 3xOlympic medalist @ShannonBoxx7 + our Dr.Tania #wesponsorshannon #lupusawarenessmonth gsk.to/2pxPNgO
-
GSK US
@GSKUS
Moncef @ #fortunehealth: What insurance is right for pandemics? "If we were buying car insurance, we wouldn't do it during the accident."
Jamey Edwards
@jameyedwards
"Vaccines are insurance. We need to anticipate instead of being reactive."
Dr. Moncef Slaoui & @mtosterholm @bstormhealth #fortunehealth -
GSK US
@GSKUS
Why are we at @NASAKennedy? @ISS_CASIS offers most innovative lab EVER for exploring meds in space #iss #nasa cards.twitter.com/cards/qfdc6p/1ux8g
-
GSK US
@GSKUS
Happy #thanksgiving! Our friends @AquafreshUS shared this photo back in 2012. #stilltrue #tbt
-
GSK US
@GSKUS
Smokers in #timessquare share reasons 2 quit + get free @nicorette + @NicoDermCQ #whatsyourwhy us.gsk.com/en-us/behind-the-science/?tag=More+than+medicine
-
GSK US
@GSKUS
Thanks to @RepHolding for visiting GSK and supporting #innovation for NC and the US. ow.ly/i/3DTgv

































































































































































































































































































































































































































































































































































































































